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Failure of Primary Total Knee Arthroplasty: Establishing a Baseline for Retrieval
Analysis Using Well-Functioning Necropsy Specimens
Abstract
Introduction
Introduction. Total knee arthroplasty (TKA) is an effective treatment for end-stage osteoarthritis of the
knee. While many patients have positive functional and pain outcomes following primary TKA, a subset of
patients have suboptimal outcomes, such as unexplained pain or aseptic loosening of the implant
components necessitating revision of the index procedure. The understanding of the exact etiology of
these suboptimal outcomes of primary TKA is in its infancy. In order to elucidate the etiology of failure in
primary TKAs, a baseline for the factors contributing to arthroplasty failure and dissatisfaction must first
be established. The purpose of this study was to investigate the relationship between soft tissue laxity,
inflammatory cytokine concentrations, tissue metal concentrations, and wear scores of well-functioning
implants retrieved from cadaveric specimens to determine the role of each of these factors in implant
survivorship. It was hypothesized that decreased joint laxity would increase metal concentrations in the
periprosthetic tissue, that cytokines specifically tied to the innate immune system would be elevated in
laxer joints, and, lastly, that elevated inflammatory cytokines in the synovial fluid would be associated with
elevated periprosthetic tissue metal concentrations.
Methodology
Methodology. A total of 33 cadaveric specimens with primary TKA were obtained from two sources, the
Medical Education and Research Institute (Memphis, TN) and RestoreLife USA (Elizabethton, TN), as part
of institution review board approved multi-institutional orthopaedic retrieval program. Prior to testing and
retrieval, fluoroscopically-assisted radiographs were taken to assess if any evidence of radiolucencies
were present and all replacements were determined to be well-fixed per the images. Synovial fluid was
then aspirated from the joint, processed, and stored in a -80˚C freezer. Each specimen was mounted into
a custom knee testing platform and the IE rotation, varus-valgus (VV) deflection, and AP translation was
measured at 0˚, 30˚, 60˚, and 90˚ of flexion. After collection of the laxity data, tissue samples were
collected from the supra- and infra-patellar regions, the medial and lateral gutter, and from the tibia. The
polyethylene inserts were assessed for wear on the condylar, backside, and stabilizing post surfaces,
when applicable, and the femoral condyle was assessed for damage. A bead-based multiplex assay using
the Luminex MAGPIX platform (R&D Systems, Minneapolis, MN) was performed on the synovial aspirates
for simultaneous detection of various inflammatory cytokines including: IL-1β, IL-6, MCP-1, and MIP-3α.
Inductively coupled plasma mass spectrometry (ICP-MS) was performed at Brooks Applied Labs (Bothel,
WA) on the periprosthetic tissue samples for determination of tissue cobalt (Co), chromium (Cr), and
titanium (Ti) concentrations. Finally, statistical analysis was conducted using SigmaPlot (Systat Software,
Chicago, IL) to elucidate whether any correlations existed between the aforementioned factors.
Results
Results. Decreased IE laxity at full extension was inversely correlated with increased Co concentrations in
the periprosthetic tissues (ρ=-0.64, p=0.02) with a sample size (n) of 13 and a 95% confidence interval
(CI) from -0.88 to -0.14. At 90° of flexion, anterior laxity was inversely correlated with Co concentrations
(ρ=-0.66, p=0.03, n=11, 95% CI: -0.90 vi to -0.10). At 60° of flexion, anterior laxity was inversely correlated
with Cr concentrations (ρ=-0.63, p=0.03, n=13, 95% CI: -0.88 to -0.12). Anterior laxity at 90° of flexion was
also inversely correlated with Cr concentrations (ρ=-0.81, p=0.003, n=11, 95% CI: -0.95 to -0.41). Lastly,
posterior laxity at 90° of flexion was inversely correlated with Cr concentrations in the periprosthetic
tissues (ρ=-0.74, p=0.01, n=11, 95% CI: -0.93 to -0.25). At 60° of flexion, IE rotational laxity was inversely
correlated with IL-1β concentrations (ρ=-0.55, p=0.02, n=18, 95% CI: -0.81 to -0.11). At 60° of flexion, VV
laxity was inversely correlated with TNF-α concentrations (ρ=-0.78, p=2x10-4 , n=14, 95% CI -0.93 to
-0.43). Additionally, VV laxity was inversely correlated with IL-1β concentrations (ρ=-0.48, p=0.04, n=18,
95% CI: -0.77 to -0.02) at 60° of flexion. At full extension, VV laxity was inversely correlated with IL-6
concentrations (ρ=-0.46, p=0.04, n=19, 95% CI: -0.76 to -0.01). Anterior laxity was directly correlated with

IL-6 concentrations (ρ=0.53, p=0.02, n=18, 95% CI: 0.08 to 0.80) at 90° of flexion. Additionally, anterior
laxity was directly correlated with MCP-1 concentrations (ρ=0.62, p=0.006, n=18, 95% CI: 0.22 to 0.84) at
90° of flexion. Cr was inversely correlated with IL-6 (ρ=-0.52, p=0.01, n=21, 95% CI: -0.78 to -0.11). Cr was
also inversely correlated with MIP-3α (ρ=-0.46, p=0.04, n=21, 95% CI: -0.74 to -0.04).
Discussion
Discussion. The specimens included in this study consisted of primary TKA implants that were retrieved
at necropsy and were determined to be well-fixed per fluoroscopic analysis. The first objective of this
study was to establish a baseline of different factors that likely contribute to failure of primary total knee
replacements. This study provided semi-quantitative assessment of wear of the condylar surface,
backside surface, and stabilizing post, when applicable, and of damage to the bearing surface of the
femoral components. Joint laxity was measured using a custom knee testing platform that had been
previously studied and utilized in published journal articles and theses. Inflammatory cytokine profiles in
the synovial fluid samples were presented and measureable levels of metal debris was found in the
periprosthetic tissue samples. The second objective of this study was to determine if any significant
relationships arose in correlation analysis of the latter three aforementioned factors. An inverse trend was
observed between joint laxity and tissue metal concentrations, such that decreased laxity induced metal
release from the implant components. A direct trend was observed specifically between increased
anteroposterior laxity and elevated inflammatory cytokines. Lastly, an inverse trend was found between
decreased tissue metal concentrations and increased inflammatory cytokines. The third, and future,
objective of this study is to utilize these measurements and observations for comparison with failed
implants retrieved at time of revision. While some meaningful relationships were observed in this study,
there were several limitations that must be noted. Firstly, this study had a relatively small sample size.
Secondly, the cohort included a wide range of implants including cruciate-retaining, posterior-stabilized,
fixed bearing, mobile bearing, monoblock, and modular designs fabricated from different materials
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ABSTRACT
Introduction. Total knee arthroplasty (TKA) is an effective treatment for end-stage
osteoarthritis of the knee. While many patients have positive functional and pain
outcomes following primary TKA, a subset of patients have suboptimal outcomes, such
as unexplained pain or aseptic loosening of the implant components necessitating
revision of the index procedure. The understanding of the exact etiology of these
suboptimal outcomes of primary TKA is in its infancy. In order to elucidate the etiology
of failure in primary TKAs, a baseline for the factors contributing to arthroplasty failure
and dissatisfaction must first be established. The purpose of this study was to investigate
the relationship between soft tissue laxity, inflammatory cytokine concentrations, tissue
metal concentrations, and wear scores of well-functioning implants retrieved from
cadaveric specimens to determine the role of each of these factors in implant
survivorship. It was hypothesized that decreased joint laxity would increase metal
concentrations in the periprosthetic tissue, that cytokines specifically tied to the innate
immune system would be elevated in laxer joints, and, lastly, that elevated inflammatory
cytokines in the synovial fluid would be associated with elevated periprosthetic tissue
metal concentrations.
Methodology. A total of 33 cadaveric specimens with primary TKA were obtained from
two sources, the Medical Education and Research Institute (Memphis, TN) and
RestoreLife USA (Elizabethton, TN), as part of institution review board approved multiinstitutional orthopaedic retrieval program. Prior to testing and retrieval,
fluoroscopically-assisted radiographs were taken to assess if any evidence of
radiolucencies were present and all replacements were determined to be well-fixed per
the images. Synovial fluid was then aspirated from the joint, processed, and stored in a 80˚C freezer. Each specimen was mounted into a custom knee testing platform and the IE
rotation, varus-valgus (VV) deflection, and AP translation was measured at 0˚, 30˚, 60˚,
and 90˚ of flexion. After collection of the laxity data, tissue samples were collected from
the supra- and infra-patellar regions, the medial and lateral gutter, and from the tibia. The
polyethylene inserts were assessed for wear on the condylar, backside, and stabilizing
post surfaces, when applicable, and the femoral condyle was assessed for damage. A
bead-based multiplex assay using the Luminex MAGPIX platform (R&D Systems,
Minneapolis, MN) was performed on the synovial aspirates for simultaneous detection of
various inflammatory cytokines including: IL-1, IL-6, MCP-1, and MIP-3. Inductively
coupled plasma mass spectrometry (ICP-MS) was performed at Brooks Applied Labs
(Bothel, WA) on the periprosthetic tissue samples for determination of tissue cobalt (Co),
chromium (Cr), and titanium (Ti) concentrations. Finally, statistical analysis was
conducted using SigmaPlot (Systat Software, Chicago, IL) to elucidate whether any
correlations existed between the aforementioned factors.
Results. Decreased IE laxity at full extension was inversely correlated with increased Co
concentrations in the periprosthetic tissues (=-0.64, p=0.02) with a sample size (n) of 13
and a 95% confidence interval (CI) from -0.88 to -0.14. At 90 of flexion, anterior laxity
was inversely correlated with Co concentrations (=-0.66, p=0.03, n=11, 95% CI: -0.90
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to -0.10). At 60 of flexion, anterior laxity was inversely correlated with Cr
concentrations (=-0.63, p=0.03, n=13, 95% CI: -0.88 to -0.12). Anterior laxity at 90 of
flexion was also inversely correlated with Cr concentrations (=-0.81, p=0.003, n=11,
95% CI: -0.95 to -0.41). Lastly, posterior laxity at 90 of flexion was inversely correlated
with Cr concentrations in the periprosthetic tissues (=-0.74, p=0.01, n=11, 95% CI: 0.93 to -0.25). At 60 of flexion, IE rotational laxity was inversely correlated with IL-1
concentrations (=-0.55, p=0.02, n=18, 95% CI: -0.81 to -0.11). At 60 of flexion, VV
laxity was inversely correlated with TNF- concentrations (=-0.78, p=2x10-4 , n=14,
95% CI -0.93 to -0.43). Additionally, VV laxity was inversely correlated with IL-1
concentrations (=-0.48, p=0.04, n=18, 95% CI: -0.77 to -0.02) at 60 of flexion. At full
extension, VV laxity was inversely correlated with IL-6 concentrations (=-0.46, p=0.04,
n=19, 95% CI: -0.76 to -0.01). Anterior laxity was directly correlated with IL-6
concentrations (=0.53, p=0.02, n=18, 95% CI: 0.08 to 0.80) at 90 of flexion.
Additionally, anterior laxity was directly correlated with MCP-1 concentrations (=0.62,
p=0.006, n=18, 95% CI: 0.22 to 0.84) at 90 of flexion. Cr was inversely correlated with
IL-6 (=-0.52, p=0.01, n=21, 95% CI: -0.78 to -0.11). Cr was also inversely correlated
with MIP-3 (=-0.46, p=0.04, n=21, 95% CI: -0.74 to -0.04).
Discussion. The specimens included in this study consisted of primary TKA implants
that were retrieved at necropsy and were determined to be well-fixed per fluoroscopic
analysis. The first objective of this study was to establish a baseline of different factors
that likely contribute to failure of primary total knee replacements. This study provided
semi-quantitative assessment of wear of the condylar surface, backside surface, and
stabilizing post, when applicable, and of damage to the bearing surface of the femoral
components. Joint laxity was measured using a custom knee testing platform that had
been previously studied and utilized in published journal articles and theses.
Inflammatory cytokine profiles in the synovial fluid samples were presented and
measureable levels of metal debris was found in the periprosthetic tissue samples. The
second objective of this study was to determine if any significant relationships arose in
correlation analysis of the latter three aforementioned factors. An inverse trend was
observed between joint laxity and tissue metal concentrations, such that decreased laxity
induced metal release from the implant components. A direct trend was observed
specifically between increased anteroposterior laxity and elevated inflammatory
cytokines. Lastly, an inverse trend was found between decreased tissue metal
concentrations and increased inflammatory cytokines. The third, and future, objective of
this study is to utilize these measurements and observations for comparison with failed
implants retrieved at time of revision. While some meaningful relationships were
observed in this study, there were several limitations that must be noted. Firstly, this
study had a relatively small sample size. Secondly, the cohort included a wide range of
implants including cruciate-retaining, posterior-stabilized, fixed bearing, mobile bearing,
monoblock, and modular designs fabricated from different materials.
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CHAPTER 1.

INTRODUCTION

Premise
Total joint replacements (TJR) are an effective treatment for end-stage
osteoarthritis and are among the most commonly performed operations in the United
States, with approximately 1 million procedures per year (1). An estimated 332,000 total
hip arthroplasties (THA) and 719,000 total knee arthroplasties (TKA) occurred in 2010
alone, with 10-15% of these operations being revision procedures (1). The number of
primary TKAs is projected to grow 673% to 3.48 million procedures by the year 2030
whereas the number of revision TKAs is projected to grow by 601% between the years
2005 and 2030, from 38,300 to 268,200 annual procedures (2). Increasing incidence of
primary TKAs is likely due to increasing longevity of the population, decreasing age at
arthroplasty, and excellent pain and functional outcomes associated with these
procedures.
A number of patients, however, have suboptimal outcomes as indicated by
increasing number of revisions or from patient reported outcome measures. Only 85% of
patients reported satisfaction following primary TKA (3). Up to 20% of patients report
long-term pain after TKA, which is dramatically more than that which is reported
following THA (4-6). Common causes of failure include: aseptic component loosening,
infection, ligament/flexion instability, periprosthetic fracture, arthrofibrosis,
patellofemoral maltracking, abnormal joint line problems, and metal hypersensitivity (7).
Oftentimes, failure of an index procedure is multifactorial; Mulhall et al. (8) analyzed the
etiologies of failure in 318 knee replacements and found that 64.4% had more than one
identifiable cause. Clinically, revision arthroplasty is a complex procedure associated
with higher complication rates, extended hospitalization, unsatisfactory functional
outcomes, and relatively shorter implant survival compared to primary procedures (7). In
order to elucidate the etiology of failure in primary TKAs, a baseline for the factors
contributing to arthroplasty failure and dissatisfaction must first be established. The
purpose of this study was to investigate the relationship between soft tissue laxity,
inflammatory cytokine concentrations, tissue metal concentrations, and wear scores of
well-functioning implants retrieved from cadaveric specimens to determine the role of
each of these factors in implant survivorship.
Functional Anatomy and Kinematics of the Natural Knee
The knee is one of the largest and most complex joints in the body. It is composed
of three compartments with different articulations: the patellofemoral joint and the medial
and lateral tibiofemoral joint. The patellofemoral joint is the articulation between the
patella and the femoral trochlear groove. The patella is covered with articular cartilage
and articulates with the trochlear groove of the femur. The primary function of the patella
is to increase the lever arm of the extensor mechanism around the knee, improving the
efficiency of quadriceps contraction (9). The knee extensor mechanism is a complex
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structure formed by the quadriceps femoris muscle group, quadriceps femoris tendon,
patella, patellar tendon, retinaculum, and surrounding soft tissue structures that help
stabilize the patellofemoral joint and the knee. The quadriceps femoris tendon connects
the rectus femoris, vastus lateralis, vastus medialis, and vastus intermedius, which make
up the quadriceps femoris, to the patella. Continuous with the quadriceps femoris tendon
is the patellar ligament that connects from the patella to the tibial tuberosity. The
quadriceps femoris tendon and patellar ligament transmit tensile forces generated by the
quadriceps to the tibia. The patella is stabilized in the middle of the knee by the medial
and lateral retinaculum. Patellofemoral stability is maintained by a combination of the
articular surface geometry and soft-tissue restraints.
The tibiofemoral joint functions to transmit body weight from the femur to the
tibia. On the distal end of the femur are two rounded condyles that project posteriorly
beyond the shaft, forming a J-shaped curve that guides movement of the joint. The
femoral and tibial condyles are covered with articular cartilage which protects the bone
and enables easy articulation at the joint. The menisci, two C-shaped layers of
fibrocartilage, are located between the articulating surfaces and act as shock absorbers
that cushion the joint. All remaining surfaces of the knee are in capsular attachment and
are covered by the synovial membrane that secretes the synovial fluid which is
responsible for cartilage nutrition, the removal of metabolites from the joint, joint
lubrication, and the provision of immune cells that are involved in the removal of foreign
materials and organisms from the joint (10). Stability of the tibiofemoral joint is
dependent upon many static and dynamic elements. The primary static stabilizers are the
ligaments of the knee: the anterior cruciate ligament (ACL), posterior cruciate ligament
(PCL), medial collateral ligament (MCL), and lateral collateral ligament (LCL). All of
these structures, shown in Figure 1-1, work in concert to provide stability and painless
function in a healthy knee joint.
Knee motion is much more complex than simple flexion and extension about a
fixed transverse axis like a simple hinge; instead, knee motion during normal gait occurs
in three separate planes and is referred to as “triaxial motion”(9). Flexion of the knee,
which occurs about a constantly changing center of rotation, is a function of the articular
geometry of the knee and the ligamentous restraints (9). Freeman et al. (11) described
sagittal plane condylar geometry as a sequence of arcs with different radii that interact
with a flat medial and convex lateral tibial plateau. In a study of in vivo knee kinematics
using fluoroscopic video surveillance with three-dimensional computed tomography (CT)
scans, Dennis et al. (12) described this flexion axis as varying in a helical fashion in a
normal knee. When plotted, the path of this changing center of rotation describes a J
shaped curve that mirrors the sagittal curvature of the femoral condyles.
Flexion is achieved by a complex coupled mechanism in which the femoral
condyles simultaneously glide and roll back on the tibial plateaus about multiple
simultaneous axes, known as “posterior rollback”. In an in vivo fluoroscopic analysis of
normal human gait, Komistek et al. (13) found that posterior rollback was substantially
greater at the lateral femorotibial articulation than medially, thereby creating a medial
pivot type of axial rotational pattern in which the tibia internally rotates relative to the
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Figure 1-1. Anatomical stabilizing structures of knee joint
Reprinted with permission. National Institute of Arthritis and Musculoskeletal and Skin
Diseases. Medial view of the knee showing anatomical features. May 2001. Accessed 18
August 2017.
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femur as flexion increases. At full extension, the femur is internally rotated with respect
to the tibia and is located anteriorly to the mid-point of the tibial plateau. As the knee
flexes, the lateral condyle of the femur consistently translates posteriorly on the lateral
tibial plateau with increasing flexion (12, 13). On the other hand, the medial condyle has
a less consistent motion pattern that includes posterior translation and anterior slide
during knee flexion, which leads to a reduced overall posterior translation of the medial
condyle on the tibial plateau. Because the medial tibial plateau articular surface is longer
than the lateral tibial plateau surface, extension is achieved by 5 external rotation of the
tibia in the last 15 of extension in the “screw home” mechanism, which results in the
tightening of both cruciate ligaments, locking the knee in place providing maximal
stability with respect to the femur and decreasing the work performed by the quadriceps
femoris while standing. This pattern of medially based pivoting of the knee explains the
observed external rotation of the tibia on the femur during extension, known as the
“screw-home mechanism,” and the internal rotation of the tibia during knee flexion (9).
Grood and Suntay Joint Coordinate System
A thorough understanding of joint kinematics is important in the diagnosis of joint
disorders resulting from injury or disease, in the quantitative assessment of treatment, in
the design of better prosthetic devices, and in the general study of gait (14). However, in
1983, two researchers found that the traditional characterization of motion was not easily
understood by clinicians, whose understanding of such material is pivotal to proper
diagnosis and treatment (14). To bridge the understanding and communication of knee
kinematics between physicians and biomechanical engineers, Grood and Suntay (14)
sought to establish a basis for description and measurement of the six motion components
in the experimental study of knee joint kinematics.
A joint coordinate system (JCS) is a reference system for a particular joint (the
knee) in relation to global coordinate systems of the whole body (the anatomic axes) and
in relation to local coordinate systems of other joints. The relative motion of two body
segments, such as the distal end of the femur and the proximal end of the tibia, can be
defined by a JCS, which is described by two segment-fixed axes and a mutually
orthogonal floating axis. Angular rotation of these bodies is about one or more of these
spatial axes. In developing a JCS for the knee, Grood and Suntay (14) stated that is first
necessary to specify: 1) the Cartesian coordinate system fixed in each bone used to
describe its shape; 2) the body-fixed axes and the reference axes of the JCS used to
describe the relative motion between the two bones; and 3) the location of the translation
reference point. The Grood and Suntay JCS served as convention behind the methods
used to quantify knee kinematics and their relationship to joint laxity in this study.
The z-axis, along the tibial mechanical axis, was selected as the tibial body fixed
axis and was defined as a vector extending from the origin at the center of the medial and
lateral malleoli to the intercondylar eminence between the medial and lateral tibial
condyles. The z-axis is deemed positive upwards from the origin and negative
downwards towards the origin. The tibial y-axis was selected as the reference axis and
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was oriented anteriorly, which was defined as the cross-product of the fixed axis (z-axis)
with a line connecting the approximate center of each plateau. The third and final axis of
the tibial body fixed system, the x-axis, was obtained by the cross-product of the
reference axis (y-axis) and the fixed axis (z-axis), such that the x-axis is positive to the
right and, therefore, oriented laterally in the right knee and medially in the left knee. The
femoral body fixed system was specified to originate from intercondylar notch between
the medial and lateral femoral condyles. The Z-axis, along the femoral mechanical axis,
was defined as a vector extending from this origin at the intercondylar notch to the center
of the femoral head. The femoral Y-axis was selected as the reference axis and was
oriented anteriorly, as defined by the cross product of the femoral body fixed axis (Zaxis) with a line connecting the two points on the posterior surface of the femoral
condyles when the knee was in full extension. Finally, X-axis was selected as the femoral
body fixed axis and was obtained by the cross-product of the reference axis (Y axis) and
the Z-axis. In summary, the JCS of the knee was composed of two body fixed axes: the
tibial z-axis and the femoral X-axis, and one floating axis as defined by the cross-product
of the two body fixed axes that is positive in the anterior direction.
Once the body fixed systems and JCS axes were established, the relative joint
rotations between the bones then could be defined with reference to the JCS, as depicted
in Figure 1-2. Flexion/extension occurred about the femoral body fixed axis, the X-axis.
The angle of flexion was defined as the angle between the floating axis and the femoral
reference axis, the Y-axis. Internal/external rotation occurred about the tibial body fixed
axis, the z-axis. The angle of internal/external rotation was defined as the angle between
the floating axis and the tibial reference axis, the y-axis. Abduction/adduction occurred
about the floating axis. The angle of abduction/adduction or the varus/valgus deflection
angle is the angle formed between the femoral body fixed axis, the X-axis, and the tibial
body fixed axis, the z-axis, minus /2, so that the varus/valgus angle will be set to 0 in
full extension. Regardless whether the knee in question was right or left, flexion was
defined as positive and extension as negative. For the other rotations, the sign
conventions differed between right and left knees because the tibial x-axis was always
designated positive to the right. In a right knee, external rotation and abduction (or varus
deflection) of the tibia with respect to the femur was deemed positive, while internal
rotation and adduction (valgus deflection) was deemed negative. In a left knee, these
conventions were reversed such that external rotation and abduction (varus deflection)
were negative while internal rotation and adduction (valgus deflection) were positive.
Grood and Suntay (14) also described the three translational motions of the joint:
medial/lateral, anterior/posterior, and axial. They defined these three joint translations by
a vector extending between the tibial and femoral origins with vector components defined
within the JCS. The three components of the translational vector were designated by S1,
S2, and S3. Used to determine the medial/lateral translational motion, S1 was defined as
the distance from the femoral origin along the femoral body fixed axis, the X-axis, to the
intersection of the X-axis and the floating axis. S2, which was used to determine the
anterior/posterior translation of the tibia with respect to the femur, was defined as the
distance between the femoral body fixed axis, the X-axis, and the tibial body fixed axis,
the z-axis, along their common perpendicular, the floating axis. Grood and Suntay (14)
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Figure 1-2. Motions of the knee as defined by the Grood and Suntay (1) joint
coordinate system
Reprinted with permission. Amiri S, Wilson DR. A computational modeling approach for
investigating soft tissue balancing in bicruciate retaining knee arthroplasty. Comput Math
Methods Med; 2012.
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designated anterior translation of the tibia with respect to the femur as positive while
posterior translation was negative. Lastly, S3, which determined the axial motion of the
joint (i.e. the vertical motion), was defined as the distance between the tibial origin along
the tibial body fixed axis, the z-axis, to the intersection of the z-axis and the floating axis.
Indications for TKA
In a healthy knee, all of the aforementioned structures facilitate painless function
of the knee joint. However, there are many arthritic conditions that destroy or damage
one or more of the joint structures causing pain, muscle weakness, and reduced function,
prompting many to seek replacement surgery. Osteoarthritis (OA) is a degenerative
disease in which the articular cartilage is worn away. This is caused by a disruption in the
factors—such as inflammatory cytokines and proteases—that regulate the dynamic
equilibrium between the continual, ongoing formation and breakdown of cartilaginous
matrix. When the catabolic influences exceed the anabolic influences, chondrocytes can
no longer compensate for the continuous breakdown of the matrix and gradual
degradation occurs. As the cartilage degrades, bone on bone articulation results in the
formation of osteophytes and narrowing of the joint space causing pain and stiffness.
Post-traumatic arthritis is a form of OA that occurs after a traumatic injury to the knee
joint, such as a fracture or ligament tear. These injuries often result in chronic
inflammation or affect the natural alignment of the knee, gradually damaging the articular
cartilage. Often, those who suffer trauma at a young age are susceptible to developing
arthritis earlier than those who naturally develop OA (15). Rheumatoid arthritis (RA) is a
chronic systemic autoimmune disease of unknown cause that primarily involves joints. In
RA, the immune system attacks the synovial membrane, causing it to become chronically
inflamed and thickened, which can damage the cartilage eventually leading to cartilage
loss. Like OA, RA is believed to be mediated by cytokines and matrix metalloproteinases
(16).
The primary indication for TKA is to relieve pain caused by severe arthritis, with
or without significant deformity. Persons with severe arthritis may report joint pain,
stiffness, and difficulty with mobility; oftentimes to the point that the reduced function
interferes with activities of daily living and compromises the quality of life (17). Other
sources of knee and leg pain must be sought and systematically excluded. Radiographic
findings must correlate with a clear clinical impression of knee arthritis. The
classification for OA described by Kellgren and Lawrence is the most widely used
radiological classification to identify and grade OA. Kellgren and Lawrence defined the
progression of OA in five grades (0, normal, to 4, severe) and combined it with important
radiological changes evident at each stage including: formation of osteophytes on the
joint margins or in ligamentous attachments; narrowing of the joint space associated with
sclerosis of subchondral bone; cystic areas with sclerotic walls situated in the
subchondral bone; and altered shape of bone ends (18, 19). Typically, patients with
Kellgren and Lawrence Grade 3 or 4 OA qualify for TKA. Furthermore, conservative
treatment measures should be exhausted prior to considering surgery. Conservative
measures may include: patient education and lifestyle modification, rehabilitation through
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physical therapy, anti-inflammatory medications, and intraarticular injections (9, 20).
Several studies have found an inverse relationship between severity of OA based on preoperative radiographs and satisfaction following TKA (21-25). More plainly, performing
a TKA on patients with early-grade arthritis may put those patients at a higher risk for
pain and dissatisfaction. As such, these guidelines are essential in ensuring optimal pain
and function outcomes for patients following primary TKA.
While the primary indication for TKA is to relieve pain and restore function in
patients suffering from severe arthritis, deformity can become the principal indication for
arthroplasty in patients with moderate arthritis and variable levels of pain when the
progression of deformity begins to threaten the expected outcome of an anticipated
arthroplasty (9). Flexion contracture, or stiffness upon extension, is a common deformity
encountered in TKA (26). When fully extended, the knee can bear weight without
constant muscle energy expenditure. In patients with a flexion contracture, a large
amount of energy is needed from the quadriceps to help the knee bear load and remain
stable. This causes standing, walking, and stair climbing to be abnormally tiring, reducing
overall knee flexion (27, 28). For contractures of 10 or more, particular techniques,
performed in a specified order, may be necessary to correct the flexion contracture.
However, previous studies have indicated that patients with large flexion contractures
preoperatively, greater than 20, are more likely to experience a flexion contracture
postoperatively (27, 29). Similarly, excessive varus or valgus laxity is a deformity that
poses a risk of compromising the outcome of arthroplasty as its severity progresses. A
varus knee has displacement of the distal tibia toward the midline of the body in the
coronal plane, in which the mechanical axis of the limb lies medially, resulting in a
“bow-legged” appearance. On the other hand, a valgus knee occurs when the distal tibia
rotates away from the midline, in which the mechanical axis of the limb lies laterally,
resulting in a “knock-kneed” appearance. As the severity of the varus or valgus deformity
progresses, a constrained condylar type of prosthesis may be necessary to prevent
subsequent instability in the coronal plane. Complications of varus/valgus constrained
designs have been well documented and result from the large stressed transmitted to the
highly constrained implant (30-32). Intervening before this degree of laxity is reached
allows the use of a prosthesis that lacks coronal plane constraint and has a more favorable
expected survivorship (9).
Implant Design Factors Related to Implant Wear
TKA is a safe and efficacious operation that relieves pain and improves function
(1, 2, 33). Originally, this operation was intended for elderly patients with severe endstage arthritis of the knee. However, more recently, TKA has been extended to younger,
more active patients with higher demands in their lifestyles. Kurtz et al. (34) projected
that by 2030, patients under the age of 65 could account for 55% of the demand for
primary TKA; furthermore, this data suggests that growth in use of TKA occurs in
patients primarily between the ages of 45 to 65. These patients often voice high
expectations prior to surgery with respect to restoration of function and even return to
leisure activities; leisure activities range between low intensity, such as walking or

8

bowling, to high intensity, such as basketball or snow skiing (35). Regardless of the
expectations of elderly or younger patients, the base requirement of a TKA is to restore
basic knee function.
To accomplish this goal, the TKA must replicate normal knee motion
characteristics. Many design variations of the femoral components and tibial inserts have
been proposed to achieve this elusive feat. However, every TKA has a finite lifespan as
demonstrated by the projection that patients below the age of 65 that have received
primary TKA could account for 62% of the demand for revision TKA by 2030 (34). This
lifespan is dependent upon the ability of the implant materials to withstand the physical
demands of the patient. Successful outcomes as well as implant longevity following
primary TKA are believed to be dependent on implant-specific factors including the
design, materials, and the manufacturing or sterilization technique. This section will
provide an overview of the evolution of TKA prostheses to the current designs employed,
the materials utilized, and how each factor may influence wear of the implant.
Evolution of Implant Designs
The first attempt of treating patients affected by knee arthropathies with joint
replacement dates back to the mid-nineteenth century. In 1860, Verneuil proposed
interpositional arthroplasty and attempted to build an artificial knee using the articular
capsule to recreate the joint. In 1880, the German surgeon, Thermistocles Gluck,
imagined the first primitive hinge joints made of ivory. However, despite his proposed
system of joint replacement, the first part of the twentieth century only used
interpositional arthroplasty using autologous tissues or metallic surfaces placed between
the articulating surfaces of the joint. In the 1950s, Walldius developed a hinged
prosthesis that replaced the joint surfaces of the femur and tibia (36). In the mid-to-late
1960s, Gunston developed polycentric knee arthroplasty by adopting the concepts of low
friction replacements proposed by Charnley; additionally, he introduced the first
cemented surface arthroplasty of the knee joint (37).
In the late 1960s, Drs. Freeman and Swanson were the first to approach condylar
total knee design from a predominantly functional perspective (38). In 1970, Drs. Walker,
Insall, Ranawat, and Inglis, at the Hospital for Special Surgery in New York, City,
combined their respective design and surgical experienced to develop the duocondylar
prosthesis. The Duocondylar was an anatomical, symmetric, cemented knee that
preserved both cruciate ligaments (39). The lessons learned from the Duocondylar
prosthesis design led to the development of the second generation of designs to come
from the Hospital for Special Surgery—the anatomically designed duopatellar prosthesis
and the functionally design total condylar prosthesis (40).
Simultaneous with the development of the Insall et al. (40) total condylar
prosthesis was the introduction of the duopatellar prosthesis. This design preserved the
PCL and resembles the shape of a normal knee joint with the sagittal plane contour of the
femoral component being anatomically shaped (39, 41). The early tibial prosthesis model
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was separated into medial and lateral parts, but a model was later developed that
connected the bilateral parts. The patellar component was similar to that used in the Insall
total condylar knee. The duopatellar prosthesis evolved into the kinematic prosthesis,
which was widely used in the 1980s (9).
Influenced largely by the previous Freeman-Swanson design, the Insall et al. (40)
total condylar design sacrificed both cruciate ligaments with sagittal plane stability
maintained by the articular surface geometry. The femoral component, made of a cobaltchromium alloy, had symmetric condyles with a double curve and a flat patellar trochlear
groove. The tibial prosthesis was made of polyethylene, had good conformity in flexion
and extension, had anterior and posterior lips in the tibial joint surface, and had an
eminence in the mid joint surface which provides anteroposterior and mediolateral
stability. The tibial prosthesis also had a stem which allowed it to endure asymmetric
loading. The patellar component was dome shaped and was composed of polyethylene
with a fixation lug in the center which is fixed to the patella with bone cement. This
original cemented total condylar prosthesis set the standard for survivorship of TKA (9).
While the total condylar prosthesis constituted the beginnings of modern TKA,
the design was not without fault. It had a tendency to subluxate posteriorly in flexion if
the flexion gap was larger than the extension gap. Moreover, the lack of femoral rollback
by the implant severely diminished flexion if the PCL was not functioning. To correct
these problems, the Insall-Burnstein PCL-substituting or posterior-stabilized (PS) design
was developed in 1978 (42). A central cam mechanism was added to the articular surface
geometry of the total condylar prosthesis; it interacted with a central post on the tibial
articular surface and effectively reproduced femoral rollback allowing further flexion. In
the Insall-Burnstein design, the post and cam were symmetric in nature (43). The post
was positioned centrally on the tibial insert and the cam was located posteriorly on the
femoral condyles. The Insall-Burnstein design engaged the cam on the post at
approximately 60 of flexion, driving femoral rollback of the condyles on the tibial insert
in a symmetric manner with increasing flexion until edge loading occurred around 120
of flexion. As the first PS design, this cam-post configuration was the basis for all PS
implants to follow. Most current total knee designs are derivatives of the Insall-Burnstein
PS/CR and kinematic designs (9).
Modern TKA Design
Today, many different TKA designs exist to address patient-specific needs. Two
major design types of TKA used today are CR implants, in which the ACL is resected but
the PCL is preserved, and PS implants, in which both of the cruciate ligaments are
sacrificed but the function of the PCL is mimicked by a post and cam design. Although
debated and investigated for many years, the superiority of one design (PS or CR) over
the other remains undetermined. In 2005, a Cochrane systematic review on this topic was
published including eight clinical trials comparing clinical, functional, radiographical,
and quality of life outcome measures in patients who had received PS or CR prostheses;
meta-analysis did not reveal a clear difference between the two treatments. The authors
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found that the inconclusiveness of their initial review prevented them from giving clear
advice on whether to retain and to sacrifice the PCL (44). In 2013, an updated version of
the review was published and expanded to include 17 total randomized controlled trials,
seven of which were included in the initial review. Again, the authors were unable to
discern a difference between clinical, functional, and pain outcomes between the two
implant designs and attributed the inconclusiveness to the variability of the
methodological quality and the quality of reporting found in the trials (45).
When clear clinical evidence prompting resection of the PCL is absent, the
selection of PS versus CR designs in TKA is largely based on the surgeon’s personal
philosophy regarding the matter, surgical training, and experience. Advocates of PCL
retention have cited maintenance of normal knee kinematics, protection of the bonecement interfaces from shear stresses, increased proprioception, and enhanced inherent
stability (46-51). Furthermore, supporters claim that there is greater passive knee range of
motion and enhanced quadriceps muscle power via the PCL-controlled femoral rollback
mechanism (52-54). On the other hand, proponents of PCL substitution argue that
resection of the PCL makes ligament balancing easier and allows for a more conforming
femorotibial articulation, which may reduce polyethylene wear (42, 55). Additionally,
those surgeons state that a more controlled replication of the rollback mechanism can be
created by modifications of the prosthetic design (56). Finally, sacrifice of the PCL is
sometimes necessary to balance knees with severe varus/valgus or flexion contracture
deformities; therefore, PS designs are integral in the treatment of patients with such
deformities.
In studies comparing kinematic patterns of native knees to knees after TKA, the
normal motion was usually not reproduced by the modern TKA designs. During in vivo
fluoroscopic analysis of normal knees, CR TKA knees, and PS TKA knees, Dennis et al.
(12) revealed a number of differences in the observed kinematic patterns. The femur of
the normal knee contacts the tibia anterior to the midpoint in the sagittal plane in full
extension and translates posteriorly during flexion. The femur of the PS TKA knee
contacts the tibia anteriorly, slightly less than the normal knee, and rolls back posteriorly
during flexion similar to the normal knees. The femurs of the CR TKA knees contact the
tibia posteriorly in extension and then translate anteriorly during midflexion; this
phenomenon, termed paradoxical motion, is kinematically opposite of the normal knees
and may be a factor in premature polyethylene wear (12). In a multicenter analysis of
subjects with PS TKA and CR TKA, Dennis et al. (57) reported data remarkably similar
to the previous study, showing a lack of customary posterior femoral rollback in CR
TKA, instead showing paradoxical anterior translation with flexion. Posterior femoral
rollback, less than that in normal knees, was routinely observed in PS TKA knees and
was attributed to engagement of the femoral component cam with the tibial post (57). In
another multicenter analysis, Dennis et al. (58) studied the axial rotation patterns of
patients with normal knees and patients with fixed and mobile bearing PS TKA and CR
TKA. While over 33 implants designs were included, the magnitude of internal rotation
was much less than the normal knees on average (58). Furthermore, they found that all
TKA subgroups had at least 19% of patients displaying reverse axial rotational pattern
during deep knee bend and at least 31% during gait. Whereas the pivot location in a
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normal knee is located medially, the effective pivot location observed by Dennis et al.
(58) was variable, including on the medial side, the center, and the lateral side. Normal
axial rotational patterns are essential for proper patellar tracking, reduction of
patellofemoral shear forces, and maximization of knee flexion (58). Blaha et al. (59)
posited that the anterior/posterior stability of the medial side of the normal knee is not
usually present in a total knee when the knee is flexed. He proposed that a TKA designed
to have a stable medial side combined with a lateral side that accommodates rotation of
the tibia around the medial side through interaction of a spherical-shaped femoral
component and a medially conforming tibial component may better replicate the
kinematic patterns of a normal knee and confer better stability throughout gait (59).
Although CR or PS implants are generally regarded as a generic “type” of TKA,
there are numerous designs available and each of these designs can vary considerably in
the coronal and sagittal radii of their bearing surfaces and, in the case of PS implants, in
the configuration of their cam-post mechanism. Variations in radii and cam-post
mechanism are likely to impact the kinematic patterns and overall performance of the
implant designs. Traditional TKA designs utilized multiple discreet radii to define the
sagittal plane curvature of the femoral component; this geometry was meant to replicate
the function of the natural knee joint by following the J-curve principle. A large primary
distal radius was used as the principal load bearing surface during low flexion, high
frequency activities, such as standing or gait, to reduce stress on the tibial insert. A
smaller posterior radius of curvature reduced implant conformity and enabled the
necessary knee rotation and rollback to facilitate deep knee flexion (60). In these
traditional multi-radius designs, the distal radius instantaneously shifts to a smaller
posterior radius at a specific flexion angle, typically between 15 and 30. However, this
abrupt reduction in J-curve radii in midflexion caused abrupt changes in the center of
rotation of the femur and abrupt reductions in tibiofemoral conformity, leading to a
decrease in stability at midflexion (61). Using a deep knee bend simulator to assess the
kinematics of multi-radius designs, Clary et al. (61) found that the sudden reduction in
the radii of curvature of the femoral condyle was the underlying cause of the clinically
“paradoxical” anterior femoral translation that is often observed in both PS and CR
knees, although reportedly occurs more frequently in PCL-retaining knees (62, 63).
Anterior motion of the femur on the tibia has the potential to adversely impact outcomes
in several ways; anterior positioning of the femur reduces tibiofemoral range of motion,
whereas relative tibiofemoral sliding increases the potential for insert wear while
reducing quadriceps moment arms and efficiency (63-66) .
While it has long been held that flexion occurs about a constantly changing center
of rotation, which is the basis for multi-radius designs, Hollister et al. (67) proposed
instead that knee motion occurs about a single, fixed flexion/extension axis located in the
posterior condyles. It was postulated that this single, fixed flexion/extension axis may be
approximated by the transepicondylar axis (67). To ensure consistent tension in the
collateral ligaments throughout the functional range of movement and to address the
midflexion instability observed in multi-radius designs, the first “single radius” femoral
component was introduced in 1996 based on this premise (Scorpio; Stryker, Mahwah,
NJ). Somewhat of a misnomer, the term single radius implies that a sudden radius
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transition does not exist, which is not the case. Instead, the transition from distal to
posterior radii occurs earlier in the flexion cycle, typically around 10 of flexion. Using
fluoroscopic evaluation of in vivo kinematics of patients with single radius and multiradius CR implants, Kessler et al. (68) found that the single radius design is more stable
in terms of varus/valgus laxity than the dual radius design in midflexion. When
comparing the multi-radius and single radius PS TKA designs, Mahoney et al. (65) and
Ostermeier et al.(69) found that the single radius design provided a more posterior
flexion/extension axis which lengthened the extensor mechanism arms, decreasing the
quadriceps muscle force while reducing the joint reaction force. In a study of 16 patients
with single radius PS TKA, Shimizu et al. (70) reported that the single radius implants
did not show any paradoxical anterior femoral movement until 70 of flexion. The
femoral component was kinematically stabilized in mid-flexion ranges and posterior
femoral rollback occurred in deeper knee flexion with this design (70).
In addition to varying the sagittal shape of femoral components, the positioning
and shape of the post-cam mechanism varies greatly among PS implant designs affecting
the guided or constrained motion of the femur on the tibia. The post-cam mechanism was
introduced to prevent posterior subluxation of the tibia and to increase posterior femoral
translation in PCL-substituting TKA designs (42). Li et al. (71) evaluated the kinematics
of PS TKA under simulated muscle loads and demonstrated that knee motion after postcam engagement was independent of muscle loads. This finding indicated that the postcam mechanism plays a critical role in knee kinematics. Consequently, it is important to
understand how different variations in positioning or geometry of the post-cam design
will affect knee motion. In a review of post and cam design variations, Mihalko et al. (72)
summarized how the differences in positioning and shape effects the kinematics and wear
of the PS designs. A centrally located post will interact with an anteriorly located cam
sooner during the flexion arc and the cam will move up the post with further degrees of
flexion, decreasing the jump height and increasing risk of posterior dislocation, a rare by
severe complication (72-74). On the other hand, a centrally positioned post will interact
with a more posteriorly positioned cam later in the flexion arc and the cam-post contact
point will remain towards the base of the post even in deep flexion, thereby maximizing
the jump height and minimizing risk of posterior dislocation (72, 74, 75). If the post is
moved or angled posteriorly, a posteriorly situated cam will engage the post sooner in the
flexion arc and will position the femoral condylar contact points more posteriorly as well
(72, 73, 75). Cam and post geometry in the transverse plane also affects tibiofemoral
kinematics. In contemporary PS prostheses, the post-cam design features can typically be
categorized into flat-on-flat or curve-on-curve surfaces (76). A post with a rectangular
cross-section will constrain rotation of the femur on the tibia in the transverse plane to an
extent, affecting the internal/external rotational laxity. The restrictive nature of the
rectangular shape will likely cause edge loading of the cam or even the condylar edges of
the femoral component, thereby potentially increasing polyethylene wear (72, 76). A post
with rounded geometry in the transverse plane may reduce internal/external rotational
constraint decreasing the likelihood of burnishing and edge wear (72-74, 76).
The contemporary TKA tibial component can either be a fixed or mobile bearing
design and the difference between these two designs is dictated by conformity.
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Conformity of an implant is defined as the difference between the corresponding femoral
and tibial curvature in the sagittal or coronal plane (77). Conformity has a direct impact
on the performance of a TKA, particularly with respect to tibiofemoral contact mechanics
and kinematics. However, oftentimes, the implications of conformity on the contact
mechanics and kinematics of the prosthetic components is conflicting. Fixed bearing
TKA with a high conformity bearing surface provides low contact stress but restricts
motion of the tibiofemoral articulation skewing the kinematic patterns and producing
high torque at the bone-implant interface. Conversely, a low conformity fixed bearing
surfaces allows for greater freedom of motion but increases contact stresses in the tibial
insert which increases polyethylene wear (78-80). The kinematic conflict between low
stress articulations and free rotation cannot be solved in a fixed bearing design because
the modular tibial insert is locked within the tibial baseplate. As such, mobile bearing
inserts were introduced with the aim to reduce polyethylene wear and component
loosening (81, 82). The mobile bearing TKA design offers the advantage of allowing
increased implant conformity and contact area without dramatically increasing stresses
transmitted to the tibial insert or fixation interface (83). By increasing sagittal plane
conformity in mobile bearing TKA, in vivo fluoroscopic analyses have demonstrated
improved control of AP translation with reduced paradoxical anterior femoral translation,
particularly during gait (57). In a study of axial rotation in fixed and mobile bearing
knees, Dennis et al. (58) found that the average magnitudes of axial rotation in the two
cohorts were similar; however, the site of rotation differed. Similarly, Komistek et al.
(84) and D’Lima et al. (85) observed that the mobile bearing TKAs typically rotated in
conjunction with the femoral component. Therefore, in TKA designs with a rotating
platform, axial rotation typically occurs on the inferior surface of the tibial insert,
whereas rotation obviously occurs on the superior surface in fixed bearing TKA. This
likely plays a role in reduction of polyethylene wear after mobile bearing TKA because
the shear forces on the superior aspect of the bearing are reduced.
Building upon the aforementioned principles factors, Walker et al. (86)
incorporated various design features of TKA implants in an attempt to achieve normal
knee motion characteristics. Two reference TKA models were included and consisted of
a simple multi-radius condylar replacement in which the PCL is resected with partially
conforming bearing surface and a posterior-stabilized simple multi-radius condylar
design with a partially conforming bearing surface. As with the previous studies, the
simple condylar replacement demonstrated lack of posterior femoral displacement and
external rotation with flexion as well as the occurrence of the paradoxical anterior
translation when a shear force was applied (86). This highlighted the fact that even when
the PCL is absent, this paradoxical motion can still occur. The PS simple condylar design
with partially conforming bearing surface was able to achieve posterior femoral
displacement once the cam and post engaged at the set point of 90 flexion (86).
However, the PS design did demonstrate anterior displacement in the range of 30 to 75
of flexion. Moreover, both “reference” designs displayed average internal femoral
rotation throughout the neutral path motions indicating that the posterior displacement of
the medial side exceeded that of the lateral side, which was contrary to the kinematic
patterns of the natural knees (86).
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The next two design variations Walker et al. (86) investigated were multi-radius
femoral components that were to facilitate posterior femoral rollback through a patellar
groove as opposed to a post and cam mechanism. It must be noted that these two designs
would require resection of the PCL. In implant model S, the central ramp guides the
posterior femoral displacement at flexion angles past 60. Model T utilized the same
femoral component as model S but included a tibial insert that is more dished medially,
which induced a medial pivot that allowed for external rotation of the femur with flexion.
In essence, model T included variations that would potentially allow for posterior femoral
rollback and external rotation of the femur with flexion. The basic symmetric ramp
model, model S, was able to produce posterior femoral displacement with flexion;
however, when an anterior shear force was applied, the design did demonstrate a
paradoxical anterior motion, albeit only 3 mm which was a vast improvement over the
prior two models (86). In model T, the more medially dished tibial insert did facilitate
progressive external rotation of the femur with flexion; however, this design also
demonstrated 3 mm of paradoxical anterior displacement (86).
Finally, to address the observed paradoxical anterior displacement observed in the
four previous designs, Walker et al. (86) applied the single radius principle to models U
and V. In model U, the posterior radius was continued anteriorly to form a profile for
medial and lateral recesses. The tibial surface from model S was altered to include medial
and lateral anterior pads, that corresponded to the recesses of the femoral component
where the larger anterior radius transitioned to the smaller posterior radius. Walker et al.
(86) hypothesized that the femoral-tibial conformity in the sagittal plane would prevent
anterior displacement up to 60 of flexion; at which point, the central patellar groove, or
ramp, can guide posterior femoral rollback. In model V, the single radius principle was
also applied; however, the medial side had a recess which the lateral side did not. Using
the same medial pivot principle as the tibial insert for model T, the tibial insert of model
was less dished laterally and more dished medially with the addition of a medial pad that
corresponded to the medial femoral recess. Walker et al. (86) hypothesized that this
design would not only eliminate the paradoxical anterior femoral displacement, but also
allow for additional rotational freedom in extension. As predicted, the anterior recesses of
the single radius design of model U and V virtually eliminated the paradoxical motion.
However, the provision of both medial and lateral recesses in model U limited the
freedom of internal/external rotation in extension to only a few degrees. By providing
only a medial recess, model V was able to have anterior-posterior stability on the medial
side, coupled with rotational freedom throughout the entire flexion cycle (86).
To date, no TKA design has been developed that perfectly reproduced normal
knee motion. Currently, there are numerous TKA designs on the market. Each of the
designs varies slightly in hopes that it will be able to recapture natural knee kinematics.
The variety of TKA designs currently on the market suggests there is still not a consensus
amongst designers and manufacturers on the effects of geometry on wear and kinematics
(79). However, investigational studies, such as the one discussed above by Walker et al.
(86), brings the orthopedic and engineering community one step closer to achieving that
elusive goal.
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Implant Materials
While there are many variations of knee implants on the market today, a modern
TKA prosthesis typically consists of a femoral component, a tibial component, a tibial
insert, and a patellar component as shown in Figure 1-3. Femoral components on the
distal end of the femur are typically made of cobalt-chromium-molybdenum (CoCrMo)
alloy, but can also be fabricated with ceramic materials, such as alumina or zirconia. The
tibial baseplate on the proximal end of the tibia is made of a metal alloy, either titaniumaluminum-vanadium (TiAlV) or CoCrMo. The metal byproducts released from the
implants are mainly due to combined effects of mechanical wear and corrosion (87). The
prostheses are fixed to the bone using polymethylmethacrylate (PMMA), also called bone
cement. More recent designs forego cement fixation and are press-fit with a porous
coating that is intended to induce biological fixation through osseointegration. The tibial
insert, which sits atop of the tibial baseplate and articulates with the femoral component,
and the patellar button, which is used to resurface the posterior side of the patella, are
composed of ultra-high-molecular-weight polyethylene (UHMWPE). Tibial insert wear
occurs from a combination of rolling, sliding, and rotational motions on the bearing
surface, which may lead to delamination, pitting, and fatigue failure of the tibial insert
surface. Polyethylene wear also has been observed on the undersurface, or backside, of
modular tibial knee inserts (88, 89). Additionally, modes of sterilization, such as gamma
radiation, used when manufacturing the polyethylene inserts have been shown to cause
increased wear by introducing oxidation to the insert when placed in the body, causing
delamination of the component surface as well as subsurface damage (90, 91).
Surgical Factors Related to Implant Wear
An estimated 20 or more surgical steps are completed during arthroplasty, and at
least 5 or more variations of each step exist. Taking these estimations into account, over 3
million different variations in surgical technique can potentially occur in primary TKA.
Successful outcomes following primary TKA and long-term implant durability are
believed to be dependent on the aforementioned implant-specific factors as well as
surgical factors. During the procedure, the surgeon must adhere to the following
principles to ensure optimal outcomes: appropriate sizing of the individual components,
alignment of the components to restore the chosen reference axis, recreation of equally
balanced soft tissues and gaps in flexion and extension, and optimal patellofemoral
tracking. While each of these factors were not specifically assessed in this study, their
role in the etiology of failure were noted in this section.
Proper Alignment of Components to Restore a Reference Axis
Rotational positioning of femoral and tibial components is regarded as a critical
aspect of TKA because malrotation of the components may lead to patellofemoral
problems, flexion instability, excessive wear of UHMWPE insert or post, stiffness, and
abnormal gait patterns (92). Proper alignment is believed to decrease both the mechanical
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Figure 1-3. Total Knee Arthroplasty components
Reprinted with permission. Manner PW. Knee replacement implants. OrthoInfo.©
American Academy of Orthopaedic Surgeons. http://orthoinfo.aaos.org. Accessed 18
August 2017.
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and shear stresses placed on the bearing surfaces, as well as the bone-implant interfaces
(80). Various alignment axes and surgical techniques have been proposed to attain the
goal of proper alignment of TKA components. There are three alignment philosophies
currently suggested for use in TKA: anatomical, mechanical and kinematic alignment
methods. Each of these philosophies use a different reference axis from which the distal
femoral and proximal tibial cuts are based.
The anatomical axis of the lower extremity is defined in relation to the
intramedullary canals of the femur and tibia. On antero-posterior evaluation, the
anatomical and mechanical axes of the tibia coincide exactly, but, in the femur, the two
axes make an angle of 5 to 7 degrees (˚) (93). Originally described by Hungerford and
Krackow (94), anatomic alignment sought to position the femoral and tibial components
in such a way as to recreate the joint line. This optimal alignment, they believed, was 2 to
3˚ varus in relation to the mechanical axis of the lower extremity (94). Per this reference
axis, the proximal tibia was cut at 3˚ varus to the anatomical axis of the tibia and the
distal femur was cut at an angle that was the difference between the anatomic and
mechanical axis of the femur, approximately 8 to 9˚ valgus (94). When combined, the
total alignment was approximately 6˚ valgus that approaches the normal tibiofemoral
angle and provided for a joint line that is parallel to the ground during normal gait (94).
The method of mechanical axis alignment in TKA was first described by John
Insall (95). The mechanical axis of the lower extremity passes from the center of the
femoral head to the center of the talar dome in the ankle (93). Insall et al. (95) posited
that the mechanical axis approximates normal knee alignment and is easily identifiable.
Furthermore, he suggested that the increased forces across the medial joint component in
an anatomically aligned knee lead to medial tibial plateau fixation failure (95). Even
though the joint loading forces between compartments are even during the stance phase
of gait, joint forces will become uneven during the gait phase due to a laterally directed
ground reaction force (96). As such, when using the mechanical axis alignment method,
the surgeon first makes a distal femoral cut at a valgus angle of typically 5 to 7˚ to the
mechanical axis of the femur, generally removing the same amount of bone that is to be
replaced by the femoral component. However, if a PS prosthesis is used, an additional
distal femoral resection of 2 millimeters (mm) can be performed to equal the increase in
the flexion gap that occurs when the PCL is removed (97).
Because the anterior and posterior femoral cuts determine the rotation of the
femoral component and the shape of the flexion gap, surgeons must take care during
resection to maintain correct alignment of the femoral component in the transverse plane
(9). With respect to femoral component alignment, excessive external rotation increases
the flexion gap medially by facilitating tightening of the lateral ligaments by overstuffing the lateral flexion gap and loosening of the medial ligaments in flexion which
can result in flexion instability (98, 99). In other words, increased external rotation of the
femoral component increases internal rotational laxity and constrains external rotational
laxity in flexion. Contrarily, internal rotation of the femoral component can cause lateral
patellar tilt/subluxation, patellofemoral instability resulting in dislocation, pain, and
patellar component failure (100). Many reference points, correlating to different
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anatomical landmarks, have been proposed and are used to determine femoral component
rotation, including: the transepicondylar axis, the anteroposterior axis, the posterior
femoral condyles, and the tibial cut first technique, also known as the “flexion gap
balancing” technique. Regardless of the method used for rotational alignment, the
thickness of the bone resected from the posterior aspect of the femoral condyles should
equal the thickness of the posterior condyles of the femoral component. The surgeon
completes the distal femoral preparation for a CR prosthesis by making anterior and
posterior chamfer cuts for the implant. If a PS design is used instead, the bone is removed
for the intercondylar box to accommodate the housing for the post and cam mechanism.
Studies have demonstrated that malalignment of the tibial component in the
transverse plane is related to chronic pain. More specifically, increased internal rotation
of the tibial component has been correlated with chronic pain (101, 102). Relative
internal rotation of the tibial component effectively increases the Q angle and changes the
force vector on the extensor mechanism. Barrack et al. (102) proposed that the abnormal
stress on the patella due and the surrounding soft tissue may explain the peripatellar pain
reported by patients following TKA. The “traditional” method for tibial component
alignment involves using the tibial tubercle as a landmark and placing the center of the
tibial component at the medial third of the tubercle. However, since the tubercle is rotated
externally relative to the tibial plateau, this method has been shown to create a tendency
for external rotation of the tibial component (103). Additional landmarks that have been
proposed to determine proper tibial component alignment include: the “Akagi” line (104),
the central third of the tibial tubercle (105), the postero-lateral tibial corner (106), and the
anterior tibial contour (107). Once proper tibial component alignment is achieved, the
proximal end of the tibia is cut perpendicular to its mechanical axis with a cutting block
oriented by an intramedullary or extramedullary guide in both the anatomical and
mechanical axes techniques. The amount of posterior slope depends on the implant
system being used and the amount of tibial resection is dependent on which side of the
joint is used for reference, i.e. the more or less arthritic side (9).
Using anatomical landmarks for the rotational alignment of the femoral and tibial
components is a widely accepted method. However, determining the component positions
separately can lead to rotational mismatch between the femoral and tibial components.
Retrieval and biomechanical studies have reported that femoro-tibial rotational
mismatches alter kinematics of the joint causing increased contact stress on the tibial
insert and patellar button leading to accelerated UHMWPE wear as well as femoro-tibial
subluxation and patellofemoral dysfunction (102, 108, 109). To address this disadvantage
of all anatomical landmark techniques, the range-of-motion (ROM) technique was
introduced in which the rotational alignment of the tibial tray is determined through
conformity to the femoral component when the knee is put through a series of full
flexion-extension cycles (110). However a study conducted by Ikeuchi et al. (110) found
that the ROM technique resulted in more internal rotation of the tibial component than
when anatomical landmarks were used.
Historically, the two aforementioned alignment strategies have been used to
replicate the mechanical axis of the lower extremity by positioning of the components.

19

Recently, following the research by Hollister et al. (67), Howell et al. (111) proposed a
technique, deemed the “kinematically aligned” TKA. Kinematic alignment in TKA is
based on the 3 functional kinematic axes about which the knee rotates as described by
Hollister et al. (67). The first axis is a transverse axis, defined by the transepicondylar
axis of the femur, in which the tibia flexes and extends. The second axis is a transverse
axis located anterior, proximal, and parallel to the first transverse axis which depicts the
motion in which the patella flexes and extends in relation to the femur. The third axis, a
longitudinal axis, is perpendicular to the 2 previous axes and dictated the dynamic
movement of internal and external rotation of the tibia in relation to the femur. In
kinematic alignment, the principles for placing the components are as follows: 1) coaligning the transverse axis of the best-fitting femoral component with the primary
transverse axis in the femur about which the tibia flexes and extends; 2) removing
osteophytes to restore ligament length, motion, and stability; and 3) placing the tibial
component so that the longitudinal axis of the tibia is perpendicular to the transverse axis
as described by the transepicondylar axis (112). This method strives to reproduce nearnormal knee function by aligning the articular surfaces of the femoral and tibial
components to the normal or pre-arthritic joint lines of the knee (111, 113). To do this,
the femoral component is placed in a slightly more valgus and internally rotated position,
while the tibial component is placed in a slightly more varus and internally rotated
position, compared with the placement of the implants in a mechanically aligned TKA
(112, 113).
Recreation of Soft Tissue Gaps in Flexion and Extension
Soft tissue balancing, or obtaining proper ligament tension, during TKA is a
paramount step to assuring longevity of the replacement because it is critical to
maintaining the stability of the implant and joint post-operation. The typical surgical
approach to properly balance a knee during TKA involves ensuring an equal gap distance
of the medial and lateral compartments in both extension and flexion restoring the knee to
proper alignment (114, 115). This is accomplished by releasing ligaments on the medial
or lateral side of the knee, depending on which side is tighter. In a varus deformity, the
medial soft tissues are tighter than the lateral side. This deforming is most commonly
found in the OA knee and multiple techniques have been described for its correction. In
both a PS and CR prosthesis, the MCL is typically released to balance tension of the
ligaments and gap distance of the joint. In a valgus deformity, the lateral soft tissues are
tighter than the medial side. This deformity is most common in patients with RA and
inflammatory arthropathies. The three-layer anatomy of the lateral side of the knee joint
makes its soft-tissue balancing more complex than those with varus deformity.
Depending on the extent of the valgus deformity, surgeons may release the LCL, iliotibial
band, popliteus tendon, or the tendon of the lateral head of the gastrocnemius (9).
Instead of ligament release, the pie-crusting technique has been introduced as a
tool to correct varus or valgus deformities with a milder affect than ligament release
(114). During balancing, the contracted side of the soft-tissue sleeve is assessed for tight
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structures and then the surgeon applies multiple stabs with a scalpel blade or large needle
parallel to the joint line to effectively elongate the areas of the soft-tissue sleeve that are
under undue tension. The advantage of pie-crusting, especially on the lateral soft-tissue
sleeve, is that is leaves a supporting tether that prevents a larger gap opening on the
lateral side of knee in flexion. Regardless of the balancing technique used, the surgeon
must be sure to check the tissue and gap balancing in both extension and flexion as laxity
of some structures changes with motion of the joint (9).
Suboptimal soft tissue and gap balancing may be implicated in the etiology of
some of the most common indications for revision—loosening, excessive wear,
instability, and malalignment (116-122). If the soft tissues are not balanced such that the
lateral and medial joint gaps are equal throughout a range of flexion angles, it may lead to
increased loading in one compartment such that the implant will not be able to function
as intended. Excessive ligamentous laxity has been reported to increase anterior-posterior
(AP) translation and internal-external (IE) rotation which leads to force concentrations
that are outside of the intended design parameters of the TKA components and that
exceed the material properties of the tibial insert facilitating increased UHMWPE wear
(78, 123-126). There is a paucity of literature evaluating the relationship between joint
laxity and metallic wear debris production following TKA. As such, optimal ligament
laxity has yet to be clearly defined and is largely subjective, based on the surgeon’s
experience and intraoperative assessment.
Proper Patellofemoral Tracking
In addition to proper alignment of components and tissue balancing, the surgeon
must ensure proper patellofemoral tracking. Patellar maltracking may result from
component malpositioning and limb malalignment, prosthetic design, improper patellar
preparation, or soft-tissue imbalance (127). As previously discussed, patellofemoral
instability may result from internal malrotation of the femoral or tibial components.
However, any alteration in knee kinematics and joint balance that increases the tightness
of the lateral retinacular structures or increases the Q angle of the extensor mechanism to
produce a laterally directed muscle vector may cause patellofemoral instability (9, 127).
If the patella is to be resurfaced, the prosthetic patella should be medialized to
approximate the median eminence of the natural patella. Centralization of the prosthetic
button requires the bony patella to track medially which forces it to function with a
higher Q angle. Surgeons use the “no thumb” test of patellar tracking to determine
adequate patellar stability. The reduced patella is observed within the femoral trochlea
throughout the range of motion before retinacular closure. If the patellar button tracks
congruently with minimal to no pressure applied to the lateral side of the patella,
patellofemoral tracking is adequate and the surgeon can proceed with component
implantation (9). If the patella does not properly track, a lateral retinacular release may be
performed. Additionally, studies have shown that deflating the tourniquet prior to the “no
thumb” test may attenuate the need for lateral release (128-130). As such, it is customary
for surgeons to deflate the tourniquet prior to assessing patellar tracking.
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Biological Responses to Wear Debris
In general, modern materials for joint replacements are well tolerated by the body
as long as they are in bulk form, are mechanically stable, and are not infected. However,
normal usage of the joint following implantation results in the wear of the bulk material
resulting in the production of debris. When wear products are generated, they may exist
in one of two forms: insoluble, particulate debris and soluble, metallic ions. Particulate
wear debris—polymers, ceramics, or metals—range in size from nanometers to
millimeters whereas metal ions exist in soluble forms that may bind to serum proteins,
remain in solution, or disseminate systemically (131). Polyethylene particles range in size
between 0.23 to 1 micrometers (µm), with an approximate mean size of 0.5 µm (131).
Metal particulate debris is generally an order of magnitude smaller with a mean size of
0.05 µm (131). The production of these particles may incite adverse inflammatory
reactions that are carried out by a variety of cells. However, the mechanisms of the
biological response to the wear debris are complex and not well understood.
Innate Immune Response to Wear Debris
Debris from joint replacements, whether polymeric or metallic, stimulates the
ingress of polymorphonuclear leukocytes (neutrophils, basophils, and eosinophils) and
macrophages into the local site (132). Macrophages are believed to dominate the
inflammatory events and recognition of wear particles by macrophages involves
scavenger receptors that act as phagocytic receptors mediating direct non-opsonic
phagocytosis of pathogenic microbes by macrophages (133). Depending on the size of
the particulate debris, interaction with the macrophages may occur in one of three ways.
Small particles, less than 150 nanometers (nm) in size, are ingested by pinocytosis or
endocytosis and do not cause cellular activation. Particles ranging in size from 150 nm to
10 µm are phagocytosed. Larger particles, greater than 10 µm in size cannot be
phagocytosed and instead may interact with cells through pattern recognition receptors
(PRRs), including nucleotide oligomerization domain-like receptors and toll-like
receptors (134-137). PRRs are important in innate immunity as first-line defense for
recognition of microbial patterns called pathogen-associated molecular patterns (133).
In response to stimulation via debris phagocytosis or interaction with PRRs,
macrophages express chemokines, cytokines, proteolytic enzymes (matrix
metalloproteinases, or MMPs), reactive oxygen and nitrogen species, prostaglandin E2
(PGE2), and other substances of inflammation (138). Proinflammatory cytokines such as
tumor necrosis factor (TNF)-, interleukin (IL)-1, and IL-6, among others, sequentially
lead to increased production of RANKL (receptor activator of nuclear factor-B ligand)
(135). The RANK/RANKL/osteoprotegerin (OPG) pathway directly regulates osteoclast
activity and bone resorption. Overactivity of RANK/RANKL system and increased
expression of these inflammatory molecules have been demonstrated in aseptic and septic
loosened THAs, suggesting a role in prosthetic failure (139). Additionally, in adaptive
immune responses, such as delayed type hypersensitivity (DTH), macrophages can
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activate T-cells through antigen presentation, which will be discussed further in the next
section. While the mechanisms of the biological response to wear debris have yet to be
delineated, this chronic inflammatory scenario ultimately leads to upregulation of
pathways leading to bone destruction and downregulation of pathways leading to bone
formation.
Delayed-type Hypersensitivity
The prevalence of metal sensitivity among the general population is
approximately 10 to 15%. Nickel is the most common metal sensitizer, with
approximately 14% of the population demonstrating dermal reactivity, followed by Co
and Cr (140). The prevalence of metal sensitivity among patients with well-functioning
and poor functioning implants has been reported to be approximately 25% and 60%,
respectively, as measured by dermal patch testing (140). Delayed cell-mediated
hypersensitivity may be implicated as a cause of tissue damage and loosening in
instances of low wear. Due to their small size, metal ions can bind to serum proteins
forming a hapten-protein complex (140, 141). The binding of metal ions alters the protein
conformation so that immunogenic neo-epitopes are formed (87). These metal-protein
complexes are considered to be candidate antigens for eliciting DTH responses (140). At
the same time, macrophages can also phagocytose metal haptens, processing them along
the endolysosomal route and finally presenting haptens on class II major
histocompatibility complex (MHC-II) molecules.
It is also postulated that metal ions can also activate T cell receptors directly (87).
Once the T-helper cells are antigen-activated, they secrete a variety of cytokines that
recruit and activate macrophages, monocytes, neutrophils, and other inflammatory cells.
Activated macrophages, because of their increased ability to present MHC-II and secrete
certain cytokines, can trigger the activation of more TDTH cells, which in turn activate
more macrophages; this self-perpetuating response can create extensive tissue damage
(140). The specific T-cell subpopulation, the cellular mechanism of recognition and
activation, and the antigenic metal-protein determinants elicited by these metals remain
incompletely characterized. DTH reactions may cause the tissue damage and loosening
observed in instances of low wear.
Adverse Local Tissue Reactions
Adverse local tissue reaction (ALTR) refers to untoward histological reactions
(often associated with clinical manifestations) that occur when metal implants corrode
(142, 143). Evidence of direct inflammatory cell-induced corrosion of non-modular
femoral components has been previously reported (144-146), although it remains a
controversial topic. When metallic particles are phagocytosed by macrophages and giant
cells, the acidic intramedullary environment of the lysosomes facilitate corrosion of the
CoCrMo particles, producing high intracellular levels of ions, which may cause cell
death. In excess, metallic corrosion products may cause adverse local tissue responses or
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systemic toxicity. Furthermore, it has been demonstrated that metallic debris, in ionic
form, decreases the proliferation of osteoblasts; as such, metal wear by-products may
play a role in the etiology of osteolysis (147-150).
ALTR may present as metallosis, aseptic lymphocytic vasculitis-associated
lesions (ALVAL), pseudotumors, or osteolysis. Metallosis, shown in Figure 1-4, is the
macroscopic staining of the soft tissues and is associated with abnormal wear, such as
micromotion at modular junctions or when the non-metal bearing fails facilitating metalon-metal articulation in TKA or THA (151, 152). ALVAL describes a periprosthetic
inflammatory reaction that is similar to a type IV hypersensitivity response; it is
characterized by soft tissue necrosis, lymphocytic infiltration including perivascular
cuffing, and abnormal joint fluid (142). Pseudotumors are large cystic masses that may be
cystic, solid, or a combination; they are usually, but not always, symptomatic, and
histology tends to show much more extensive lymphocyte infiltration and tissue necrosis
than ALVAL (142, 153). It has been suggested that these abnormal soft-tissue reactions
may be attributed to two etiologies: wear-related cytotoxicity and hypersensitivity (154).
Although ALTRs were originally believed to be associated with metal-on-metal THAs,
clinicians and researchers continue to present case reports and studies in which patients
with metal-on-polyethylene THA or TKA have metallosis (151, 152), pseudotumor
formation (155), elevated tissue metal concentrations (140), and elevated systemic metal
levels (156-158) highlighting the need for further research into the wear of metallic
orthopaedic components.
Systemic Effects and Associated Toxicity of Metallic Debris
Because many of these metal ions are naturally occurring in the human body and
are required for normal physiology, the normal human serum concentrations must first be
established. Cobalt, whose reference value is 0.8 microgram per liter (µg/L) in serum, is
an essential cofactor in vitamin B12 metabolism. Chromium, an essential trace element,
is required for maintenance of proper carbohydrate and lipid metabolism and exists in
valence states ranging from -2 to +6, with hexavalent chromium, Cr6+, and trivalent
chromium, Cr3+, being the most prevalent forms. While Cr3+ is the most prevalent form
found in food and is generally regarded as nontoxic, Cr6+, a strong oxidizing agent, is
classified by WHO as a class 1 human carcinogen (159). Normal serum level of Cr is
approximately 0.15 µg/L.
In recent past, excessive metal wear has been a concern for patients who have
received metal-on-metal hip replacements because of the adverse immune reactions, such
as hypersensitivity, metallosis, and pseudotumor formation, that have been reported (149,
160, 161). As such, certain cutoff values have been established that may be indicative of
excessive wear or ALTR. Serum Co concentrations exceeding 1 µg/L is typically
associated with excessive wear in a poorly functioning prosthesis (131). Serum
concentrations of Cr greater than 0.6 µg/L suggests significant prosthesis wear (162).
Plummer et al. (163) reported average serum Co and Cr concentrations of 11.2 µg/L and
2.2 µg/L in patients with ALTR and trunnionosis at the modular head-neck junction,
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Figure 1-4.
metallosis

Specimen RLU0426161B-L, retrieved in this study, presented with
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whereas McGrory et al. (164) reported average serum Co and Cr concentrations as low as
5.4 µg/L and 0.75 µg/L in a similar cohort of patients. Large doses of Co can produce
adverse clinical manifestations such as polycythemia, hypothyroidism, cardiomyopathy,
and carcinogenesis (142). In excessive levels, chromium can lead to nephropathy,
hypersensitivity, and carcinogenesis (140, 165).
Titanium alloys are commonly used in medical applications due to their
osteoconductive and corrosion resistant properties. Normal human serum level of Ti is
less than 4.1 µg/L. While Ti is not an essential trace metal required for normal
homeostasis like Co and Cr, patients with Ti-base alloy implants have demonstrated
elevated levels in joint pseudocapsules as well as elevated spleen and liver concentrations
(131). Furthermore, titanium particles appear have been demonstrated to be more
inflammatory than Co, Cr, UHMWPE, or alumina particles and induce pro-inflammatory
cytokine production, include IL-6, TNF-α, and monocyte chemotactic protein (MCP) -1
(166), all of which are implicated in mediating osteolysis. The systemic release of
metallic ions is a major concern and requires diligent monitoring, although acute and
forthright toxicity is exceedingly rare.
In a prospective study, Lons et al. (156) sought to quantify metallic ion release
after TKA. In their cohort, average preoperative Co, Cr, and Ti blood levels were 0.22
µg/L, 0.45 µg/L, and 2.94 µg/L. At 1 year following the index procedure, average Co, Cr,
and Ti blood levels increased significantly to 1.41 µg/L, 1.27 µg/L, and 4.08 µg/L,
exceeding the normally occurring reference values. Additionally, a few clinical studies
have reported increased systemic metal ion levels in TKA patients following loosening or
malfunctioning of the implant (156, 167). These studies highlight the ability for clinically
significant metal release in metal-on-polyethylene non-modular primary TKA. As such,
the present study sought to further investigate the release of metallic debris in primary
TKA.
Inflammatory Cytokines as Biomarkers of Inflammation and Osteolysis
Many studies have assessed the prognostic and diagnostic utility of various
inflammatory cytokines as biomarkers in improving evaluation of suboptimal outcomes
following total joint replacement. Prior to selecting which cytokines to test in this study,
previous studies were consulted to establish that each of these cytokines had been
demonstrated to induce an inflammatory or immune response when exposed to wear
debris. The majority of research on potential biomarkers that was found in literature used
patients with THA. Furthermore, the studies that were consulted used synovial-like
interface membrane, surrounding periprosthetic tissue, or serum as their medium for
cytokine analysis. It is difficult to conclude if elevated serum cytokine levels are result of
events at the total joint replacement interface or if other inflammatory processes are
contributing to the cytokine release (168). As such, this study sought to investigate the
concentrations of various inflammatory cytokines present in synovial fluid in wellfunctioning cadaveric primary TKAs.
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Because TNF-α and IL-1 were the first cytokines shown to stimulate bone
resorption in vitro, these inflammatory cytokines have been at the center of the search to
identify a biomarker for damage in total joint replacements. TNF-α has a catabolic effect
on bone, indirectly supporting the survival and differentiation of osteoclasts (169). IL-1β
induces differentiation and proliferation of osteoclasts as well as the production of MMPs
and PGE2 from fibroblasts and synovial cells (170). In vitro studies have also
demonstrated that wear particles generated from TKA implants stimulate macrophages to
produce IL-6, which is believed to have a regulatory role in maintaining the inflammatory
response within the bone-implant interface as well as having an adverse effect on bone
remodeling and mediating the effects of IL-1β and TNF-α during human osteoclast
formation (171, 172). Consistent with these in vitro findings, several clinical studies have
demonstrated increased production of these cytokines in periprosthetic tissues and fluids
of loosened prostheses (166, 173, 174).
Chemokines are an important subset of cytokines that produce chemotactic agents
for the purpose of cell recruitment. The chemokines particular to implant aseptic
loosening pathology include IL-8, MCP-1, and macrophage inflammatory protein (MIP1α). IL-8 has been demonstrated in vitro to be secreted by peri-implant cells such as
macrophages and mesenchymal stem cells when exposed to different types of wear
particles like Ti, CoCr, and polyethylene (175). Nakashima et al. (176) observed MCP-1
and MIP-1𝛼 expression in all tissue samples from failed arthroplasties, establishing their
presence in the inflammatory cascade of arthroplasty failure. Moreover, they were able to
induce expression of MIP-1𝛼 and MCP-1 by macrophages in cell culture after exposure
to different types of wear particles (176). MCP-1 is potently chemotactic for monocytes
but can also recruit macrophages, natural killer cells and T cells. A study by Dasa et al.
(177) revealed elevated MCP-1 concentrations in revision samples of aseptically
loosened TKAs when compared to OA and RA synovial fluid samples, demonstrating its
potential as a biomarker for inflammation and osteolysis. MIP-1𝛼 has a less clear role in
implant debris-induced inflammation. Produced by a variety of peri-implant cell types, it
is believed to likely be a central feature of adaptive immune responses via T-cells and Bcells to implant debris (178).
In addition to these major cytokines and chemokines associated with implant
failure, granulocyte macrophage-colony stimulating factor (GM-CSF) and macrophagecolony stimulating factor (M-CSF) have both been suggested as mediators of the
inflammatory cascade. GM-CSF is a hematopoietic growth factor with a regulatory effect
on the transformation of immature macrophages into multinucleated giant cells that
exhibit phenotypic and functional characteristics of osteoclasts (179). M-CSF is
considered to be an essential mediator of osteoclast formation and release of M-CSF by
activated cells in the peri-implant region is likely to be an important factor osteolysis
(171). Recently, both GM-CSF and M-CSF have been implicated macrophage
polarization. Macrophages exposed to lipopolysaccharide, IFN-γ, or GM-CSF assume a
pro-inflammatory phenotype known as classical macrophage activation or M1
polarization. In contrast, macrophages exposed to IL-4, IL-13, or M-CSF assume an antiinflammatory phenotype known as alternative macrophage activation or M2 polarization
(180). M1 macrophages are effective in antigen presentation and killing of phagocytosed

27

pathogens and also produce inflammatory cytokines and chemokines, whereas M2
macrophages produce anti-inflammatory cytokines and instead participate in tissue
regeneration and angiogenesis by secreting various growth factors and extracellular
matrix precursors (181).
While the aforementioned inflammatory cytokines are involved in the innate
immune response, several cytokines, including IFN-γ and IL-2, mediate the adaptive
immune response via lymphocytes. The type of lymphocytes that dominate the implant
debris-associated responses are T helper cells, which are divided into two subtypes: Th1
cells that are critical in macrophage activation and Th2 cells that are engaged in B cell
activation and humoral immunity. Th1 cells, characterized by production of IFN-γ and
IL-2, have been implicated as mediating metal DTH responses. While it has been difficult
to readily identify these responses in peri-implant tissues by such signature cytokines,
some studies using mRNA detection instead of tissue immunohistochemistry have shown
the increased expression of these Th1 cytokines (182, 183).
Objectives, Hypotheses, and Rationale
As total knee arthroplasty continues to be one of the most commonly performed
orthopaedic procedures performed annually, revision arthroplasties will continue to
increase as well. The understanding of the etiology of aseptic implant loosening is still in
its infancy and implant retrieval studies are of utmost importance to expanding this
understanding. Of the implant retrieval programs in existence, most analyze failed
implants retrieved at time of revision surgery. In choosing to solely analyze wellfunctioning implants retrieved at time of necropsy, the first objective of this study was to
provide a baseline measurement of certain implant, surgical, and biological factors—such
as polyethylene wear scores, femoral component damage scores, soft tissue laxity
profiles, periprosthetic tissue metal concentrations, and inflammatory cytokine
concentration in synovial fluid—that dictate the longevity and success of a TKA. The
second objective was to compare the laxity profiles, periprosthetic tissue metal
concentrations, and synovial fluid cytokine concentrations to determine if a correlation
existed between each factor. Additionally, the tibial insert wear scores and the femoral
component damage scores will be presented but not analyzed for comparison due to their
subjective nature. The final and future objective of this study is to utilize these “baseline
measurements” for comparison against failed implants retrieved at time of revision to
elucidate if any meaningful relationships emerge. To this end, the following hypotheses
were tested:
(a) Elevated tissue metal concentrations will be associated with decreased joint
laxity. In other words, an inverse correlation will exist between periprosthetic
tissue metal concentrations and joint laxity profiles. A more constrained laxity
profile will cause increased contact pressures between the articulating surfaces
facilitating abrasive and adhesive wear via third body particles and the subsequent
release of Co and Cr particles or ions. Additionally, higher loads in the transverse
plane will cause backside wear of the UHMWPE tibial insert against the TiAlV
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alloy or CoCrMo alloy baseplate inducing the release of Ti, Co, or Cr particles or
ions.
(b) Elevated synovial fluid inflammatory cytokine concentrations will be associated
with increased joint laxity. In other words, a positive correlation will exist
between synovial fluid inflammatory cytokine concentrations and joint laxity
profiles. A laxer joint profile has been demonstrated to increase UHMWPE wear
of the tibial insert. Increased UHMWPE debris production will incite an
inflammatory response mediated by the innate immune system. As such,
cytokines specifically tied to the innate immune system will be elevated. It must
be noted that an increase in inflammatory cytokines may also be caused by
metallic debris.
(c) Elevated inflammatory cytokines in the synovial fluid will be associated with
elevated periprosthetic tissue metal concentrations. In other words, a positive
correlation will exist between tissue metal concentrations and inflammatory
cytokine concentrations in the synovial fluid. Increased metal debris production
will incite an inflammatory response that may be innate, adaptive, or a
combination of the two in nature. Regardless of the type of immune response,
macrophages are activated when challenged with wear debris and release
inflammatory cytokines in response. It must be noted that an increase in
inflammatory cytokines may also be caused by UHMWPE debris.

29

CHAPTER 2.

METHODOLOGY

Experimental Overview
The purpose of this study was to determine whether a correlation exists between
laxity, inflammatory cytokines, tissue metal ion content, and wear scoring in wellfunctioning necropsy specimens to establish a baseline role of each of these factors in
implant survivorship. Due to the many facets of this investigation, this section will
provide a brief overview outlining the processes involved in the data collection and
processing. Total knee arthroplasty necropsy specimens were retrieved from Medical
Education and Research Institute (Memphis, TN) and RestoreLife USA (Elizabethton,
TN) with prior institution review board approval.
Dissection and retrieval were performed by a fellowship-trained, board-certified
orthopaedic surgeon, Dr. William Mihalko. All superfluous skin and muscles tissue was
excised from the area surrounding the joint capsule while carefully preserving the
ligaments and other structures that contribute to stability of the joint. The joint center was
identified and transverse cuts were made 180 mm superior and inferior to joint center
along femur and tibia using a sagittal saw (Stryker Corporation, Kalamazoo, MI). The
fibula was also transected 100 mm from the joint center (114, 184-189).
After retrieval, the specimens were labeled and placed in biohazard bags to be
stored in the freezer until further testing. Thirty-six hours prior to testing, the specimens
were removed from the freezer and thawed in a refrigerator. Before testing, fluoroscopy
images (OrthoScan HD Model 1000-0001, OrthoScan, Scottsdale, AZ) were taken to
assess if radiographic signs of osteolysis were present and all replacements were
determined to be well-fixed per the images. Synovial fluid was aspirated from the joint
using a syringe, centrifuged at 1,600 revolutions per minute (rpm) for 20 minutes to
remove cell particulates, aliquoted into 1.5 milliliters (mL) micro-centrifuge tubes, and
stored in a -80˚C freezer.
Following synovial fluid collection, laxity testing was performed on a custom
knee testing platform which has been previously studied and reported in published
journal articles and theses (114, 184-193). Each specimen was mounted into the testing
platform and the IE rotation, varus-valgus (VV) deflection, and AP translation was tested
at 0˚, 30˚, 60˚, and 90˚ of flexion. At each flexion angle, the specimen was subjected to a
1.5 Newton-meter (Nm) IE rotational torque, 10 Nm VV torque, and a 35 Newton (N) AP
directed force, and the corresponding deflection data was recorded using a custom
LabVIEW program (National Instruments, Austin, TX) that had been previously detailed
and validated (184).
After collection of the laxity data, a medial parapatellar incision was made to gain
access to the TKA components. Tissue samples were collected from the supra- and infrapatellar regions, the medial and lateral gutter, and from the tibia as depicted in Figure
2-1. Tissue was placed into collection tubes and stored at -80˚C. The tissue-implant
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Figure 2-1.

Periprosthetic tissue collection locations
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interface was assessed noting any abnormal conditions at time of retrieval. The implant
was then removed from the bone using a chisel and hammer as recommended by ASTM
Standard F561-13 (194), placed into biohazard bags, and shipped to Drexel University
(Philadelphia, PA) for cleaning and wear scoring.
At Drexel University, the implants were cleaned per ASTM Standard F561-13
(194). Polyethylene inserts were analyzed for wear using the protocol proposed by Hood
et al. (195) and the femoral condyle damage was assessed as previously described by
Arnholt et al (196).
A bead-based multiplex assay using the Luminex MAGPIX platform (R&D
Systems, Minneapolis, MN) was performed on the synovial aspirates for simultaneous
detection of human TNF-α, IL-1β, IL-6, IL-8, MCP-1, MIP-1α, MIP-3α, GM-CSF, MCSF, IFN-γ, and IL-2. Inductively coupled plasma mass spectrometry (ICP-MS) was
performed at Brooks Applied Labs (Bothel, WA) on the periprosthetic tissue samples for
determination of tissue metal concentrations. Finally, statistical analysis was conducted
using SigmaPlot (Systat Software, Chicago, IL) to elucidate whether any correlations
existed between the aforementioned factors.
The steps in this protocol were summarized in Figure 2-2 for each cadaveric
TKA specimen. Procedures 2, 4, 5, 7, 8, and 9 will be explained in greater detail in the
following sections.
Fluoroscopic Analysis
Prior to laxity testing and implant retrieval, fluoroscopically-assisted radiographs
of each specimen were taken to assess if radiolucent signs of osteolysis were present.
Since very small degrees of obliquity can obscure radiolucent lines adjacent to
prostheses, fluoroscopy is useful for obtaining radiographs with clear visualization of the
bone-prosthesis interface (197-200). An OrthoScan HD (Model 1000-0001, OrthoScan,
Scottsdale, AZ) was utilized and standard AP and lateral views of each specimen were
taken. Fluoroscopic radiographs of each specimen are included in the Appendix A
(Figures A-1 through A-33). Fixation of the tibial component was examined in the AP
and lateral planes. The beam was centered on the knee and rotation of the knee was set so
that the pegs of the prosthetic component were symmetrical. To best visualize the fixation
of the tibial bone-implant interface, vertical height of the tibial component was
minimized such that the surface appeared two-dimensional, thereby ensuring that the
beam was parallel to the interface. Fixation of the femoral component is examined in the
lateral plane only. When assessing the fixation of the femoral component, the anterior
and posterior bone-implant interfaces as well as the distal interfaces were examined.
Again, the knee was aligned in the lateral plane such that the component was
superimposed creating a two-dimensional view. All specimens were determined to be
well-fixed per the absence of radiolucencies using the previously described and validated
fluoroscopically-assisted radiographic technique (197-200).
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Figure 2-2.

Summary of retrieval analysis process
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Laxity Testing
Laxity testing was performed on a custom knee testing platform, designed and
manufactured in 1991 by Paul McLeod, shown in Figure 2-3. This testing apparatus was
acquired by Dr. John William’s laboratory at the University of Memphis in 2009 where it
was restored to full working condition by 2010 through major efforts from Dr. Williams’
graduate students: John Connor (190), Devin Conner (192), David Knox (191), and Jason
Lindsey (193). Dr. Williams and the aforementioned students replaced bearings,
transducers, and electronics, converted data acquisition platform from the original 1980s
software to modern data acquisition software, and developed new programs for the
kinematic analysis. It was then transferred to Dr. William Mihalko’s laboratory at the
University of Tennessee Health Science Center in April 2013. In 2014, Erik Woodard
used the platform in his thesis, and, building upon Dr. Williams’ students previous work,
Erik further developed the programs that processed the data (184).
One of the functions of the knee testing platform is to measure the laxity or,
conversely, the stiffness of the knee at various flexion angles. For this purpose, the knee
was held at a fixed flexion angle and a pre-determined torque or force was applied at the
tibial end while the resulting rotation or displacement was recorded. Cable connections
on the knee testing machine provided data outputs from five force transducers and five
angle potentiometers. The signals from the transducers and potentiometers travelled to
their specific boards and were amplified before travelling through an analog to digital
converter and an input/output board to a 12-bit data acquisition device which digitized
the signals and displayed them in the custom LabVIEW program. The LabVIEW files
were converted to Excel files and then run through a previously developed Matlab
(Mathworks Inc, Natick, MA) program to extract data of interest and perform
interpolations to identify points of interest in the data from the files (184).
Prior to testing, the femur and tibia were transversely cut approximately 180 mm
from the joint center. The femur and tibia were centered using six pointed screws in metal
pots coated with petroleum jelly and aluminum foil, for ease of removal. Once the femur
and tibia were secured in place in their respective pots, urethane epoxy (Goldenwest
MFG Inc, Cedar Ridge, CA) was poured into the pot and allowed to set for 30 minutes
until completely hardened. The specimens were mounted in the machine with the tibia
secured vertically and the femoral coupling locked in a neutral position as defined by the
tibial position. Neutral rotation was defined as placing the femoral epicondylar axis
perpendicular to the centerline of the machine. Because some specimens demonstrated
flexion contracture, full extension was not always obtained and was instead defined as the
minimum flexion angle of the knee specimen.
Specimens were tested throughout 0˚, 30˚, 60˚, and 90˚ flexion. An applied
upward body weight force of 30 N was placed under the tibia to maintain joint contact
during all tests. Each test was performed 3 times to pre-condition the specimen, and data
was recorded on the fourth iteration. At each flexion angle, a 1.5 Nm IE rotational torque
was applied about the tibial axis while the femur was fixed and the tibia free to rotate
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Figure 2-3.

Custom knee testing platform in Dr. William Mihalko’s lab
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about the joint center in the coronal plane. The deflection in degrees at ± 1.5 Nm IE
torque in the transverse plane referenced from the normal neutral position was recorded
to determine rotational laxity. A 10 Nm VV torque was also applied to each specimen at
the distal end of the tibia, while internal-external rotation was unconstrained. The angular
deflection in degrees at ± 10 Nm of VV torque in the coronal plane referenced from
normal neutral position was recorded to determine the valgus laxity for each test. Lastly,
a device, which attached to the tibia, was used to apply a 35 N AP shear force
perpendicular to the tibial axis. Both coronal motion and axial rotation of the tibia were
unconstrained during this test. The displacement of the tibia relative to the femur at ± 35
N was recorded to determine the AP laxity of each specimen. For all tests, sign
conventions followed the Grood and Suntay coordinate system which specifies anterior
displacement of the tibia in relation to the femur as positive, posterior displacement as
negative, internal rotation as negative, external rotation as positive, varus motion as
negative, and valgus motion as positive (14). While the tibia and femur each have a
separate coordinate system, it is only necessary to define tibial motion in its own
coordinate system since the femur is fixed throughout each test.
Implant Cleaning
The retrieved implants were cleaned using a method designed by Drexel
University in accordance with ASTM Standard F561-13 (194, 196). Upon receipt of the
shipment, implants were removed from biohazard packaging, examined to ensure all
parts were present, and photographed for inventory with implant number visible. Each
component was rinsed in cold water in a biohazard sink to wash away loose tissue. A
1:10 ratio of Discide detergent (AliMed, Dedham, MA) to water solution was prepared in
a mixing cup and implants were placed in the solution for a 20 minutes soak. Implants
were removed from the solution and brushes were then used to carefully remove
remaining tissue from implant ensuring that the implant surface was not damaged or
scratched. Next, the components were placed in a 1:10 ratio of bleach to water solution
for a 20 minutes bath after which brushes were again used to remove loose debris.
Following the bleach bath, the implant components were no longer considered a
biohazard and were placed in a clean mixing cup. For the polyethylene components, the
cleaning process ended at this stage. The metallic femoral and tibial components were
then placed in a clean mixing cup filled with water. The cups were then placed in the
ultrasonicator for 25 minutes. After the time period, the water was drained and refilled
and the cups were replaced in the ultrasonicator for an additional 25 minutes water to
remove any loose debris. The implants were then laid out on Versidry sheets (Thermo
Fisher Scientific Inc, Rochester, NY) overnight to dry within the fume hood. The
components were then packaged into separate bags to avoid scratching and labeled to
await visual inspection for wear and damage scoring.
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Wear Scoring
After the cleaning process, wear was semi-quantitatively assessed by inspecting
the articulating surfaces using a modified method of that proposed by Hood et al in 1983
(195). The superior side of the tibial insert, which articulates with the femoral condyles,
was divided into 8 zones with 4 quadrants on each condyle as shown in Figure 2-4. The
inferior side of the tibial insert, which is in direct contact with the tibial tray and should
be fixed unless it is a mobile bearing design, was divided into 8 zones similar to the
divisions shown in Figure 2-3. For PS implants, the stabilizing post was divided into
anterior, posterior, medial, and lateral zones. Each zone was inspected using a light
microscope with 10x magnification, when necessary, for 7 modes of damage: burnishing,
pitting, delamination, abrasion, embedded debris, scratching, and surface deformation.
Burnishing refers to highly polished areas on the articulating surface whereas pitting
describes irregularly shaped depressions in the articulating surface measuring
approximately 2 to 3 mm across and 1 to 2 mm in depth. Delamination wear is the
removal of large sheets of polyethylene from the surface and abrasion is large areas with
a shredded or tufted appearance often caused by contact with bone or cement. Embedded
debris damage describes areas containing metal or PMMA debris deposited into the
polyethylene surface. Scratching damage consists of areas containing indented lines
generally found in the anteroposterior direction. Lastly, surface deformation refers to any
permanent deformation of the surface of the insert and is typically caused by cold flow or
creep of the polyethylene. Each section was graded for each wear mode and given a score
of 0 to 3 based on the levels of damage present. A score of 0 was used to indicate that the
damage mode was not present on that section of the insert, while 1 denoted damage
covering less than 10% of the section, 2 denoted damage covering 10-50%, and 3
indicated damage was present on over 50% of the section, as summarized in Table 2-1.
Two independent observers inspected each implant and any significant discrepancy
between observers were resolved in a meeting among the investigators. The two total
scores were averaged for a final total score. The condylar scores were then summed to
find the total condylar wear score, with a maximum possible score of 168. The backside
scores were summed to find the total backside wear score, with a maximum possible
score of 168. When applicable, the post wear scores were summed to find the total post
wear score, with a maximum possible score of 84.
Similarly, the bearing surface of the CoCr femoral component was divided into 4
quadrants; zones 1 and 2 denote medial and lateral posterior surfaces whereas zones 3
and 4 denote medial and lateral anterior surfaces, as shown in Figure 2-5. Each section
was assessed for three damage modes: scratching, indentations or lacerations, and pitting.
As summarized in Table 2-2, a score of 1 described damage that covered less than 10%
of the section, a score of 2 indicated damage present over 10-30% of the surface, a score
of 3 meant damage covering 30-50% of the section, and a score of 4 was given when
damage covered more than 50% of the surface. The maximum possible damage score was
a score of 16.
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Figure 2-4. Technique used to divide the bearing and backside surface of tibial
insert into 8 sections for wear scoring

Table 2-1.
Summary of the polyethylene wear score quantification as proposed
by Hood et al.
Score
0
1
2
3

Criteria
Wear mode absent
Wear mode covers less than 10% of regional area
Wear mode covers 10-50% of regional area
Wear mode covers greater than 50% of regional area

Source: Hood RW, Wright TM, Burstein AH. Retrieval analysis of total knee prostheses:
a method and its application to 48 total condylar prostheses. Journal of Biomedical
Materials Research Part A. 1983;17(5):829-42.
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Figure 2-5.

Scoring method for the femoral component.

Note: The femoral component bearing surface was split into posterior (1 and 2) and
anterior (3 and 4) regions for damage scoring

Table 2-2.
Damage
Minimal

Criteria for femoral component damage scoring
Score
1

Mild

2

Moderate

3

Severe

4

Criteria
0 to 1 surface scratches with minimal coverage and
no apparent corrosion
Penetrating scratches on > 10% surface, very faint
scratching with large surface coverage, or small
localized area of corrosion
Penetrating scratches on > 30% surface, faint
scratching with larger surface coverage and < 20%
areas of deeper gouging into the bulk material, or
area of corrosion on the surface > 30%
Penetrating scratches on majority (> 50%) of
surface, or major area of corrosion > 50%
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Cytokine Assay
Synovial aspirates were collected from the necropsy knees with well-fixed
primary total knee replacement after IRB approval. A magnetic bead-based multiplex
assay using the Luminex MAGPIX platform (R&D Systems, Minneapolis, MN) was
performed for simultaneous detection of the following human analytes: TNF-α, IL-1β,
IL-6, IL-8, MCP-1, MIP-1α, MIP-3α, GM-CSF, M-CSF, IFN-γ, and IL-2. Per the
instructions, the standards, calibrator diluent RD6-52, synovial samples, and diluent
RD2-1 were brought to room temperature. The Certificate of Analysis provided with the
kit was followed in order to reconstitute each standard cocktail with RD6-52 diluent. The
reconstituted standards were left under gentle agitation for 15 minutes after which the
standards 1 through 6 were created according to the directions in the booklet. The RD652 diluent was then added to dilute each sample by a factor of 2, using 80 microliters
(µL) of synovial sample and 80 µL if diluent, resulting in 160 µL solution in each
microparticle cocktail. The lights were turned off and the microparticle cocktail was
centrifuged for 30 seconds at 1,000 G. The cocktails were then gently vortexed and then
diluted with RD2-1. The standards and microparticle cocktails were added to their
corresponding wells on the 96-well plate and covered with a foil seal before incubation
for two hours at room temperature on a microplate shaker. During this period, the wash
buffer was created by adding 20 mL wash buffer concentrate to 480 mL deionized water.
After the 2 hours incubation period with the lights still off, a magnet was placed on the
bottom of the microplate and the plate was then shaken over a sunk to remove the liquid.
Each well was filled with 100 µL if wash buffer which was then shaken out. This step
was repeated a total of three times. The biotin antibody cocktail was then centrifuged and
diluted with the RD2-1 diluent. Each well received 50 µL of the diluted biotin cocktail
before the microplate was incubated for 1 hour at 800 rpm under a foil seal. The
streptavidin cocktail was then prepared by mixing 220 µL with 5.35 µL of wash buffer.
After the 1 hour incubation period, the wells were washed with wash buffer three times in
the same manner as discussed previously and then 50 µL of the prepared streptavidin
cocktail was added to each well. The microplate was then incubated for 30 minutes at
room temperature at 800 rpm. After the incubation period, the wells were then washed
three times again as previously described. Finally, 100 µL of wash buffer was added to
each well and incubated for 2 minutes at 800 rpm before the plate was analyzed using the
Luminex MAGPIX platform which reported each cytokine concentration in picograms
per milliliter (pg/mL).
ICP-MS Analysis
ICP-MS is an analytical technique used to measure elemental determinations in a
material. Tissue samples were collected from the medial and lateral gutters, supra- and
infra-patellar regions, and from along the tibia-implant interface. Each of these tissue
samples were digested using a modified method from Kerger et al. (201).
Prior to acid digestion to prepare the samples for analysis, the laboratory equipment
had to be prepared. An acid solution of 5 to 10% trace metal nitric acid was combined with
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18 mega ohm ultrapure water to rinse and soak the sample containers, digest vessel, and
any equipment that may come into direct contact with samples or fluids during the acid
digestion. Minor tools were washed twice and then dried with Kimtech wipes (KimberlyClark Professional, Rosswell, GA) whereas tools that would come in direct contact with
the samples were soaked overnight in the solution and then were dried.
After preparing the laboratory space and equipment, the tissue samples were cut
to 25 milligrams in size using a ceramic knife and plastic tweezers. Care was taken to
ensure the samples did not contact any form of metal. A water bath was set to 95°
Celsius, and centrifuge tubes were labeled to identify the samples. The samples were then
washed with 18 mega-ohm ultrapure water to remove ethanol and were placed in the
correctly labeled tube. The acid solution was created by adding 2 mL of 70% trace metal
grade nitric acid to each tube under a fume hood. Next, 1 mL of hydrogen peroxide was
added to each tube followed by 3 mL of 37% trace metal grade hydrochloric acid, also
under the fume hood. Three samples of only acid solution were also prepared in 3 tubes
with no tissue samples as blank samples. The hydrogen peroxide was allowed to react as
the water bath heated to the correct temperature. Once heated, the tubes were placed in
the water bath for a 2 hours incubation period. After the 2 hours, the tubes were removed
and placed in the fume hood for 30 minutes to cool. After the cooling period, an addition
1 mL of hydrogen peroxide was added to each tube and given 30 minutes to react. The
tubes were then placed back into the water bath for an additional incubation period of 2 to
3 hours.
The samples were then placed into labeled 2 mL micro-centrifuge tubes to be sent
to Brooks Applied Labs (Bothell, WA). Each tube received 1 mL of the sample and acid
mixture and 1 mL of 18 mega-ohm ultrapure water. The remaining sample was diluted to
a 15 mL volume with the 18 mega-ohm ultrapure water. The method for analysis used by
Brooks Applied Labs was validated using the Luts-1 certified reference material from the
National Research Council of Canada. This material is a solid biological matrix that
contains certified quantities of cobalt and chromium.
Once Brooks Applied Labs completed the analysis, the data was first checked to
ensure the blank samples had low levels of metal. Any amount of metal in the blank
sample was considered to be a contamination. If the contaminants were low in value and
consistent between the blanks, they were averaged and the average was subtracted from
the remaining samples. This allows the final data to be represented without the
background noise present due to uncontrollable contamination. The data was then
reported in µg/L.
Statistical Analyses
Before statistical analyses were performed, the data was analyzed for normality.
Using Microsoft Excel (Microsoft, Redmond, WA), a Shapiro-Wilk normality test
revealed that the data sets were not normally distributed. As such, these data sets were
reported as median and interquartile ranges (IQR). A nonparametric Wilcoxon Signed-
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Rank Test for paired samples was performed on the tibial insert wear and femoral
component scores to determine if any significant difference existed between the scores
given by the two observers. Additionally, Mann-Whitney rank sum test was performed to
determine if significant differences in laxity, particularly AP and IE laxity, existed
between PS and CR implants. Because the wear and damage scores were subjective,
ordinal data, no correlation analyses were performed between those data sets and the
objective, nominal data sets of the laxity, cytokine, and tissue metal measurements. Using
SigmaPlot statistical software, the nonparametric Spearman’s rank correlation test was
performed with an assumed significance of =0.05 to determine if significant
correlations existed between the remaining parameters.
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CHAPTER 3.

RESULTS

Clinical and Implant Information
In total, 35 necropsy specimens were retrieved. However, 2 specimens were
excluded from analysis: a unicompartmental implant and a modular revision implant. The
final sample size was 33 well-functioning primary TKA specimens. Full clinical
information was not available for all implants; the average age at autopsy was 76 years
(range: 62 to 94 years of age) and there were 12 males, 22 females, and 1 unknown
gender included in the cohort. The implant lifespan in situ when available was included
in the summary of the implant information presented in Table 3-1. All femoral
components were CoCrMo alloy except for DRLU0104160-R, a Smith & Nephew
(Memphis, TN) Genesis II design with an Oxinium femoral component, and
RLU1018161B, a Zimmer (Warsaw, IN) Miller-Galante II design with a TiAlV femoral
component. With respect to fixation, 28 femoral components were cemented while 5
were uncemented and well-fixed with porous titanium (n=1), small beads (n=3), or fiber
mesh (n=1). The tibial components retrieved in this study included 2 monoblock designs
(RLU0722161B-L—an all-polyethylene design and RLU1121161A-L—a compressionmolded, non-modular monoblock design), 18 TiAlV tibial baseplates, and 14 CoCrMo
tibial baseplates. With respect to tibial component fixation, 29 tibial trays were cemented
while 4 were uncemented and well-fixed with porous titanium (n=1), small beads (n=2),
and fiber mesh (n=1). Of the 33 specimens retrieved, 26 were fixed bearing implant
systems, 5 were mobile bearing implant systems, and, as previously mentioned, 2 were
monoblock implant systems. 15 of the retrieved implants were PS while 18 were CR
designs. The sterilization methods of the retrieved tibial inserts included: gamma air
(n=8), gamma inert (n=19), ethylene oxide (n=3; Smith & Nephew, Memphis, TN), X3
(n=1; Stryker, Kalamazoo, MI), ArCom (n=1; Zimmer Biomet, Warsaw, IN), and
Duracon (n=1; Stryker Howmedica, Kalamazoo, MI). The X3 sterilized insert
(RLU0829162C-R) was the only highly-cross linked UHMWPE tibial insert in the
cohort. All implants had resurfaced patellas with polyethylene patellar buttons except for
specimen DRLU051714-L, a Zimmer Natural Knee implant system (Warsaw, IN).
Implant Wear and Damage Assessment
A nonparametric Wilcoxon Signed-Rank Test for paired samples revealed that
there was no significant difference between the two scorers of the femoral component
damage or polyethylene wear analysis. Thirty-two tibial inserts were available to be
assessed for wear on the condylar, backside, post surface (when applicable) as shown in
Table 3-2, which includes the sterilization technique of each tibial insert. As previously
stated, the maximum condylar wear score that could be given was a score of 168 while
the maximum possible score for each of the 7 damage modes was 24. The median wear
score for the condylar region of the insert was a score of 38 (IQR: 11), with a range of
scores from 27 (RLU0426162B-R, shown in Figure 3-1) to 64 (DRLU081315-R).
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Table 3-1.
Implant information of study cohort including manufacturer, design,
and time in situ (years)
Specimen

Manufacturer

Design

DRLU051714-L

Zimmer

Natural Knee

Time in Situ
> 10

DRLU081315-R

Zimmer

Nexgen Legacy PS (LPS)

20

DRLU030815-R

Zimmer

Nexgen LPS Flex

DRLU121515-R

Zimmer

Nexgen LPS Flex

15
> 10

DRLU010416-R

Smith & Nephew

Genesis II

21

DRLU112815-R

Stryker

Scorpio

11

DRLU101615-R

Stryker

Scorpio Flex CR

22

RLU1016151A-L

Stryker

Scorpio

21

2013-678L

Depuy

Low Contact Stress (LCS) Mobile Bearing

--

RLU0510162A-R

Zimmer

Nexgen LPS Flex

7

RLU0728161A-L

Smith & Nephew

Unknown

27

RLU0309161B-L

Depuy

Anatomic Modular Knee (AMK)

45

RLU0722161B-L

Cintor Division of Codman

Unknown

RLU0126161C-L

Smith & Nephew

Genesis II

40
--

RLU0510161A-L

Zimmer

Nexgen LPS Flex

RLU0426161B-L

Depuy

LCS Mobile Bearing

6
--

RLU0126162C-R

Smith & Nephew

Genesis II

--

RLU0720161B-L

Depuy

Press Fit Condylar (PFC) Sigma

13

RLU1028161B-L

Zimmer

Miller-Galante (MG) II

37

RLU1115162B-R

Zimmer

Nexgen LPS Flex

11

RLU0913162A-R

Zimmer

Insall Burnstein (IB) PS II

RLU0426162B-R

Depuy

LCS Mobile Bearing

45
--

RLU0829162C-R

Stryker

Triathlon CR

< 11

16-04-765R

Biomet

Vanguard

--

16-10-1103R

Depuy

Sigma Mobile Bearing

--

16-10-1103L

Depuy

Sigma Mobile Bearing

--

RLU0204172A-R

Stryker

Triathlon PS

19

RLU0317172B-R

Stryker

Triathlon CR

15

RLU0319171A-L

Stryker Howmedica

Duracon

15

RLU1121161A-L

Biomet

Anatomical Graduated Component (AGC)

27

RLU1121162A-R

Johnson & Johnson

Press Fit Condylar (PFC)

27

RLU1125161A-L

Zimmer

Natural Knee

22

RLU1125162A-R

Zimmer

Natural Knee

21
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Table 3-2.

Summary of total tibial insert wear scores by location

Specimen

Condyle

Backside

Post

DRLU051714-L
DRLU081315-R
DRLU030815-R
DRLU121515-R
DRLU010416-R
DRLU112815-R
DRLU101615-R
RLU1016151A-L
2013-678L
RLU0510162A-R
RLU0728161A-L
RLU0309161B-L
RLU0722161B-L
RLU0126161C-L
RLU0510161A-L
RLU0426161B-L
RLU0126162C-R
RLU0720161B-L
RLU1028161B-L
RLU1115162B-R
RLU0913162A-R
RLU0426162B-R
RLU0829162C-R
16-04-765R
16-10-1103R
16-10-1103L
RLU0204172A-R
RLU0317172B-R
RLU0319171A-L
RLU1121161A-L
RLU1121162A-R
RLU1125161A-L
RLU1125162A-R
Median
IQR

27
64
31
36
47
32
U/A
51
42
42
36
37
42
42
38
42
36
29
57
31
58
31
41
44
30
40
33
43
35
54
54
45
41
41
9

44
34
48
46
U/A
31
16
19
41
57
21
32
U/A
18
52
32
17
23
84
25
56
59
23
13
33
57
16
12
11
U/A
U/A
32
8
32
28

-22
2
7
-5
---12
---6
9
-5
--2
16
--8
9
12
7
---15
--8
7

Sterilization
Method
Gamma Inert
Gamma Inert
Gamma Inert
Gamma Inert
EtO
Gamma Inert
Gamma Inert
Gamma Air
Gamma Inert
Gamma Inert
Gamma Air
Gamma Air
Gamma Air
EtO
Gamma Inert
Gamma Inert
EtO
Gamma Inert
Gamma Air
Gamma Inert
Gamma Air
Gamma Inert
X3
ArCom
Gamma Inert
Gamma Inert
Gamma Inert
Gamma Inert
Duration
Gamma Air
Gamma Air
Gamma Inert
Gamma Inert

Data points denoted by “--” signifies that the implant in question was a CR design that
would not have a post
“U/A” signifies that those scores were unavailable
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Figure 3-1.

Specimen RLU0426162B-R tibial insert

Note: The implant received a score of 27 out 168 and had least amount of total condylar
wear.
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Burnishing was the most common type of damage with a median score of 20 (IQR: 4,
range: 15 to 24). Pitting and scratching followed with median scores of 8 (IQR: 5, range 4
to 23) and 9 (IQR: 3, range: 4 to 17), respectively. Two implants had moderate to severe
delamination with total scores of 17 (RLU1016151A-L) and 22 (RLU1028161B-L,
shown in Figure 3-2), while the rest demonstrated minimal delamination of the condylar
surface. Very few of the implants had minimal abrasion, surface deformation, or
embedded debris.
The maximum backside wear score that could be given was a score of 168 with a
maximum possible score of 24 for each of the 7 damage modes. The median wear score
for the backside region of the insert was a score of 32 (IQR: 28), with a range of scores
from 13 (16-04-765R) to 84 (RLU1028161B-L). Again, burnishing was the most
common mode of damage with a median score of 9 (IQR: 15, range 0 to 24). Scratching
and pitting followed with median scores of 7 (IQR: 8, range 0 to 24) and (IQR: 9, range:
2 to 24). Fifteen implants demonstrated mild to moderate backside surface deformation
with a median score of 9 (IQR: 4, range: 3 to 15). One specimen had moderate
delamination with a score of 12, but no specimens had backside abrasion or embedded
debris.
As previously mentioned, 15 of the 32 retrieved TKAs were PS designs. The 7
wear modes were assessed on this additional interface to determine if the stabilizing post
contributes to the production of polyethylene debris. The maximum possible wear score
for the post of each PS implant was a score of 84 while each wear mode had a possible
maximum score of 12. The median wear score of the stabilizing post was a score of 8
(IQR: 7), with a range from 2 (RLU1115162B-R and DRLU030815-R) to 22
(DRLU081315-R). The most prominent wear mode was burnishing with a median score
of 6 (IQR: 4, range 0 to 10). Specimen RLU1121162A-R demonstrated severe wear on
the anterior surface of the stabilizing post, as shown in Figure 3-3, and received a total
wear score of 15 for the post surface. The remainder of the wear modes were nonexistent
or minimal on the stabilizing post surfaces.
Twenty-nine femoral components were analyzed for damage. For each
component, the maximum possible damage score was 16. The median damage score was
a score of 5 with an interquartile range of 4. Minimal damage (score of 1) was observed
in 31% (n=9/29) femoral components. The femoral component of specimen
RLU0829162C-R, shown in Figure 3-4, was among those with minimal damage with a
total score of 4. Mild damage (score of 2) was observed in 45% (n=13/29) femoral
components. Moderate damage (score of 3) was observed in 21% (n=6/29) femoral
components. Severe damage (score of 4) was observed on 1 of the 29 (3%) femoral
components. The femoral component of specimen RLU1028161B-L had the most severe
damage with a score of 14, shown in Figure 3-5. This implant exhibits severe scratching
along both its medial and lateral bearing surface which garnered damage scores of 3 for
the lateral and medial anterior surface and damage scores of 4 for the lateral and medial
posterior surfaces. Of the study samples, 70% of the specimens demonstrated mild to
severe damage in at least one quadrant (score ≥ 2).
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Figure 3-2.

Specimen RLU1028161B-L tibial insert

Note: The implant received a score of 22 out of 24 and demonstrated severe delamination
accompanied by oxidation.
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Figure 3-3.

Specimen RLU1121162A-R tibial insert

Note: Tibial insert post demonstrates severe anterior impingement wear.
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Figure 3-4.

Specimen RLU0829162C-R femoral component

Note: This implant exhibited minimal damage with lowest possible total score of 4.
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Figure 3-5.

Specimen RLU1028161B-L femoral component

Note: This implant exhibited severe damage with a total score of 14 out of 16.
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Laxity
Laxity profiles were measured for 23 cadaveric primary TKA specimens.
Specimens exhibited large variations in laxity. Some specimens were not able to reach
full extension or 90˚ of flexion. All laxity values reported in this discussion and in the
tables follow the Grood and Suntay sign conventions. Mann-Whitney rank sum test was
performed to determine if significant differences in laxity existed between PS and CR
implants.
As shown in Table 3-3, internal rotation ranged from -4.59 to -29.11˚ at full
extension, -8.99 to -31.39˚ at 30˚ flexion, -1.92 to -35.05˚ at 60˚ flexion, and -4.70 to 42.92˚ at 90˚ flexion. External rotation ranged from 4.01 to 28.05˚ at full extension, 11.70
to 32.76˚ at 30˚ flexion, 1.59 to 39.82˚ at 60˚ flexion, and 1.24 to 44.62˚ at 90˚ flexion. At
full extension and 90˚ of flexion, the median internal rotational laxity was 0.53˚ and 0.88˚
greater than the median external rotational laxity, whereas, at 30˚ and 60˚ of flexion, the
median external rotational laxity was 0.28˚ and 0.72˚ greater than the median internal
rotational laxity, respectively. Mann-Whitney rank sum test revealed significant
differences in the measured external laxity at full extension (p=0.01) and 30˚ of flexion
(p=0.04) between the PS and CR implants. At full extension, the PS specimens had a
median external rotation of 14.16˚ (IQR: 5.02˚) while the CR specimens had a median
external rotation of 7.43˚ (IQR: 2.07˚). At 30˚ of flexion, the PS specimens had a median
external rotation of 20.35˚ (IQR: 5.07˚) while the CR specimens had a median external
rotation of 15.70˚ (IQR: 3.99˚). There were not any statistically significant differences in
internal or external rotation at the remaining flexion angles between the PS and CR
implants.
As shown in Table 3-4, varus deflection ranged from -1.07 to -10.76˚ at full
extension, -3.24 to -13.53˚ at 30˚ flexion, -2.71 to -18.12˚ at 60˚ flexion, and -3.24 to 25.26˚ at 90˚ flexion. Valgus deflection ranged from 0.61 to 7.98˚ at full extension, 2.29
to 14.90˚ at 30˚ flexion, 1.67 to 26.57˚ at 60˚ flexion, and 2.68 to 38.49˚ at 90˚ flexion. At
0˚, 30˚, 60˚, 90˚, the median varus laxity was 1.22˚, 3.25˚, 2.16˚, and 3.58˚ greater than
the median valgus laxity, respectively. Mann-Whitney rank sum test did not reveal any
significant differences in varus or valgus deflection across the flexion angles between the
PS and CR implants.
As shown in Table 3-5, anterior displacement ranged from 0.13 to 9.37 mm at
full extension, 0.54 to 7.69 mm at 30˚ flexion, 0.01 to 10.77 mm at 60˚ flexion, and 0.01
to 6.51 mm at 90˚ flexion. Posterior displacement ranged from -1.06 to -6.64 mm at full
extension, -0.25 to -24.23 mm at 30˚ flexion, -0.16 to -16.91 mm at 60˚ flexion, and -0.04
to -18.04 mm at 90˚ flexion. At 0˚, 30˚, 60˚, 90˚, the median posterior displacement was
0.51, 0.34, 1.41, and 1.49 mm greater than the median anterior displacement,
respectively. Mann-Whitney rank sum test revealed a significant difference in the
measured posterior laxity at 30˚ of flexion between the PS and CR implants (p=0.007).
The PS specimens had a median posterior displacement of -9.83 mm (IQR: 7.29 mm)
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Table 3-3.
Summary of internal and external rotational laxity at each flexion
angle for each specimen

Specimen
RLU0510162A-R
RLU0728161A-L
RLU0722161B-L
RLU0126161C-L
RLU0510161A-L
RLU0426161B-L
RLU0126162C-R
RLU0720161B-L
RLU1028161B-L
RLU1115162B-R
RLU0913162A-R
RLU0426162B-R
RLU0829162C-R
16-04-765R
16-10-1103R
16-10-1103L
RLU0204172A-R
RLU0317172B-R
RLU0319171A-L
RLU1121161A-L
RLU1121162A-R
RLU1125161A-L
RLU1125162A-R
Median
IQR

Internal Rotation ( ˚ )
0˚
30˚
60˚
90˚
-16.62 -17.62 -24.47 -25.17
-6.81 -13.28 -18.00 -24.60
-11.01 -17.09 -1.92
---20.56 -22.77 -20.71
---14.16 -13.02 -15.10 -17.65
-7.09 -18.55 -21.73 -21.81
-6.48 -15.69 -16.98 -18.50
-7.51 -16.82 -19.52 -19.21
---8.99 -9.23 -14.12
-5.76 -13.17 -16.44 -9.71
-4.59 -10.84 -3.48 -21.28
-11.29 -19.36 -21.69 -25.30
-9.96 -21.11 -22.79 -27.01
-16.06 -12.69 -12.28 -4.70
-13.71 -16.70 -17.91 -12.24
-29.11 -31.39 -35.05 -38.24
---11.58 -14.27 -17.24
-7.20 -17.33 -18.26 -24.07
-11.67 -15.99 -23.45 -26.38
-10.41 -20.73 -25.60 -28.78
---18.59 -26.96 -42.92
-12.94 -18.06 -29.44 -36.75
-9.09 -19.99 -28.79 -5.20
-10.71 -17.09 -19.52 -21.81
6.65
5.70
8.19
9.14
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External Rotation ( ˚ )
0˚
30˚
60˚
90˚
14.16 20.35 20.59 22.68
7.43 15.60 22.42 26.29
11.35 13.02 1.59
--15.50 20.44 22.52
--12.69 22.92 22.12 20.93
7.43 18.37 19.38 20.97
11.62 18.97 18.27 16.51
8.22 17.37 17.77 17.28
--12.01 9.40 17.37
4.01 11.70 14.06 15.48
28.05 25.20 39.82 35.88
15.46 21.68 23.58 16.96
5.92 15.80 18.67 20.06
13.59 21.10 7.89
1.24
17.71 17.29 12.61 13.42
24.49 32.76 33.74 37.38
--12.49 16.45 18.52
6.25 15.48 20.82 27.38
6.64 13.78 15.37 16.16
6.58 12.19 20.24 30.23
--16.60 25.88 44.62
8.37 17.58 25.05 34.31
9.00 17.59 32.25 30.13
10.18 17.37 20.24 20.93
7.26
5.76
7.14 13.18

Table 3-4.
specimen

Summary of varus and valgus laxity at each flexion angle for each

Specimen
RLU0510162A-R
RLU0728161A-L
RLU0722161B-L
RLU0126161C-L
RLU0510161A-L
RLU0426161B-L
RLU0126162C-R
RLU0720161B-L
RLU1028161B-L
RLU1115162B-R
RLU0913162A-R
RLU0426162B-R
RLU0829162C-R
16-04-765R
16-10-1103R
16-10-1103L
RLU0204172A-R
RLU0317172B-R
RLU0319171A-L
RLU1121161A-L
RLU1121162A-R
RLU1125161A-L
RLU1125162A-R
Median
IQR

Varus Deflection ( ˚ )
0˚
30˚
60˚
90˚
-3.64
-5.12
-4.47 -11.96
-2.64
-3.90
-8.43
-3.24
-6.54
-9.20
-2.71
---6.24
-7.91 -11.98
---6.72
-7.06
-6.43
-9.27
-4.64
-8.99
-9.19 -10.38
-3.82
-6.55
-8.02 -11.57
-3.23
-9.69 -10.27 -6.74
---7.25
-8.00
-7.99
-4.03
-7.50
-8.53 -11.64
-7.12
-9.26 -18.12 -13.16
-8.56
-8.65
-8.36
-4.46
-9.10 -10.10 -13.29 -22.89
-3.89
-9.15
-8.51
-4.00
-5.32
-7.51
-8.53
-9.36
-10.76 -13.53 -17.29 -15.93
---3.24
-7.61
-9.47
-2.47
-5.14
-6.30 -13.15
-1.07
-3.68
-4.43
-9.80
-2.17
-5.52
-9.74 -15.92
---12.69 -14.59 -25.26
-9.34
-6.57
-3.18 -10.34
-4.68
-8.21
-9.72
-9.15
-4.66
-7.51
-8.51 -10.34
3.28
3.13
2.98
4.00
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Valgus Deflection ( ˚ )
0˚
30˚
60˚
90˚
3.10
3.76
6.12
3.06
2.24
4.08
4.70
3.19
3.95
6.52
1.67
--3.55
5.73
7.89
--0.61
2.96
5.14
3.95
3.32
3.34
6.34
6.75
3.64
4.25
6.82
5.45
1.77
3.75
4.26
9.53
--4.18
6.57
8.64
1.63
4.73
7.43
5.84
2.77
3.84
6.46
19.68
3.97
5.09
5.88
4.82
4.04
5.52
10.69
9.01
7.98
4.43
5.33
2.85
2.89
2.57
4.36
3.25
7.54
9.61
13.28
24.22
--2.82
4.73
7.63
2.05
2.29
5.52
8.35
5.41
6.24
8.59
14.42
2.26
5.09
11.87
13.29
--14.90
9.42
38.49
3.84
4.04
2.56
6.20
5.28
6.92
8.74
2.68
3.44
4.25
6.34
6.75
1.73
1.87
3.72
5.57

Table 3-5.
Summary of anterior and posterior laxity at each flexion angle for
each specimen

Specimen
RLU0510162A-R
RLU0728161A-L
RLU0722161B-L
RLU0126161C-L
RLU0510161A-L
RLU0426161B-L
RLU0126162C-R
RLU0720161B-L
RLU1028161B-L
RLU1115162B-R
RLU0913162A-R
RLU0426162B-R
RLU0829162C-R
16-04-765R
16-10-1103R
16-10-1103L
RLU0204172A_R
RLU0317172B_R
RLU0319171A_L
RLU1121161A_L
RLU1121162A_R
RLU1125161A_L
RLU1125162A_R
Median
IQR

Anterior Displacement (mm)

Posterior Displacement (mm)

0˚
----4.54
2.49
3.51
2.68
3.47
1.00
--2.44
9.37
0.13
1.12
3.94
1.99
1.82
--3.59
3.99
1.78
--2.64
1.83
2.57
1.74

0˚
-----2.89
-2.28
-3.02
-3.64
-3.38
-1.24
---1.45
-5.63
-2.60
-2.12
-4.44
-3.56
-6.64
---1.06
-2.14
-3.62
---3.14
-4.43
-3.08
1.46

30˚
----3.14
3.25
4.72
5.35
7.69
5.34
5.07
7.29
5.34
0.54
2.31
4.77
3.99
5.18
3.73
2.98
5.51
2.55
2.25
2.25
5.35
4.72
2.36

60˚
----0.79
0.27
2.21
2.71
4.59
3.48
1.65
1.94
6.33
1.62
0.01
2.35
2.41
5.16
0.37
1.36
4.70
10.77
0.34
1.93
0.69
1.94
2.69
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90˚
--------2.33
1.60
1.46
2.48
1.62
1.44
6.51
0.06
0.04
0.35
0.88
1.86
2.12
1.86
0.94
3.27
0.40
0.01
0.02
1.49
1.62

30˚
60˚
90˚
-------------7.41 -0.24
---1.26 -0.26
---5.50 -0.92 -7.94
-3.23 -6.24 -9.02
-9.40 -3.34 -4.87
-4.57 -5.12 -4.52
-0.25 -3.64 -2.95
-13.37 -7.22 -3.02
-10.26 -14.77 -8.09
-2.89 -1.13 -0.11
-1.40 -0.22 -0.04
-10.65 -3.94 -0.35
-5.37 -3.20 -1.61
-24.23 -9.30 -11.44
-4.58 -4.94 -0.54
-1.68 -0.16 -1.14
-5.06 -16.91 -8.95
-8.31 -9.21 -18.04
-21.16 -0.80 -1.98
-2.62 -1.18 -0.26
-0.46 -0.32 -0.28
-5.06 -3.34 -2.95
6.78
5.45
7.57

while the CR specimens had a median posterior displacement of -2.89 mm (IQR: 3.28
mm). There were not any statistically significant differences in anterior or posterior
displacement at the remaining flexion angles between the PS and CR implants.
Inflammatory Cytokines
The inflammatory cytokine concentrations in the synovial fluid of 32 specimens
were measured using two separate cytokine assays, as presented in Table 3-6. The first
assay screened for TNF-α, IL-1β, IL-6, IL-8, MCP-1, MIP-1α, MIP-3α, GM-CSF, MCSF, IFN-γ, and IL-2. In the second assay, MIP-1α, GM-CSF, and IFN-γ were omitted
because none of the specimens had concentrations above the detectable limit in the first
assay (MIP-1α <181 pg/mL, GM-CSF <11.9 pg/mL, and IFN-γ <299 pg/mL).
The range of detection for TNF-α was 8.9 to 2,170 pg/mL; 8 specimens were
below the minimum detection limit for TNF-α (<8.9 pg/mL) while the remaining 14
specimens were barely about the minimum detection limit. The range of detection for IL1β was 16.3 to 3,950 pg/mL; 3 specimens were below the minimum detection limit for
IL-1β (<16.3). The range of detection for IL-6 was 4.9 to 1,180 pg/mL; 5 specimens were
above the maximum detection limit for IL-6 (>1,180 pg/mL). The detection range for IL8 was 4.7 to 1,140 pg/mL; all but 2 of the specimens had concentrations of IL-8 that
exceeded the maximum detection limit of the assay platform (>1,140 pg/mL). The range
of detection for MCP-1 was 98 to 7,940 pg/mL; 7 specimens were above the maximum
detection limit for MCP-1 (>7,940 pg/mL). The detection range for MIP-3α was 7.9 to
1,920 pg/mL; 2 specimens had concentrations above the maximum detection limit
(>1,920 pg/mL) while 1 specimen was below the minimum detection limit (<7.9 pg/mL).
All specimens had concentrations of M-CSF that were within the detection range, 514 to
124,810 pg/mL. The minimum and maximum M-CSF concentration were 5,566 pg/mL
and 63,135 pg/mL, respectively.
Tissue Metal Concentrations
Periprosthetic tissues from 23 necropsy specimens were available for ICP-MS
analysis, as shown in Table 3-7 which includes the femoral component and tibial
baseplate materials. Statistical analysis revealed no significant difference between the
tissue locations and the metal concentrations; the concentrations were reported as
averages of all five tissue collection locations: the supra- and infra-patellar regions, the
medial and lateral gutters, and the tibial tuberosity. Specimens DRLU081315-R and
RLU1028161B-L had elevated concentrations of Ti in their periprosthetic tissues
(1,136.3 g/L and 12,775.1 g/L, respectively). Specimen RLU1028161B-L was an
uncemented TKA with Ti fiber mesh coating on the femoral component, the tibial tray,
and the metal-backing of the patellar button. Specimen RLU0426161B-L had extremely
elevated tissue concentrations of Co (28,705.3 g/L) and Cr (66,532.2 g/L); this
specimen also presented with severe metallosis, as shown previously in Figure 1-5.
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Table 3-6.
(pg/mL)

Concentrations of inflammatory cytokines for cadaveric specimens

Specimen
TNF-α IL-1 IL-6
DRLU051714-L
13.8
45.9
345
DRLU081315-R
11.1
201
41.6
DRLU030815-R
18.8
44.9
51.1
DRLU121515-R
8.9
32.9
28.6
DRLU010416-R
15.6
324 >1180
DRLU112815-R
25.7
248
136
DRLU101615-R
<8.9
151
103
RLU1016151A-L
<8.9
408
60.0
2013-678L
12.0
328
47.1
RLU0510162A-R
13.8
50.3
180
RLU0728161A-L
<8.9
21.1
279
RLU0722161B-L
23.8
962 >1180
RLU0126161C-L
9.3
52.0
218
RLU0510161A-L
16.0
84.6
135
RLU0426161B-L
<8.9
16.9
62.9
RLU0126162C-R
<8.9
31.0
238
RLU0720161B-L
12.0
204
109
RLU1028161B-L
10.9
50.0
92.5
RLU1115162B-R
<8.9
<16.3 79.5
RLU0913162A-R
9.3
71.5
862
RLU0426162B-R
<8.9
<16.3 37.3
RLU0829162C-R
<8.9
<16.3 70.1
16-04-765R
10.7
310
132
16-10-1103R
14.3
372 >1180
RLU0204172A-R
12.5
35.3
26.9
RLU0317172B-R
15.4
74.8 >1180
RLU0319171A-L
15.9
210
75.3
RLU1121161A-L
13.3
29.7 >1180
RLU1121162A-R
11.0
46.2
119
RLU1125161A-L
<8.9
<16.3 14.8
RLU1125162A-R
<8.9
23.0
28.7
Median
12.9
73.2
114
IQR
4.5
177
238

IL-8
>1140
>1140
>1140
>1140
>1140
>1140
>1140
>1140
>1140
>1140
1077
>1140
>1140
>1140
>1140
>1140
>1140
>1140
>1140
>1140
>1140
623
>1140
>1140
>1140
>1140
>1140
>1140
>1140
>1140
>1140
-----
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MCP-1 MIP-3α M-CSF
>7940
105
19308
2384
58.5
37827
>7940
341
36977
2465
18.8
39802
2033
>1920
20708
>7940
402
25495
235
108
48829
<98
<7.9
63135
>7940
131
37272
716
649
11472
1514
48.6
27263
>7940
473
25296
1660
238
5566
1739
361
16623
3055
93.7
27070
500
198
8362
3388
143
45793
3930
18.2
28538
773
191
13145
>7940
27.7
29092
1333
116
28094
567
38.1
16681
213
26.1
56552
598
>1920
37681
>7940
22.0
32826
990
159
55165
1948
26.8
40339
416
78.5
31780
1021
10.5
57380
195
33.9
25511
251
41.4
38353
1739
108
30436
5277
254
14566

IL-2
36.8
<35
75.6
<35
<35
49.9
<35
<35
38.0
<35
<35
84.2
<35
<35
<35
<35
<35
<35
<35
46.4
<35
<35
<35
39.8
53.6
37.9
42.1
46.7
<35
<35
<35
-----

Table 3-7.

Periprosthetic tissue metal concentrations reported in (g/L)

Specimen

Cobalt

Chromium

Titanium

DRLU051714-L
DRLU081315-R
DRLU030815-R
DRLU121515-R
DRLU010416-R
DRLU112815-R
DRLU101615-R
RLU0510162A-R
RLU0728161A-L
RLU0309161B-L
RLU0722161B-L
RLU0126161C-L
RLU0510161A-L
RLU0426161B-L
RLU0126162C-R
RLU1028161B-L
RLU1115162B-R
RLU0913162A-R
RLU0426162B-R
RLU0829162C-R
16-04-765R
16-10-1103R
16-10-1103L
Median
IQR

16.4
56.6
14.8
4.2
0.4
18.4
49.1
1.6
75.1
3.5
23.3
48.2
1.8
28705.3
39.1
0.7
146.4
1.3
51.2
39.0
6.3
10.0
2.0
16.4
45.9

46.6
87.8
37.3
301.6
7.4
76.8
134.7
23.5
91.7
7.4
21.3
188.5
13.4
66532.2
111.3
23.4
38.3
5.1
38.5
154.1
55.2
21.3
11.8
38.5
80.2

44.3
1136.3
37.1
50.9
4.4
2.3
3.2
46.8
9.6
3.8
4.3
6.9
51.6
3.5
16.2
12775.1
28.9
98.7
7.3
8.8
9.8
0.6
0.5
9.6
41.5

58

Condyle
Material
CoCrMo
CoCrMo
CoCrMo
CoCrMo
Oxinium
CoCrMo
CoCrMo
CoCrMo
CoCrMo
CoCrMo
CoCrMo
CoCrMo
CoCrMo
CoCrMo
CoCrMo
CoCrMo
TiAlV
CoCrMo
CoCrMo
CoCrMo
CoCrMo
CoCrMo
CoCrMo

Tray
Material
TiAlV
TiAlV
TiAlV
TiAlV
TiAlV
CoCrMo
CoCrMo
TiAlV
TiAlV
TiAlV
UHMWPE
TiAlV
TiAlV
CoCrMo
TiAlV
TiAlV
TiAlV
TiAlV
TiAlV
CoCrMo
CoCrMo
CoCrMo
CoCrMo

Correlation of Study Parameters
In the following sections, comparisons of the data sets were presented in graphical
form. For internal/external rotational laxity and varus/valgus laxity, the data was
presented as the sum of the absolute value of the two poles. For anterior and posterior
laxity, the data was presented separately so that it was not skewed by the sample
population containing both PS and CR implants. PS and CR implants were plotted with
different symbols as indicated in the legend of each figure.
Because the data was not normally distributed, nonparametric Spearman Rank
correlation analysis was performed. In Spearman rank correlation analysis, the ranks of
each data point in the two data sets were calculated and then the difference in rank of data
points between data sets was then used to compute the correlation coefficient. A
coefficient of +1 indicated a perfect positive correlation and a coefficient of -1 indicated a
perfect negative correlation. Spearman correlation coefficients () with respective pvalues (p) were included in tabular form. As previously mentioned, three specimens had
extremely elevated Ti, Co, or Cr levels. These outliers were removed in the respective
comparisons.
Hypothesis (a)—Laxity and Tissue Metal Concentrations
Graphical representation of the comparison between the joint laxity and tissue
metal concentrations was presented in Appendix B, Figures B-1 through B-24.
Spearman rank correlation analysis of the comparison between IE rotational laxity and
tissue metal concentrations identified one significant relationship as reported in Table
3-8. Decreased IE laxity at full extension was inversely correlated with increased Co
concentrations in the periprosthetic tissues (=-0.64, p=0.02). This comparison, shown in
Figure B-1A, had a sample size of 13 and a 95% confidence interval from -0.88 to -0.14.
While spearman rank correlation analysis of VV laxity and tissue metal content
did not reveal any statistically significant relationships, as shown in Table 3-9, VV laxity
was moderately correlated with Ti in periprosthetic tissues at full extension and 30 of
flexion. At full extension, decreased VV laxity correlated with increased Ti content in the
periprosthetic tissues (Figure B-11A, =-0.46, p=0.09) with a sample size of 13 and a
95% confidence interval from -0.79 and 0.09. Similarly, at 30 of flexion, decreased VV
laxity correlated with increased Ti concentrations (Figure B-11B, =-0.49, p=0.07) with a
sample size of 14 and a 95% confidence interval from -0.81 to 0.05.
Spearman rank correlation analysis identified four significant relationships
between AP laxity and tissue metal concentrations as reported in Table 3-10. At 90 of
flexion, anterior laxity was inversely correlated with Co concentrations (Figure B-14B,
=-0.66, p=0.03) with a sample size of 11 and a 95% confidence interval from -0.90 to 0.10. At 60 of flexion, anterior laxity was inversely correlated with Cr concentrations
(Figure B-18A, =-0.63, p=0.03) with a sample size of 13 and a 95% confidence interval
from -0.88 to -0.12. Anterior laxity at 90 of flexion was also inversely correlated with Cr
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Table 3-8.
Spearman correlation coefficients () for IE rotational laxity and
periprosthetic tissue metal concentrations
Metal
Co
Cr
Ti

Internal/External Rotational Laxity
0˚
30˚
60˚
90˚
-0.64*
-0.07
-0.01
-0.21
-0.42
0.01
-0.05
-0.27
-0.15
-0.28
-0.06
-0.07

*

p=0.02

Table 3-9.
Spearman correlation coefficients () for VV laxity and periprosthetic
tissue metal concentrations
Metal
Co
Cr
Ti

Varus/Valgus Laxity
0˚
30˚
60˚
-0.22
0.09
-0.13
-0.07
0.002
0.03
-0.46
-0.49
-0.11

90˚
-0.27
-0.33
0.02

Table 3-10. Spearman correlation coefficients () for AP laxity and periprosthetic
tissue metal concentrations
Metal
Co
Cr
Ti

0˚
-0.50
-0.28
0.45

Anterior Laxity
30˚
60˚
90˚
-0.22
-0.45
-0.66***
-0.28 -0.63***
-0.81*
0.29
0.04
0.34

*

p=0.003
p=0.01
***
p=0.03
**
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Posterior Laxity
0˚
30˚
60˚
90˚
-0.38
-0.01
-0.34
-0.43
-0.52
-0.41
-0.50 -0.74**
-0.20
0.20
0.13
-0.02

concentrations (Figure B-18B, =-0.81, p=0.003) with a sample size of 11 and a 95%
confidence interval from -0.95 to -0.41. Lastly, posterior laxity at 90 of flexion was
inversely correlated with Cr concentrations in the periprosthetic tissues (Figure B-20B,
=-0.74, p=0.01) with a sample size of 11 and a 95% confidence interval from -0.93 to 0.25.
Hypothesis (b)—Laxity and Inflammatory Cytokines
Graphical representations of each laxity and cytokine comparison was shown in
Appendix C in Figures C-1 through C-48. Spearman rank correlation analysis revealed
only one statistically significant correlation between IE rotational laxity and
inflammatory cytokines in the joint synovial fluid, as shown in Table 3-11. At 60 of
flexion, IE rotational laxity was inversely correlated with IL-1 concentrations (Figure C4A, =-0.55, p=0.02) with a sample size of 18 and a 95% confidence interval from -0.81
to -0.11.
As shown in Table 3-12, Spearman rank correlation analysis identified two
statistically significant relationships between VV laxity and concentrations of
inflammatory cytokines in the synovial fluid. At 60 of flexion, VV laxity was inversely
correlated with TNF- concentrations (Figure C-14A, =-0.78, p=2x10-4). This strong
correlation had a sample size of 14 and a 95% confidence interval from -0.93 to -0.43.
However, it must be noted that levels of TNF- were barely above the minimum
detection limit; as such, this correlation was likely clinically insignificant. Additionally,
VV laxity was inversely correlated with IL-1 concentrations (Figure C-16A, =-0.48,
p=0.04) at 60 of flexion with a sample size of 18 and a 95% confidence interval from 0.77 to -0.02. At full extension, VV laxity was inversely correlated with IL-6
concentrations (Figure C-17A, =-0.46, p=0.04) with a sample size of 19 and a 95%
confidence interval from -0.76 to -0.01.
Spearman rank correlation analysis revealed two statistically significant
relationships, as shown in Table 3-13. Anterior laxity was directly correlated with IL-6
concentrations (Figure C-34B, =0.53, p=0.02) at 90 of flexion with a sample size of 18
and a 95% confidence interval from 0.08 to 0.80. Additionally, anterior laxity was
directly correlated with MCP-1 concentrations (Figure C-38B, =0.62, p=0.006) at 90 of
flexion with a sample size of 18 and a 95% confidence interval 0.22 to 0.84. While not
statistically significant, posterior laxity was directly correlated with IL-6 at 30 and 90
of flexion. At 30 of flexion, increased posterior laxity correlated with increased IL-6
concentrations in the synovial fluid (Figure C-35B, =0.39, p=0.09) with a sample size of
20 and a 95% confidence interval from -0.06 to 0.71. At 90 of flexion, increased
posterior laxity correlated with increased IL-6 concentrations in the synovial fluid (Figure
C-36B, =0.46, p=0.06) with a sample size of 18 and a 95% confidence interval from 0.01 to 0.76.
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Table 3-11. Spearman correlation coefficients () for IE laxity and inflammatory
cytokine concentrations in the synovial fluid
Cytokine
TNF-
IL-1
IL-6
MCP-1
MIP-3
M-CSF

Internal/External Rotational Laxity
0˚
30˚
60˚
90˚
-0.46
-0.30
-0.23
0.07
*
0.42
-0.14
-0.55
-0.33
0.16
-0.16
-0.24
0.13
0.05
-0.24
-0.36
0.02
0.17
0.27
-0.17
-0.19
-0.16
-0.30
0.04
0.04

*

p=0.02

Table 3-12. Spearman correlation coefficients () for VV laxity and inflammatory
cytokine concentrations in the synovial fluid
Cytokine
TNF-
IL-1
IL-6
MCP-1
MIP-3
M-CSF

Varus/Valgus Laxity
0˚
30˚
60˚
-0.19 -0.41
-0.78*
0.30
0.11
-0.48**
-0.46** -0.16
-0.05
-0.22 -0.04
-0.06
-0.24 -0.12
-0.35
-0.14
0.01
0.07

*

p=2x10-4
p=0.04

**
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90˚
-0.18
-0.10
0.07
0.21
-0.30
0.08

Table 3-13. Spearman correlation coefficients () for AP laxity and inflammatory
cytokine concentrations in the synovial fluid
Cytokine
TNF-
IL-1
IL-6
MCP-1
MIP-3
M-CSF

0˚
0.11
0.40
0.36
0.32
-0.11
0.05

Anterior Laxity
30˚
60˚
90˚
-0.16
0.04
0.03
-0.14
0.03 -0.06
-0.03
0.30 0.53**
0.13
0.00 0.62*
0.10
0.08
0.14
-0.09
0.10
0.01

*

p=0.006
p=0.02

**
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0˚
-0.39
-0.31
0.02
-0.23
-0.30
0.12

Posterior Laxity
30˚
60˚
-0.03 -0.24
0.22 -0.14
0.39 -0.10
-0.02 0.20
0.01 -0.30
0.12 0.14

90˚
0.22
-0.19
0.46
0.38
0.16
-0.08

Hypothesis (c)—Tissue Metal Concentrations and Inflammatory Cytokines
Graphical representation of the comparison between inflammatory cytokines and
tissue metal concentrations was presented in Appendix D in Figures D-1 through D-18.
Spearman rank correlation analysis with outliers removed identified only two statistically
significant relationships between tissue metal concentrations and inflammatory cytokines
as reported in Table 3-14. As shown in Figure D-9, Cr was inversely correlated with IL-6
(=-0.52, p=0.01) with a sample size of 21 and a 95% confidence interval from -0.78 to 0.11. Cr was also inversely correlated with MIP-3 (Figure D-11, =-0.46, p=0.04) with
a sample size of 21 and a 95% confidence interval from -0.74 to -0.04. While not
statistically significant, Spearman rank correlation analysis also revealed four other
inverse correlations. In Figure D-8, periprosthetic tissue Cr content was inversely
correlated with IL-1 concentrations in the synovial fluid (=-0.41, p=0.09) with a
sample size of 18 and a 95% confidence interval from -0.74 to 0.07. The measured Cr
concentrations was also inversely correlated with MCP-1 concentrations (Figure D-10,
=-0.40, p=0.07) with a sample size of 21 and a 95% confidence interval from -0.71 and
0.04. Increased Ti concentrations was correlated with decreased IL-1 concentrations
(Figure D-14, =-0.41, p=0.09) with a sample size of 17 and a 95% confidence interval
from -0.74 to -0.09. Lastly, Ti was inversely correlated with MIP-3 concentrations in
the synovial fluid (Figure D-17, =-0.40, p=0.08) with a sample size of 20 and a 95%
confidence interval from -0.71 to 0.05.

Table 3-14. Spearman correlation coefficients () for tissue metal concentrations
and inflammatory cytokine concentrations in the synovial fluid with outliers
removed
Cytokine
TNF-
IL-1
IL-6
MCP-1
MIP-3
M-CSF

Co
0.19
-0.11
-0.32
-0.31
-0.14
-0.10

*

p=0.01
p=0.04

**
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Cr
-0.23
-0.41
-0.52*
-0.40
-0.46**
-0.02

Ti
-0.44
-0.41
-0.22
0.08
-0.40
-0.21

CHAPTER 4.

DISCUSSION

The specimens included in this study consisted of primary TKA implants that
were retrieved at necropsy and were determined to be well-fixed per fluoroscopic
analysis. The first objective of this study was to establish a baseline of different factors
that likely contribute to failure of primary total knee replacements. This study provided
semi-quantitative assessment of wear of the condylar surface, backside surface, and
stabilizing post, when applicable, and of damage to the bearing surface of the femoral
components. Joint laxity was measured using a custom knee testing platform that had
been previously studied and utilized by published articles and theses in literature (114,
184-193). Inflammatory cytokine profiles in the synovial fluid samples were presented
and measurable levels of metal debris was found in the periprosthetic tissue samples. The
second objective of this study was to determine if any significant relationships arose in
correlation analysis of the latter three aforementioned factors. An inverse trend was
observed between joint laxity and tissue metal concentrations, such that decreased laxity
induced metal release from the implant components. A direct trend was observed
specifically between increased anteroposterior laxity and elevated inflammatory
cytokines. Lastly, an inverse trend was found between decreased tissue metal
concentrations and increased inflammatory cytokines. The third, and future, objective of
this study is to utilize these measurements and observations for comparison with failed
implants retrieved at time of revision.
Implant Wear and Damage Assessment
Wear in TKA is inevitable. While the current knowledge of the mechanisms
involved in debris-induced TKA failure is still in its infancy, it is believed that excessive
polyethylene wear particles stimulate a cascade of biological events that lead to
degradation of bone and inhibition of bone formation (131, 132, 137, 166, 169, 171, 202,
203). This wear and biologic response pathway is termed osteolysis, and oftentimes
necessitates revision of the index procedure. Orthopedic implant retrieval programs are of
utmost importance in expanding the understanding of the etiology of aseptic implant
loosening. While most retrieval programs analyze failed implants retrieved at time of
revision, the implants in this study were retrieved at necropsy and were deemed to be
well-functioning primary TKAs based on fluoroscopic analysis. In order to assess how
soft tissue laxity, periprosthetic tissue metal concentrations, and inflammatory cytokines
concentrations in the synovial fluid contribute to the interaction between human
physiology and the implant, the degree of wear and damage to the implant systems
themselves first were established.
The modes of wear can be grouped by the following mechanisms: adhesive wear,
abrasive wear, and fatigue wear. Characteristic of adhesive or abrasive wear, burnishing
of the condylar, backside, and post surfaces may result from cyclic loading and
micromotion which leads to progressive buffing of the original matte surface finish. As in
many other retrieval studies, burnishing was the most common wear mode on every

65

assessed surface (32). From a biological perspective, burnishing produces wear debris
that is within the size range that may stimulate an inflammatory response. Pitting, a
mechanism of fatigue wear, is sometimes referred to as “cratering” and involves the
liberation of millimeter-sized pieces of wear debris from the articulating surface. The
wear debris produced by pitting is considered to be too large to provoke an osteolytic
response; as such, pitting is believed to be a more benign wear mechanism than adhesive
or abrasive wear, which produces micrometer-sized debris (204). Scratching is a mode of
abrasive wear produced by plowing of microscopic asperities on the opposing metallic
surface or by third body debris (204). Pitting and scratching were common wear
mechanisms observed on all insert surfaces. Burnishing, pitting, and scratching were the
predominant wear modes for all surfaces assessed.
Tibial insert wear on the condylar surface, backside surface, and stabilizing post,
when applicable, was assessed using a modified Hood et al. (195) method. While the
predominant modes of wear included burnishing, pitting, and scratching for all surfaces
assessed, there were 2 implants with severe delamination on the condylar surface and 11
implants with mild to severe backside surface deformation. Specimen DRLU081315-R, a
posterior-stabilized, fixed bearing tibial insert sterilized with gamma radiation in an inert
gas environment, had the highest condylar wear with a total score of 64. Severe
burnishing was identified on the condylar and backside surfaces, with the maximum
possible score of 24. Additionally, this implant had the highest wear of the stabilizing
post with a total score of 22; burnishing was the predominant mode of wear (score of 10
out of 12) followed by abrasion (score of 5 out of 12). Specimen RLU0913162A-R, a
posterior-stabilized, fixed bearing tibial insert sterilized with gamma radiation in air,
demonstrated the second highest condylar wear with a total score of 58, moderate
backside wear with a total score of 56, and the second highest wear of the stabilizing post
with a total score of 16. Specimen RLU1028161B-L, a fixed bearing tibial insert
sterilized with gamma radiation in air, had a total condylar wear score of 57 with severe
condylar delamination (score of 22 out of 24) accompanied by oxidation. This implant
had the highest backside wear with a total score of 84; the modes of burnishing, pitting,
and scratching each had the maximum score of 24, while the mode of surface
deformation had a score of 12.
Many factors contribute to wear of the tibial insert on all aforementioned surfaces,
including but not limited to: patient-specific factors such as body mass index and
duration of implantation (195, 205-207); surgical-related factors such as ligament
balancing or alignment of the components (78, 123-125, 208, 209); and lastly implantspecific factors such as method of fabrication, mode of sterilization, and design (210212). In this study, duration of implantation was not a statistically significant factor
(p>0.05) in the degree of wear. However, this is likely due to the fact that these were all
well-functioning specimens retrieved at necropsy instead of revision. The contribution of
ligament balancing will be discussed further in context of measured laxity in the
following sections. The mode of fabrication was not available for the implants and thus
was not considered in this study, but the mode of sterilization was available for the
implants.
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Gamma irradiation in air was the method utilized by most to sterilize UHMWPE
for use in both total hip and total knee arthroplasty components prior to 2000 (204).
However, oxidative degradation of the polyethylene components occurred following
gamma radiation sterilization in air and prolonged shelf storage in air (213, 214).
Additionally, oxidation during long-term shelf aging following gamma irradiation was
discovered to cause a loss in mechanical properties and in some cases, more rapid
polyethylene wear often through delamination, especially with respect to TKA (205, 211,
215, 216). Repeated cyclic loading of the UHMWPE, which results in subsurface fatigue
and failure of the UHMWPE tibial insert, causes delamination wear (216, 217).
Delamination is often associated with production of large amounts of debris and gross
component failure. To address the concern of oxidation in gamma-air sterilized implants,
orthopaedic manufacturers in the mid-to-late 1990s discontinued gamma sterilization in
air and introduced gamma sterilization in low-oxygen or inert gas environment in
combination with barrier packaging to reduce risk of oxidation prior to implantation
(204). Although many biomechanical and material factors induce and accelerate
delamination failure, stabilization of UHMWPE through sterilization without irradiation
or irradiation sterilization in an inert atmosphere is thought to eliminate subsurface
oxidation which contributes to delamination. Specimen RLU1028161B-L, in Figure 3-2,
illustrates the detrimental effects of oxidation caused by gamma-air sterilization.
The contemporary TKA tibial component can either be a fixed or mobile bearing
design. Mobile bearing designs were introduced to provide congruity of the tibiofemoral
articular surface and to allow relative movement between the lower surface of the
polyethylene insert and the metal tibial baseplate for reduction of the constraint force (81,
82, 218). Because the contact forces are theoretically reduced on the articular surface
mobile bearing knees, the risk of polyethylene wear may also be reduced. However, the
articulation between the inferior surface of the tibial insert and the superior surface of the
tibial tray provides an additional source of wear debris generation. Lu et al. (218) found
that while the polyethylene wear on the superior surface was in fact reduced with the
mobile bearing design, there was a higher incidence of high-grade wear patterns, such as
scratching, pitting, embedded debris, and delamination (218). A student’s t-test revealed
that the differences in condylar and backside wear scores between mobile bearing and
fixed bearing implants in this cohort were not statistically significant (p>0.05). Moreover,
the incidence of “high-grade” wear patterns on the backside surface, as mentioned in the
study by Lu et al. (218) was not statistically significant with respect to fixed bearing
versus mobile bearing designs. Again, this is likely due to the fact that the implants in this
cohort are well-functioning implants.
Although the articulating surface of polyethylene insert was thought to be the
main source of debris generated in total knee arthroplasty, the tibial tray-insert interface
has also been established as a contributing source of polyethylene debris (89, 206, 208,
210, 219) and in many cases has been related to tibial osteolysis (89, 220, 221). Factors
influencing backside interface micromotion and the resultant wear include: implant
design, tibial tray material (CoCrMo or TiAlV), locking mechanism design in fixed
bearing tibial components, and surface roughness (222, 223). Previous studies have
indicated that the backside surface of a fixed bearing tibial insert can still move relative
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to the tray despite being secured to the tibial tray with a locking mechanism (206, 224,
225). This present study gives further evidence of micromotion occurring between fixed
bearing tibial insert-tray designs.
While burnishing was the predominant mode of wear on the backside surface,
pitting and scratching were also observed. Surace et al. (210) proposed that pitting on the
backside surface may occur by a different mechanism than that on the condylar surface
because contact-induced stresses near the backside surface of the insert are much smaller
than those observed on the condylar surface. Instead, the formation of pits or scratches
may be due to the presence of third-body particles, such as Ti particles, produced by
micromotion at the interface (78, 125, 126). Additionally, surface deformation on the
backside surface was observed on 11 out of 25 of the inserts. Surface deformation,
oftentimes referred to as cold flow in literature, was characterized by cylindrical
protrusions of polyethylene extending from the undersurface of the insert into screwholes within the tibial base-plate. This method of wear has been well-documented in
literature and has been attributed to cold flow or creep of the polyethylene under the
action of compressive forces applied to the upper surface of the insert during weightbearing activities (89, 206, 210, 219). However, the results of a study by Conditt et al.
(206) suggested that the protrusions on the underside of worn retrieved tibial components
were not primarily due to creep or cold flow of the polyethylene through the screw-holes
on the baseplate, but instead were primarily due to wear of the inserts. They found that
the surfaces of all of the polyethylene material descending below the worn backside
surface existed in a single plane, independent of the location of each individual cylinder,
an observation unlikely to occur if the protrusions were due to cold flow or creep (206).
Another design element that contributes to the polyethylene debris burden is the
presence of a stabilizing post in PCL-substituting designs. While PCL-substituting
designs were developed to prevent uncontrolled sliding of the femoral component
without requiring excessive conformity, thereby reducing wear of the condylar insert
surface, several studies have reported that the cam-post articulation in PS implants is an
additional source of polyethylene wear debris (32, 109, 205, 226, 227). Burnishing,
scratching, pitting, and abrasion were the most prevalent wear modes in the current study.
As shown in Figure 3-3, specimen RLU1121162A-R had significant damage to the
anterior surface of the stabilizing post with little wear on the posterior surface. Wear on
the posterior surface of the stabilizing post is expected as that is the surface where
articulation occurs with the cam. However, many of the implants in this study exhibited
wear of the anterior surface as well. Anterior impingement damage may occur on both PS
and CR designs. The incidence of anterior impingement damage in PS designs has been
reported to range from 36% to 75% in literature (109, 228). Banks et al. (228) suggested
that as the femoral component moves from flexion to extension to hyperextension, the
intercondylar notch contacts the polyethylene tibial eminence or post causing damage.
The wear caused by anterior impingement could compromise the structural integrity of
the stabilizing post leading to fracture and also likely generates micrometer-sized wear
which may lead to stimulation of inflammatory processes.
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An important limitation of the Hood et al. (195) approach to assessing wear is that
a high damage score does not necessarily indicate that a large amount of wear has
occurred. Instead, this method only expresses damage in terms of the area covered by the
defect. While thickness measurements can account for some loss of material, original
implant thickness must be known and the irregular shape of a tibial insert likely would
skew the measurements. Moreover, Puloski et al. (109) noted that discerning between
mechanisms of wear in which material is lost and plastic deformation in which polymer is
distorted without loss of material also poses another complication in quantifying or
qualifying tibial insert wear.
Total knee arthroplasty femoral components present large metal surface areas that
can undergo material loss due to wear and/or corrosion, generating metal particles and
metal ions. While, historically, polyethylene debris was believed to be the primary cause
of osteolysis and aseptic loosening, recent attention has been directed towards the role of
metal debris in adverse events following primary total joint replacements. Possible
corrosive mechanisms of metal debris production in primary TKAs include: direct
inflammatory cell-induced corrosion (145, 146, 196) and degradation at the backside
interface with the bone cement layer in the form of discoloration (196). Possible abrasive
wear mechanisms included scratching due to third-body debris (196, 229, 230) and metalon-metal articulation due to complete wear-through of the polyethylene tibial insert or
patellar button, in cases of metal-backed patellar resurfacing. In addition to generating
debris that may incite inflammatory reactions, femoral component surfaces roughened by
abrasive mechanisms have been shown to increase wear of the tibial insert (229-231). As
such, wear of the femoral component may induce additional wear of the polyethylene
insert.
Only one study was found in literature that analyzed damage of femoral
components. Arnholt et al. (196) analyzed the aforementioned corrosive and abrasive
wear mechanisms on 52 CoCr femoral components retrieved at time of revision. They
found evidence of metal release of corrosive damage in 51 of the 52 (98%) femoral
components included in their study with 98% (n=51/52) of the implants demonstrating
third-body wear, primarily in the form of scratching. Such a high incidence of damage
highlights the critical need for additional research that considers the role of femoral
component damage in the failure of TKA. Using the same method employed by Arnholt
et al. (196), the present study analyzed the damage in four quadrants of 29 wellfunctioning femoral components retrieved at autopsy. While the median damage score of
the sample population was a score of 5, mild to severe damage (score 2) was observed
in at least one quadrant of 70% of the femoral condyles included in this study. Two
implants in particular displayed significant abrasive damage of the femoral component.
Specimen RLU1028161B-L, shown in Figure 3-5, had severe scratching of the bearing
surface and received a score of 14 out of the maximum score of 16. The specimen was a
Miller-Galante II design (Zimmer Inc.; Warsaw, IN) with a TiAlV femoral component.
The lower modulus of elasticity of TiAlV with respect to CoCrMo makes it more prone
to damage and wear. As such, TiAlV is not a suitable bearing material in total knee
arthroplasty. This specimen also had significant condylar and backside wear of the tibial
insert, which is in accordance with previous reports (229-231) of roughened femoral
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components increasing wear of the tibial insert. Specimen RLU0426161B-L, a press-fit,
LCS Mobile Bearing design (Depuy; Warsaw, IN) with a condylar coating of CoCr small
beads, had moderate scratching of the bearing surface, receiving a score of 10. This
specimen, shown in Figure 1-5, presented with metallosis which is associated with
abnormal metallic wear (151, 152). The corresponding tibial insert condylar surface for
specimen RLU0426161B-L demonstrated severe burnishing (22 out of 24), mild
scratching and pitting (score 7 out of 24), mild delamination (score of 4), and some
evidence of embedded metallic debris (score of 2).
Tissue Metal Concentrations
While the femoral component damage scores qualitatively described the wear that
occurred in vivo, ICP-MS analysis quantitatively measured the metallic debris that had
accumulated in the periprosthetic tissues. Kretzer et al. (232) was the first to question
whether wear debris-induced failure in TKA was solely due to polyethylene. Seeking to
quantify the extent of metal debris generation in TKA, they employed a wear simulator
with all polymer bearings allowing the resultant metallic wear to be solely from the
CoCrMo implants. While wear of metallic components has traditionally been attributed to
third body particles such as bone chips or bone cement, Kretzer et al. (232) observed
wear of the metal components without the presence of these third bodies in their
simulation. Despite the absence of these “traditional” third body particles, the metallic
femoral components displayed pitting as well as third body and abrasive wear mainly
originating from the cobalt-rich matrix. They postulated that the third bodies inducing the
pitting or abrasive wear were carbides released from the bulk alloy. Carbides are known
to be very hard and rich in Mo and Cr (233). Consequently, the higher hardness of the
carbides or fragments within the articulation may have caused the observed abrasive and
third body wear of the femoral components (232). Additionally, Kretzer et al. (232) noted
the release of titanium from the tibial plateau, although that tibial plateau is not intended
for articulation. However, TiAlV alloy has a very thin oxide layer that is sensitive to
fretting (234). Kretzer et al. (232) stated that, even with softer material like polyethylene
which has a lower elastic modulus than TiAlV, micromotions may cause a relevant
release of Ti wear products. Previous wear simulator studies have also reported evidence
of large pits where particles had been removed from the superior surface of the TiAlV
baseplate (78, 123, 125, 126). One shortcoming of wear simulator studies is that they
typically measure debris release over five million cycles which translate to an implant
lifespan of approximately five years.
While there is a plethora of studies that have investigated metal release in metalon-metal THAs , only five previous studies were found that reported metal ion
concentrations in serum (157, 235) and metal concentrations in synovial fluid (236, 237)
of patients with TKA. For sake of comparison to the present study, the reported values
were converted to g/L, as presented in Table 4-1. Three studies were identified that
measured metal release from TKA in serum. Jacobs et al. (238) measured Ti release from
cementless TiAlV alloy total knee replacements in three cohorts: control patients without
implants (n=21), well-functioning, unilateral primary TKA patients (n=10), and patients
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Table 4-1.
Compilation of previous studies investigation metal concentrations
from TKA for comparison for current study
Study
Jacobs et al.
Luetzner et al.
Savarino et al.
Cracchiolo et al.

Milosev et al.
Present Study

Sample
Population
Control
Stable Unilateral
Failed Unilateral
Control
Stable Unilateral
Stable Bilateral
Control
Stable Unilateral
Failed Unilateral
Control
Synovitis Hinged
Synovitis
Non-hinged
Control
Failed
Stable Necropsy

Co
(g/L)
---0.25
3.27
4.28
0.26
0.44
1.10
800
6,540
1,230

Cr
(g/L)
---<0.25
0.92
0.98
0.24
0.24
0.45
0
36,240
1,930

Ti
(g/L)
2.67
3.15
135.57
---3.20
2.91
3.05
----

Sample
Medium
Serum

Implant
Materials
TiAlV

Serum

CoCrMo

Serum

CoCrMo
and TiAlV

Synovial
Fluid

Unknown

<0.2
1.13
16.36

<0.02
5.92
38.54

1.92
2.20
9.62

Synovial
Fluid
Tissue

CoCrMo
and TiAlV
CoCrMo
and TiAlV

Sources:
Jacobs JJ, Silverton C, Hallab NJ, Skipor AK, Patterson L, Black J, et al. Metal release
and excretion from cementless titanium alloy total knee replacements. Clinical
orthopaedics and related research. 1999(358):173-80.
Luetzner J, Krummenauer F, Lengel AM, Ziegler J, Witzleb W-C. Serum metal ion
exposure after total knee arthroplasty. Clinical orthopaedics and related research.
2007;461:136-42.
Savarino L, Tigani D, Greco M, Baldini N, Giunti A. The potential role of metal ion
release as a marker of loosening in patients with total knee replacement. Bone Joint J.
2010;92(5):634-8.
Cracchiolo A, Revell P. Metal concentration in synovial fluids of patients with prosthetic
knee arthroplasty. Clinical orthopaedics and related research. 1982(170):169-74.
Milošev I, Levašič V, Vidmar J, Kovač S, Trebše R. pH and metal concentration of
synovial fluid of osteoarthritic joints and joints with metal replacements. Journal of
Biomedical Materials Research Part B: Applied Biomaterials. 2017;105(8):2507-15.
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with failed porous Ti coated patellar components (n=8). The Ti concentrations measured
in the failed cohort was statistically greater than the control cohort (p<0.005) while the Ti
concentrations measured in the stable cohort were not statistically different from the
control cohort. A study by Luetzner et al. (235), using atomic absorption spectrometry,
reported median Co serum concentrations in patients with well-functioning unilateral
(n=18) and bilateral (n=23) TKAs. They compared these Co and Cr concentrations to a
control group from a previous study by Witzleb et al. (239). While no differences
between serum levels in patients with unilateral and bilateral arthroplasties were
observed, the researchers reported elevated serum levels of Cr and Co in both study
groups when compared to the control group (235). A cohort study performed by Savarino
et al. (157) investigated the role of ion release in the assessment of fixation of the implant
after unilateral TKA. Their study compared serum levels of Ti, Cr, and Co, measured by
atomic absorption spectrometry, for three sample groups: no implants, stable implants,
and failed implants. Evaluation of Ti was underestimated because of the high
instrumental detection limit employed in the study. Based on the high specificity and
positive predictive value, Savarino et al. (157) concluded that elevated Cr ion levels
appears to be a good diagnostic indicator of loosening when clinical and radiological
signs are unclear.
Two studies were identified that measured metal release from TKA in synovial
fluid. Using atomic absorption spectrometry, a study by Cracchiolo et al. (236) measured
the Co and Cr concentrations in the synovial fluid of patients with primary arthritis,
patients with hinged (metal-on-metal) TKA prostheses, and patients with non-hinged
(metal-on-polyethylene) TKA prostheses. Additionally, Cracchiolo et al. (236) measured
the Co and Cr concentrations in the sera of only the control patients and patients with
hinged prostheses. Interestingly, the only significant difference they observed was that
the control patients had higher Co sera concentrations than the patients with hinged
prostheses. As such, using serum as the medium for testing metal concentrations may
underestimate the actual degree of metal debris accumulating in the joint. While
measuring metal ion levels in serum may suit clinical detection of excessive wear,
measuring metal debris in the synovial fluid or periprosthetic tissues is likely to be more
indicative of how much debris has accumulated in the local periarticular environment.
Milosev et al. (237) measured the Co, Cr, and Ti concentrations using inductivelycoupled mass spectrometry in the synovial fluid of a patients with primary OA collected
at time of index TKA (n=2) and patients with failed primary knee arthroplasty collected
at time of revision (n=11). Cobalt and chromium were not detected in the control group
but were detected in 82% (n=9/11) and 45% (n=5/11) of the failed cohort. When
measuring metal concentrations in synovial fluid, the authors (236, 237) were unable to
identify whether the debris was in ionic or particle form; the same concept will be applied
to the present study.
To the author’s knowledge, this is the first study to document Co, Cr, and Ti
concentrations in the periprosthetic tissues of well-functioning TKA specimens retrieved
at autopsy. Despite Co being the predominant element in the composition of CoCrMo
alloys, the median Co concentration found in the periprosthetic tissues was 16.4 g/L,
whereas the median Cr concentration was 38.5 g/L. Similarly, Ichinose et al. (240)
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examined the metal composition in the synovial tissues surrounding failed TKAs revised
due to unexplained pain and swelling. Using backscattered scanning electron microscopy,
they found that the ratio of Co, Cr and Mo was 4.16:69.15:20.67, respectively, in the
synovial cells of patients with CoCrMo TKA components. The authors speculated that
Co may dissolve from periarticular cells, disseminating throughout the body, whereas Cr
remains within the cells (240). Similarly, Woodman et al. (241) and Merritt et al. (242)
indicated that Co dissolved into the fluid, ultimately removed from the body in urine,
although Cr remained in the tissues around CoCrMo components. Taking this into
consideration, the Co concentrations in this study may potentially underestimate the
actual amount of Co released. Despite this potential limitation, this study presents a novel
finding of elevated Co, Cr, and Ti concentrations in the periprosthetic tissues of wellfunctioning TKA specimens.
In the present study, three specimens had notably elevated Co, Cr, or Ti
concentrations and were excluded from statistical analysis. Specimen DRLU081315-R
had a Ti concentration of 1,136.3 g/L in the periprosthetic tissues. This implant system
was a cemented CoCrMo alloy femoral component with TiAlV tibial baseplate. A fixed
bearing implant system, this specimen demonstrated significant backside wear of the
tibial insert (scratching score of 24 out of 24, pitting score of 10 out of 24, burnishing
score of 24 out of 24, and surface deformation score of 8 out of 24) indicating
micromotion occurred. The micromotion may have contributed to the wear of the TiAlV
tibial baseplate. Specimen RLU0426161B-L had extremely high Co and Cr
concentrations—28,705 g/L and 66,532 g/L, respectively. As previously stated, this
implant also endured significant damage in vivo, receiving a femoral component damage
score of 10 and presented with severe metallosis, as shown in Figure 1-5. Additionally,
this implant system was uncemented with a porous coating of small beads on the femoral
condyle and tibial baseplate; however, the material composition of the coating is
unknown. The Co and Cr concentrations observed in this specimen were greater than the
mean Co and Cr concentrations measured in the synovial fluid of the patients with both
non-hinged and hinged prostheses (Table 4-1) that had suspected synovitis, which were
the highest metal concentrations reported in the included literature. Specimen
RLU1028161B-L, a cementless, Ti fiber mesh coated TiAlV alloy femoral component
and tibial baseplate, had extremely elevated Ti concentrations (12775 g/L) in the
periprosthetic tissues. This implant received the highest femoral component damage
score (14 out of 16), the third highest wear score of the tibial insert condylar surface (57
out of 168) with notable delamination present (score of 22 out of 24), and the highest
wear score of the tibial insert backside surface (84 out of 168). While each of these
outliers have periprosthetic tissue concentrations that exceed the Co, Cr, and Ti
concentrations measured in the sera and synovial fluid of stable and failed implants in
previous studies, the median values reported in this study, which analyzed only wellfunctioning implants retrieved at autopsy, were higher than the average values reported in
both the sera or synovial fluid.
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Inflammatory Cytokines
Through normal use of prosthetic joints, polyethylene and metallic wear particles
are generated, as documented through the wear analysis of implants and measurements of
tissue metal concentrations. These wear particles evoke an inflammatory response
through the stimulation of macrophages and other immune cells prompting the release of
powerful chemical mediators, which in turn may stimulate osteolysis. Inflammatory
cytokines have been proposed as possible biomarkers for detection of TKA failure (177,
203, 243, 244). To establish the role of certain chemical mediators in the present study’s
cohort of well-functioning primary TKA retrieved at necropsy, a cytokine assay was
performed for the detection of multiple analytes (TNF-, IL-1, IL-6, MCP-1, MIP-3,
and M-CSF) in the synovial fluid samples. However, to elucidate which the significance
of the cytokine concentration measurements, the concentrations of these inflammatory
mediators must first be established in those without prosthetic implants to serve as a
standard for comparison. Several studies were identified that measured the concentrations
of TNF-, IL-1, IL-6, MCP-1, MIP-3, and M-CSF in the synovial fluid of patients
diagnosed with OA or RA of the knee. While these cytokines may also play a role in the
inflammatory processes in these conditions and are likely to elevated, these reported
values will serve as a lower limit guideline for comparison. Additionally, a few studies
were identified that measured the concentrations of the same cytokines in patients with
aseptically failed total knee implants. These reported values will serve as an upper limit
guideline for comparison.
Kahle et al. (245) measured the levels of TNF- and IL-1 in the synovial fluid of
patients with OA, patients with RA, and healthy control patients at necropsy. The
researchers reported the following mean TNF- concentrations in the OA, RA, and
control cohorts: 80 pg/mL, 170 pg/mL, and 289 pg/mL. Additionally, they reported the
following mean IL-1 concentrations in the OA, RA, and control cohorts: 21 pg/mL, 193
pg/mL, and <20 pg/mL (245). This particular study was novel as it was the only one
found that presented the levels of these two inflammatory cytokines in the synovial fluid
of healthy controls at autopsy. Mabey et al. (243) sought to quantify the concentrations
of proinflammatory and anti-inflammatory cytokines in plasma and synovial fluid of
primary knee OA patients (n=32) and healthy controls. As is the case with most studies,
plasma was the only type of sample collected from the healthy controls for analysis. Due
to this ethical constraint, it is difficult to discern the naturally occurring concentrations of
the cytokines of interest. However, for reference, Mabey et al. (243) reported the
following average cytokine concentrations in the cohort of OA patients—TNF-: 1.0
pg/mL (lower detection limit: 0.20 pg/mL), IL-1: 1.9 pg/mL (lower detection limit: 0.10
pg/mL), and IL-6: 356.5 pg/mL (lower detection limit: 0.29 pg/mL). Interestingly, Mabey
et al. found that TNF- and IL-1 in OA plasma were significantly higher than in paired
synovial fluid samples (p<0.001). On the other hand, Steiner et al. (246) measured TNF and IL-6 in the synovial fluid from patients with RA (n=33) and reported the following
average cytokine concentrations—TNF-: 157 pg/mL and IL-6: 4,700 pg/mL, both of
which had a lower detection limit of 30 pg/mL. In investigating solely the role of IL-1
in OA and RA, Richette et al. (247) reported average IL-1 concentrations of 1.0 pg/mL
in the cohort of OA patients (n=42) and average IL-1 concentrations of 24.0 pg/mL in
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the cohort of RA patients (n=11) in the synovial fluid, with a lower limit of detection of
0.1 pg/mL. They detailed that detectable levels of IL-1 were found in 71% (n=30/42) of
patients with OA and all patients with RA. In an explorative study comparing levels of
cytokines in control and OA synovial fluid, Beekhuizen et al. (248) tested for TNF-, IL1, IL-6, and MCP-1. Their control cohort (n=16) consisted of synovial fluid collected
from the patient within 24 hours post-mortem, whereas the test cohort (n=18) consisted
of synovial fluid collected from patients with primary OA. TNF- levels in both cohorts
were below the lower detection limit, which was not detailed. Median IL-1
concentrations were 0.0 pg/mL in the control cohort and 4.8 pg/mL in the test cohort with
a lower detection limit of 0.7 pg/mL. Median IL-6 concentrations were 4.8 pg/mL in the
control cohort and 135.8 in the test cohort with a lower detection limit of 0.4 pg/mL.
Beekhuizen and colleagues (248) reported that IL-6 was significantly elevated in the OA
cohort when compared to the control cohort (p=0.001). Lastly, median MCP-1
concentrations were 542.4 pg/mL in the control cohort and 824.8 pg/mL in the OA cohort
with a lower detection limit of 1.2 pg/mL. Ruth et al. (249) measured MIP-3 in the
synovial fluid from patients with OA (n=9) and patients with RA (n=25) and reported
that RA synovial fluid samples exhibited significantly elevated levels of MIP-3 (3,001
pg/mL) compared to patients with OA (100 pg/mL). Although, no value of significance
was given.
To determine if IL-1 may be indicative of increased synovial activity, an
inflammatory reaction, or osteolysis following TKA, Kovacik et al. (203) compared the
IL-1 concentrations in synovial fluid aspirates from OA patients receiving primary TKA
with patients receiving revision TKA for aseptic loosening. They reported a significant
difference (p<0.0001) between the average IL-1 concentrations in the OA synovial fluid
aspirates (0.25 pg/mL) compared to the revision synovial fluid aspirates (6.25 pg/mL).
Furthermore, Kovacik et al. (203) found significantly higher IL-1 concentrations
(p<0.0001) in the synovial fluid of the patients receiving revision for failure of a TiAlV
component (9.92 pg/mL) versus revision for failure of a CoCrMo component (2.57
pg/mL). Similarly, Dasa et al. (177) measured the concentrations of TNF-, IL-1, and
MCP-1 in patients with OA (n=10), patients with RA (n=4), and patients with
radiographic evidence of aseptic loosening undergoing revision arthroplasty (n=6). An
average TNF- concentration of 208.0 pg/mL was reported only for the aseptically failed
patient cohort. IL-1 was not detected (<0.6 pg/mL) in any of the patients undergoing
revision TKA. The mean MCP-1 concentration for the revision patients was 21,233
pg/mL. The mean MCP-1 concentration was 3012 pg/mL for the OA cohort and 690
pg/mL for the RA cohort. Statistical analysis revealed that the mean MCP-1
concentration in revision samples was larger than OA and RA samples (p=0.011 and
p=0.014, respectively), but no difference existed between MCP-1 in the OA and RA
cohorts. Moreover, Dasa et al. (177) noted that patients with OA fell into two distinct
subsets based on MCP-1 concentration: greater than 4,000 pg/mL and less than 2,500
pg/mL. In their investigative study of potential inflammatory biomarkers, Perkins et al.
(244) measured TNF-, IL-1, IL-6, MCP-1, MIP-3, and M-CSF in the synovial fluid
of patients with a unexplained, painful TKA (n=12) and patients receiving revision due to
aseptic loosening (n=7). TNF- and IL-1 concentrations were below the minimum
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detection limits in both cohorts (<8.9 pg/mL and <16.3 pg/mL, respectively). The
average IL-6 concentration for the painful TKA cohort was 572 pg/mL and for the
revision TKA cohort was 476 pg/mL. The average MCP-1 concentration for the painful
TKA cohort was 4,481 pg/mL and for the revision TKA cohort was 4,726 pg/mL. The
average MIP-3 concentration for the painful TKA cohort was 355 pg/mL and for the
revision TKA cohort was 40 pg/mL. Lastly, the average M-CSF concentration for the
painful cohort was 1,559 pg/mL and for the revision TKA cohort was 1,663 pg/mL. No
statistical differences were detected (244).
To the author’s knowledge, the present study is the first to document TNF-, IL1, IL-6, MCP-1, MIP-3, and M-CSF in the synovial fluid aspirated post-mortem from
specimens with well-functioning primary TKAs. Ten specimens (31%, n=10/32) had
TNF- concentrations below the minimum detection limit (8.9 pg/mL). The remaining
69% (n=22/32) specimens had a median TNF- concentration of 12.9 pg/mL which is
much lower than the concentration reported for the RA cohort (157 pg/mL) in the study
by Steiner et al. (246) as well as the concentration reported for the revision cohort (208
pg/mL) in the study by Dasa et al. (177). Whereas the previous studies reported IL-1
concentrations ranging from 0.00 pg/mL (248) to 24 pg/mL (247) in OA, RA, and
necropsy control patients, the present study found a median IL-1 concentration of 73.2
pg/mL with 85% (n=28/32) of the specimens having concentrations above the minimum
detection limit (16.3 pg/mL). TNF- and IL-1 have both been well established as
mediators in osteolysis through modulation of the RANK/RANKL/OPG axis. These
findings demonstrate near-basal levels present in the well-functioning necropsy
specimens. This is expected, however, because the patients included in the present study
were well-functioning as dictated by no evidence of radiolucencies on the fluoroscopes
taken at retrieval. An additional factor that may modulate the activity of the cytokines is
the fact that their presence is likely transient in the inflammatory process. Wear debris is
generated, macrophages are stimulated, cytokines are released, macrophages and other
immune cells travel to the site of aggravation, and eventually, anti-inflammatory,
homeostatic mechanisms begin, restoring the equilibrium. Some of the specimens in this
study may have been collected when they were in the aggravation time-point whereas
others may have been collected when they were in the anti-inflammatory, homeostatic
time-point.
IL-6, in particular, has been implicated in modulating the response to periprosthetic infections in joint arthroplasties (250-252). However, IL-6 is also regarded as a
pleiotropic cytokine whose duty is to “ramp” up the inflammatory response whether it be
in the pro- or anti-inflammatory direction (253). Six specimens had IL-6 concentrations
above the maximum detection limit (1180 pg/mL). The median IL-6 concentration
reported fell between the IL-6 concentrations reported in the post-mortem control cohort
and the OA cohort of the study by Beekhuizen et al. (248). The concentrations fell into
two subsets: those greater than 400 pg/mL and those less than 400 pg/mL. This follows
what was reported by Mabey et al. and Perkins et al. in which the OA, painful, and
revision cohorts averaged around 400 pg/mL (244). IL-6 concentrations exceeding 400
pg/mL may be indicative of the inflammatory process “ramping” up. With respect to
MCP-1, all but one specimen had concentrations above the minimum detection limit (98
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pg/mL). Furthermore, 8 specimens had MCP-1 concentrations over the maximum
detection limit (7940 pg/ml). Similar to what was found in the study by Dasa et al. (177),
the MCP-1 concentrations for these specimens seem to fall into two separate subsets:
those greater than 4000 pg/mL and those less than 4000 pg/mL. More specifically, all of
the specimens with MCP-1 levels greater than 4000 pg/mL surpassed the detection limit
of the assay platform (>7940 pg/mL). This may indicate a certain stimulus threshold
exists at which macrophages will increase the production of MCP-1.
MIP-3 is a chemokine that is strongly chemotactic for lymphocytes and has been
implicated in modulating the adaptive immune system (254) Additionally, MIP-3 is
chemotactic for leukocytes to joints afflicted by RA (249). As such, it follows logically
that the MIP-3 levels reported in the present study would align with those reported in
literature for OA , painful, or revision patients, while the MIP-3 concentrations in
patients with RA would be elevated (244, 249). Recent research indicates that GM-CSF
polarizes M0 macrophages into M1 (pro-inflammatory) phenotype whereas M-CSF
polarizes M0 macrophages into M2 (healing) phenotype (255). None of the specimens of
each sample group had GM-CSF concentrations above the minimum detection limit.
These results are in accordance with previous studies that demonstrated negligible levels
of GM-CSF in loosened THA and fixed THA (256, 257). On the other hand, all of the
specimens had M-CSF concentrations that were within range. The present study found
noticeably elevated levels of M-CSF in the synovial fluid of cadaveric primary TKAs
compared to the painful and revision synovial fluid reported in Perkins et al. (244). Each
cadaveric sample had M-CSF concentrations that were an order of magnitude greater than
those observed in the living patients. While previous studies found elevated levels of MCSF in aseptically loosened THAs compared to well-fixed THAs, this present study does
not support this notion with respect to TKAs (258, 259). Future research may investigate
the roles of GM-CSF and M-CSF concentrations as indicators as to whether the body is
entering a cyclic inflammatory cascade, which may precede failure, or if the body is
simply going through the normal inflammation-healing sequence.
Certain limitations of cytokine and inflammatory marker measurements in clinical
research must be acknowledged. Many cytokines have a short half-life in vivo and are
also subject to rapid degradation in vitro following sample collection if appropriate
storage and handling procedures are not followed (260-263). While literature has not
elucidated the effect of processing and storage on the degradation of cytokines in
synovial fluid, several reports on serum and plasma have indicated that most cytokines
are prone to degradation if samples are not processed correctly and stored at -70C (264266). Furthermore, the amount of freeze-thaw cycles has been demonstrated to effect
cytokine measurements. Thavasu et al. (266) found that most cytokines are stable for up
to three freeze-thaw cycles. However, Flower et al. (267) found that TNF- concentration
increased with each successive free-thaw cycle, becoming significant after three cycles.
Time of day of sample collection has also been demonstrated to impact reported levels of
circulating cytokines (262, 268-270). While every effort was taken to mitigate the
aforementioned limitations, measured cytokine levels in the synovial fluid of this study
cohort may not entirely reflect the presence or activity of those cytokines in vivo.
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Joint Laxity
Suboptimal soft tissue and gap balancing, which dictate the laxity of the joint,
may be implicated in the etiology of some of the most common indications for revision—
loosening, excessive wear, instability, and malalignment (116-122). The IE, VV, and AP
laxity were measured using a platform that has been previously studied and utilized in
previously published biomechanical studies of TKA kinematics (114, 184-193). Of the
studies cited, only four provided data points that were used for comparison to the present
study (184, 187-189). Contrary to the present study, Jojima et al. (188) evaluated the IE
laxity at  5 Nm, VV laxity at  15 Nm, and AP laxity at  70 N. Similarly Kanamiya et
al. (189) applied a  10 Nm torque to evaluate rotational laxity, as shown in Figures 4-1
through 4-3. While there were great variations in IE and VV laxity, across the flexion
angles between each of the studies, the current study follows the trend of increasing IE
and VV laxity throughout the flexion angles. Furthermore, the current study PS implants
had maximum AP laxity at 30, which is in accordance with the PS implants evaluated by
Saeki et al. (187). The trend of CR implant laxity reported in the current study closely
mimics that which was reported by Jojima et al. (188) in their evaluation of CR implant
designs although their AP laxity was measured at  70 N. Although similar trends were
observed, there is a significant difference between the cited studies and the present study
which likely affects the kinematics of the specimens. The specimens used by Saeki et al.
(187), Kanamiya et al. (189), and Jojima et al. (188) were five fresh-frozen knee
specimens who received total knee arthroplasty post-mortem. As such, the incisions and
trauma sustained during TKA were not healed. Additionally, the cited studies all used the
Profix total knee system (Smith & Nephew Inc, Memphis, TN). The current study
included several different implant designs from various manufacturers. Because knee
kinematics is affected by the implant design (72, 271), this variation must be considered
in the comparisons. A previous graduate student in Dr. Mihalko’s laboratory, Erik
Woodard (184), evaluated IE, VV, and AP laxity using the same simulator and at the
same IE and VV torque and AP force poles as the present study. However, his cohort
included both CR and PS implant designs. As such, the comparison between his study
and the present study is presented in Figures 4-4 through 4-6, in which the PS and CR
designs were included together. Again, the IE, VV, and AP laxity reported for both the
current study and the study by Woodard (184) follow the similar trends. Similar to the
present study, Woodard (184) included a variety of implant designs from several
manufacturers.
Correlation of Study Parameters
Hypothesis (a)—Laxity and Tissue Metal Concentrations
Excessive ligamentous laxity has been reported to increase AP translation and IE
rotation which leads to force concentrations that are outside of the intended design
parameters of the TKA components. More specifically, researchers found that these force
concentrations exceeded the material properties of the tibial insert facilitating increased
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Figure 4-1. IE rotational laxity comparison between the present study and Saeki
et al., Kanamiya et al., and Jojima et al.
Sources:
Jojima H, Whiteside LA, Ogata K. Effect of tibial slope or posterior cruciate ligament
release on knee kinematics. Clinical orthopaedics and related research. 2004;426:194-8.
Kanamiya T, Whiteside LA, Nakamura T, Mihalko WM, Steiger J, Naito M. Effect of
Selective Lateral Ligament Release on Stability in Knee Arthroplasty. Clin Orthop Relat
Res. 2002;404:24-31.
Saeki K, Mihalko WM, Patel V, Conway J, Naito M, Thrum H, et al. Stability after
medial collateral ligament release in total knee arthroplasty. Clinical orthopaedics and
related research. 2001;392:184-9.
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Figure 4-2. VV laxity comparison between the present study and Saeki et al. and
Jojima et al.
Sources:
Jojima H, Whiteside LA, Ogata K. Effect of tibial slope or posterior cruciate ligament
release on knee kinematics. Clinical orthopaedics and related research. 2004;426:194-8.
Saeki K, Mihalko WM, Patel V, Conway J, Naito M, Thrum H, et al. Stability after
medial collateral ligament release in total knee arthroplasty. Clinical orthopaedics and
related research. 2001;392:184-9.
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Figure 4-3. Comparison of measured AP laxity between current study, Saeki et al.
and Jojima et al.
Sources:
Jojima H, Whiteside LA, Ogata K. Effect of tibial slope or posterior cruciate ligament
release on knee kinematics. Clinical orthopaedics and related research. 2004;426:194-8.
Saeki K, Mihalko WM, Patel V, Conway J, Naito M, Thrum H, et al. Stability after
medial collateral ligament release in total knee arthroplasty. Clinical orthopaedics and
related research. 2001;392:184-9.
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Figure 4-4.

Comparison of IE laxity between current study and Woodard

Source: Woodard EL. Total knee arthroplasty wear is caused by malrotation and
excessive laxity [Theses and Dissertations (ETD)]. Memphis, TN: University of
Tennessee Health Science Center; 2014.
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Figure 4-5.

Comparison of VV laxity between current study and Woodard

Source: Woodard EL. Total knee arthroplasty wear is caused by malrotation and
excessive laxity [Theses and Dissertations (ETD)]. Memphis, TN: University of
Tennessee Health Science Center; 2014.
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Figure 4-6.

Comparison of AP laxity between current study and Woodard

Source: Woodard EL. Total knee arthroplasty wear is caused by malrotation and
excessive laxity [Theses and Dissertations (ETD)]. Memphis, TN: University of
Tennessee Health Science Center; 2014.
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UHMWPE wear (78, 123-126). However, there is a paucity of literature evaluating the
relationship between joint laxity and metallic wear debris production following TKA. It
was hypothesized that decreased joint laxity would increase metal concentrations in the
periprosthetic tissue.
In the present study, decreased IE rotation at full extension was strongly
correlated with increased Co concentrations in the periprosthetic tissues. When taking a
closer look at the correlation, constrained external rotation specifically induced elevated
concentrations of Co. While not statistically significant, a similar trend was observed
between IE laxity at full extension and Cr. The PCL and the posterolateral corner work
synergistically to control external rotation whereas the ACL is the primary stabilizer to
internal rotation. In a normal flexion/extension cycle, the tibia externally rotates 5 in the
last 15 of extension in the “screw home” mechanism. With the application of 1.5 Nm
torque, this study observed that the primary TKA specimens were able to achieve a
median external rotation of 10.18. However, when comparing the external rotation to the
Co and Cr concentrations observed, decreased external rotation in full extension was
associated with elevated Co and Cr concentrations. The decreased ability of the knee to
externally rotate may have increased the contact pressures on the bearing surface
facilitating abrasive wear of the CoCrMo bearing surface. Elevated concentrations of Co
indicate that wear may be dominant within the cobalt rich matrix of the CoCrMo alloy.
This agrees with observations reported by Kretzer et al. (232) in their in vitro analysis of
metal release kinetics in TKA using a wear simulator.
Statistical significance was not detected in correlations between VV laxity and
Co, Cr, or Ti debris. However, at full extension and 30 of flexion, the relationship
between VV laxity and Ti debris in the periprosthetic tissues displayed an inverse trend.
All but two implants had femoral components fabricated from CoCrMo alloy. The
implant with TiAlV femoral component was excluded from the statistical analysis due to
extremely elevated Ti concentrations. As such, the only material that could contribute to
the generation of Ti debris is the baseplate. In this comparison, 6 of the 9 PS implant
systems had CoCrMo femoral components with TiAlV tibial baseplates, while the
remaining 3 had CoCrMo baseplates. Furthermore, 3 of 5 CR implant systems had
CoCrMo tibial baseplates, while the remaining 2 were an all-UHMWPE monoblock
component and TiAlV baseplate. When analyzing Figures B-11A and B-11B, the
posterior-stabilized implants seem to be the major contributing factor to this trend. The
primary stabilizers to VV deflection is the MCL and LCL. Additionally, the secondary
function of the cruciate ligaments is to resist VV motion at full extension. When the ACL
and PCL are sacrificed, as in patients receiving a PS design, the post also must resist this
motion. In response to VV stresses, articulation of post with the medial and lateral sides
of the femoral component between the bearing surfaces may increase loads in the
transverse plane. This may inadvertently cause micromotion between the inferior surface
of the tibial insert and the superior surface of the tibial baseplate, facilitating the release
of Ti.
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Because the study population included both PS and CR implant designs, anterior
translation and posterior translation were compared separately with tissue metal across
the flexion angles. Across each flexion angle, the relationship between anterior
translation and Co debris strongly trended towards an inverse correlation, as shown in
Figures B-13 and B-14. Statistical analysis highlighted significance between decreased
anterior laxity at 90 and increased Co debris. Similarly, statistical significance was
revealed between decreased anterior laxity at 60 and 90 of flexion and increased Cr
concentrations in the periprosthetic tissues. Most implant designs require the sacrifice of
the ACL, creating an inherent deficiency in resisting anterior translation. To compensate
for ACL deficiency, many designs have a more dished surface on condylar surface of the
tibial insert. Decreased anterior translation, particularly at 60 and 90 of flexion, may
increase wear of the femoral component causing the release of Cr-rich carbides which
then abrade the Co-rich matrix of the CoCrMo alloy, elevating the release of Co.
Interestingly, a strong trend of inverse correlations between posterior laxity across the
measured flexion angles and Cr concentrations was observed. Statistical analysis
highlighted a significant relationship between decreased posterior laxity at 90 of flexion
and increased Cr concentrations in the periprosthetic tissues. When looking at the
graphical representation of the correlation at 90 of flexion in Figure B-20B, both the CR
and PS designs seem to follow the negative trend. In a cruciate-retaining TKA, the
primary stabilizer to posterior displacement, especially at 90 of flexion, is the PCL.
However, in a cruciate-sacrificing design, the post engages the cam at 90 of flexion,
preventing posterior translation. Regardless if the implant is a cruciate-retaining or
cruciate-sacrificing design, these results suggest that decreased posterior translation may
induce increased release of Cr debris.
Hypothesis (b)—Laxity and Inflammatory Cytokines
As previously stated, suboptimal soft tissue laxity has been demonstrated to
influence the degree of polyethylene wear, such that excessive AP and IE laxity induced
elevated rates of polyethylene wear due to the contact forces that exceed the design
parameters of the insert (78, 123-126). Historically, wear-induced osteolysis and aseptic
loosening was attributed to excessive polyethylene wear. In 2002, Sharkey et al. (272)
reported polyethylene wear was the most common cause of failure in TKA, accounting
for almost 25% of all revisions. Recently, however, the manufacturing of polyethylene
has improved, with particular attention paid to the sterilization and packaging techniques.
It was found that during shelf storage, UHMWPE inserts that were gamma sterilized in
air-permeable packaging could undergo oxidative degradation, resulting in an increase in
density and crystallinity; more importantly, the oxidative degradation led to a loss of
mechanical properties associated with progressive embrittlement (213, 215, 273, 274). As
such, air-permeable packaging was replaced by barrier packaging with a low oxygen
environment starting during the mid 1990s (204). In 2014, Sharkey et al. (275) repeated a
systematic retrospective review of all revisions performed at their institution to see if the
reasons for revision have changed in the past 10 years. They found that polyethylene
wear was no longer a major cause for failure while aseptic loosening accounted for 40%
of all revisions at their institution (275). The reduction in polyethylene wear-related
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failures is likely due to changes in sterilization and storage techniques and improved
locking mechanisms. Because aseptic loosening still persists despite improvements in
articulating materials and increased laxity has been reported to elevate polyethylene wear,
it was hypothesized that a direct correlation would be observed between increased laxity
and elevated inflammatory cytokines.
An inverse correlation was observed between IE rotational laxity at 60 of flexion
and IL-1 concentrations in Figure C-4A. IL-1 is a cytokine that has been well
established as a mediator of osteolysis (170). Furthermore, macrophages have been
shown to release IL-1 in response to UHMWPE debris (166, 276). If increased IE laxity
induces UHMWPE wear, then it would follow that increased laxity would also induce
elevation of inflammatory cytokine concentrations. As such, the inverse correlation was
unexpected. Further statistical analysis determined that this trend was strongly influenced
by the CR implants and the trend did not persist with the removal of implant
RLU0722161B-L, an all-polyethylene monoblock design, that had extremely restricted
IE rotation at 60 of flexion and the highest IL-1 concentration of 962 pg/mL. This data
point likely was pulling the trend for inverse correlation.
To date, no studies have demonstrated the relationship between degree of laxity in
the coronal plane and wear of the TKA components. This study found that, at 60 of
flexion, VV laxity was inversely correlated with TNF- concentrations as shown in
Figure C-14A. However, it must be noted that levels of TNF- were barely above the
minimum detection limit; as such, this correlation was likely clinically insignificant.
Additionally, VV laxity was inversely correlated with IL-1 concentrations at 60 of
flexion as shown in Figure C-16A. Again, the specimen RLU0722161B-L had extremely
restricted VV rotation at 60 of flexion and the highest IL-1 concentration of 962
pg/mL. This data point likely was pulling the trend for inverse correlation. At full
extension, VV laxity was inversely correlated with IL-6 concentrations. This correlation
seems to be due to specimens RLU0317172B-R and RLU1121161A-L which had IL-6
concentrations above the maximum detection limit (>1180 pg/mL) and very constrained
VV deflection at full extension. These two data points seem to be pulling the trend for
this inverse correlation. In conclusion, none of the correlations reported between VV
laxity and inflammatory cytokine concentrations likely have any clinical implications.
Anterior laxity was directly correlated with IL-6 and MCP-1 concentrations at 90
of flexion, shown in Figures C-34B and C-38B, respectively. Additionally, posterior
laxity was directly correlated with IL-6 at 30 and 90 of flexion as shown in Figures C35B and C-36B, respectively, although statistical significance was not detected. Both IL6 and MCP-1 have been implicated in the response to UHMWPE debris (166, 177).
Kaufman et al. (166) posited that IL-6 and MCP-1 may function cooperatively at the
periimplant tissue; MCP-1 actively recruits macrophages to the site of inflammation
while IL-6 potently enhances the recruitment of osteoclast precursors and promotes
osteoclastogenesis (172, 253, 277). These findings suggest that increased AP translation
may increase the production of UHMWPE debris which incites an inflammatory response
and the subsequent release of IL-6 and MCP-1.
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Hypothesis (c)—Tissue Metal Concentrations and Inflammatory Cytokines
The in vivo biological response to wear debris is complex, involving a range of
cell types, including fibroblasts, osteoclast precursor cells, and monocytes/macrophages,
that may release a variety of inflammatory mediators including, cytokines, chemokines,
prostanoids, reactive oxygen species, and MMPs, into the synovial fluid and
periprosthetic tissues. To the author’s knowledge, this is the first study to measure the
concentrations of a various inflammatory mediators in the synovial fluid of patients with
well-functioning primary TKA at autopsy. Furthermore, this is the first study to examine
the relationships of in vivo tissue metal concentrations and the levels of these
inflammatory mediators. Several in vitro studies have demonstrated that macrophages
will increase their release or expression of the cytokines included in this study when
challenged with Ti or CoCr wear particles (150, 166, 176, 276, 278-280). Also, each of
these cytokines or chemokines have been demonstrated in retrieved at revision in tissues
or synovial fluid from patients with aseptically loosened primary total hip and total knee
implants (177, 181, 203, 244, 257, 258, 281). As such, it was hypothesized that a direct
correlation would be observed between the inflammatory cytokines and tissue metal
concentrations.
No significant correlations were found between Co concentrations and
inflammatory cytokines. The periprosthetic tissue Cr concentrations displayed a trend of
inverse correlation with IL-1, IL-6, MCP-1, and MIP-3 concentrations in the synovial
fluid, although significance was only detected for IL-6 and MIP-3. Similarly, Ti was
trending towards an inverse correlation with IL-1 and MIP-3, although statistical
significance was not detected. These results may be interpreted in many ways. The
inverse trend suggests that the cytokines measured may not be particularly sensitive to
metallic debris. However, when investigating the human macrophage response to
UHMWPE, TiAlV, CoCrMo, and alumina particles in vitro, Kaufman et al. (166)
reported that TiAlV debris consistently elicited the release of the cytokines of interest and
was the second most stimulatory species behind the positive control, lipopolysaccharide
(LPS). After TiAlV challenge, TNF- (895-fold), IL-1 (46-fold), IL-6 (20-fold), IL-8
(5-fold), and MCP-1 (19-fold) release was increased at a statistically significant level
when compared to the nonstimulated macrophages that served as a negative control
(166). They found that the CoCr particles were less inflammatory than the Ti particles
and only marginally more inflammatory than the UHMWPE particles. The CoCrMo
particulates only elicited significant increases in TNF-, IL-6, and IL-8 release when
compared to the nonstimulated cells; however, the fold-increase was 17-fold, 2.3-fold,
and 2.3-fold, which is vastly lower than the fold-increase reported for TiAlV challenge
(166). This study demonstrates that each of these cytokines are released by macrophages
when challenged with Ti particles and CoCr particles although to varying degrees. Thus,
it is unlikely that the Ti, Co, and Cr particles present in the tissues of the present study’s
cohort did not stimulate an inflammatory response. Instead, some of the patients in the
present study may not have been in an actively “stimulated” inflammatory state. The
cycle of inflammation is transient and the levels of inflammatory cytokines will rise and
fall as the cycle transitions from a pro-inflammatory to anti-inflammatory state. The

88

cytokine release observed by Kaufman et al. (166) was measured within a 24 hour time
period when the macrophages were likely at their “stimulated” inflammatory peak state.
Wang et al. (282) investigated how Ti, Cr, and Co ions modulate the release of boneassociated cytokines by human monocytes/macrophages in vivo. Similar to Kaufman et
al. (166), Wang and colleagues (282) demonstrated that Ti, Cr, and Co modulate cytokine
release, specifically TNF-, IL-1 and IL-6, in LPS-stimulated cells. However, they
reported that cytokine production was not affected by the metals in the absence of LPS.
This finding highlights the fact that often the inflammatory process is like a light switch:
it is either “on” or “off”. The correlations observed in the present study may have been
induced by prior stimulation by other types of wear debris in the periarticular
environment.
Limitations
While some meaningful relationships were observed in this study, there were
several limitations that must be noted. Firstly, this study had a relatively small sample
size. Furthermore, not every specimen underwent each of the analyses or tests. As such,
some important correlations may have not been recognized in statistical analysis or the
power of the observations may not be clinically significant. Secondly, the cohort included
a wide range of implants including cruciate-retaining, posterior-stabilized, fixed bearing,
mobile bearing, monoblock, and modular designs. Each of these design variations have
been shown to affect the kinematics of the knee joint. As such, it is difficult to determine
how the design may have affected the measured laxity of the joint or the degree of wear
debris generated. Furthermore, one of the specimens included was produced in the late
1980s or early 1990s by a manufacturer that no longer exists. Additionally, the implants
included were fabricated with different materials. However, every effort was made to
take into account these variations and discuss how the different designs may have
impacted the results of the study. Thirdly, because the Hood et al. (195) method for wear
analysis is essentially qualitative, it was impossible to take into account how the degree
of polyethylene debris produced from the tibial insert may have altered the cytokine
measurements or even the laxity. Again, every effort was made to note instances of
excessive wear when meaningful relationships were observed. Fourthly, many variables
were uncontrollable in the collection of the synovial fluid and measurement of
inflammatory cytokines. These limitations were previously discussed and every effort
was taken to mitigate them. Lastly, the state of the measured metal debris (e.g. large
metal particulate or metal oxide) could not be elucidated with the current methods
represented in this study. The ICP-MS analysis technique ionizes all metal present and
reports a final concentration; it does not differentiate between larger particles or ions.
Future Research
Dr. Mihalko’s laboratory has obtained institution review board approval and has
begun to collect revision devices. Currently, the sample size is small, but is anticipated to
expand in the upcoming months. Once a sufficient sample size is achieved, the graduate
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student researchers at University of Tennessee Health Science Center and Drexel
University will begin assessing the wear and damage of these devices. Furthermore, a
cytokine analysis will be performed to measure the levels of inflammatory cytokines and
ICP-MS analysis will be conducted to measure the concentrations of metal debris in the
collected tissues. Future comparisons between the two cohorts will hopefully elucidate
what factors are instrumental in mediating negative outcomes so that one day a treatment
modality, alternate bearing surface, or improved surgical technique may be developed to
improve patient outcomes following total knee arthroplasty.
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APPENDIX A. FLUOROSCOPIC ANALYSIS OF POST MORTEM RETRIEVED
IMPLANTS

Figure A-1.

Fluoroscopic A) AP and B) lateral views of specimen DRLU051714-L

Figure A-2.

Fluoroscopic A) AP and B) lateral views of specimen DRLU081315-R
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Figure A-3. A) Medial and B) lateral views of specimen DRLU081315-R on a
fluoroscopy-guided radiograph

Figure A-4.

Fluoroscopic A) AP and B) lateral views of specimen DRLU121515-R
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Figure A-5.

Fluoroscopic A) AP and B) lateral views of specimen DRLU010416-R

Figure A-6.

Fluoroscopic A) AP and B) lateral views of specimen DRLU112815-R
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Figure A-7.

Fluoroscopic A) AP and B) lateral views of specimen DRLU101615-R

Figure A-8.

Fluoroscopic views of specimen RLU1016151A-L
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Figure A-9. Fluoroscopic A) oblique posterior condylar and B) lateral views of
specimen 2013-678L

Figure A-10. Fluoroscopic A) AP and B) lateral views of specimen RLU0510162AR
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Figure A-11. Fluoroscopic A) AP and B) lateral views of specimen RLU0728161A-L

Figure A-12. Fluoroscopic A) AP and B) lateral views of specimen RLU0309161B-L
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Figure A-13. Fluoroscopic A) AP and B) lateral views of specimen RLU0722161B-L

Figure A-14. Fluoroscopic A) AP and B) lateral views of specimen RLU0126161C-L
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Figure A-15. Fluoroscopic A) AP and B) lateral views of specimen RLU0510161A-L

Figure A-16. Fluoroscopic A) AP and B) lateral views of specimen RLU0426161B-L
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Figure A-17. Fluoroscopic A) AP and B) lateral views of specimen RLU0126162CR

Figure A-18. Fluoroscopic A) AP and B) lateral views of specimen RLU0720161B-L
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Figure A-19. Fluoroscopic A) AP and B) lateral views of specimen RLU1028161B-L

Figure A-20. Fluoroscopic A) AP and B) lateral views of specimen RLU1115162B-R
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Figure A-21. Fluoroscopic A) AP and B) lateral views of specimen RLU0913162AR

Figure A-22. Fluoroscopic A) AP and B) lateral views of specimen RLU0426162B-R
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Figure A-23. Fluoroscopic A) AP and B) lateral views of specimen RLU0829162CR

Figure A-24. Fluoroscopic A) AP and B) lateral views of specimen 16-04-765R

120

Figure A-25. Fluoroscopic A) AP and B) lateral views of specimen 16-10-1103R

Figure A-26. Fluoroscopic A) AP and B) lateral views of specimen 16-10-1103L
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Figure A-27. Fluoroscopic A) AP and B) lateral views of specimen RLU0204172AR

Figure A-28. Fluoroscopic A) AP and B) lateral views of specimen RLU0317172B-R
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Figure A-29. Fluoroscopic A) AP and B) lateral views of specimen RLU0319171A-L

Figure A-30. Fluoroscopic A) AP and B) lateral views of specimen RLU1121161A-L
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Figure A-31. Fluoroscopic A) AP and B) lateral views of specimen RLU1121162AR

Figure A-32. Fluoroscopic A) AP and B) lateral views of specimen RLU1125161A-L
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Figure A-33. Fluoroscopic A) AP and B) lateral views of specimen RLU1125162AR
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APPENDIX B. CORRELATIONS BETWEEN LAXITY AND TISSUE METAL
CONCENTRATIONS

Figure B-1. Relationship between IE rotational laxity at (A) 0 and (B) 30 of
flexion and Co concentrations in periprosthetic tissue
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Figure B-2. Relationship between IE rotational laxity at (A) 60 and (B) 90 of
flexion and Co concentrations in periprosthetic tissue

E
Figure B-3. Relationship between IE rotational laxity at (A) 0 and (B) 30 of
flexion and Cr concentrations in periprosthetic tissue
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Figure B-4. Relationship between IE rotational laxity at (A) 60 and (B) 90 of
flexion and Cr concentrations in periprosthetic tissue

Figure B-5. Relationship between IE rotational laxity at (A) 0and (B) 30 of
flexion and Ti concentrations in periprosthetic tissue
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Figure B-6. Relationship between IE rotational laxity at (A) 60 and (B) 90 of
flexion and Ti concentration in periprosthetic tissue

Figure B-7. Relationship between VV laxity at (A) 0 and (B) 30 of flexion and Co
concentrations in periprosthetic tissue
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Figure B-8. Relationship between VV laxity at (A) 60 and (B) 90 of flexion and
Co concentrations in periprosthetic tissue

Figure B-9. Relationship between VV laxity at (A) 0 and (B) 30 of flexion and Cr
concentrations in periprosthetic tissue
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Figure B-10. Relationship between VV laxity at (A) 60 and (B) 90 of flexion and
Cr concentrations in periprosthetic tissue

Figure B-11. Relationship between VV laxity at (A) 0 and (B) 30 of flexion and Ti
concentrations in periprosthetic tissue
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Figure B-12. Relationship between VV laxity at (A) 60 and (B) 90 of flexion and
Ti concentrations in periprosthetic tissue

Figure B-13. Relationship between anterior displacement at (A) 0 and (B) 30 of
flexion and Co concentrations in periprosthetic tissue
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Figure B-14. Relationship between anterior displacement at (A) 60 and (B) 90 of
flexion and Co concentrations in periprosthetic tissue

Figure B-15. Relationship between posterior displacement at (A) 0 and (B) 30 of
flexion and Co concentrations in periprosthetic tissue
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Figure B-16. Relationship between posterior displacement at (A) 60 and (B) 90 of
flexion and Co concentrations in periprosthetic tissue

Figure B-17. Relationship between anterior displacement at (A) 0 and (B) 30 of
flexion and Cr concentrations in periprosthetic tissue
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Figure B-18. Relationship between anterior displacement at (A) 60 and (B) 90 of
flexion and Cr concentrations in periprosthetic tissue

Figure B-19. Relationship between posterior displacement at (A) 0 and (B) 30 of
flexion and Cr concentrations in periprosthetic tissue
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Figure B-20. Relationship between posterior displacement at (A) 60 and (B) 90 of
flexion and Cr concentrations in periprosthetic tissue

Figure B-21. Relationship between anterior displacement at (A) 0 and (B) 30 of
flexion and Ti concentrations in periprosthetic tissue
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Figure B-22. Relationship between anterior displacement at (A) 60 and (B) 90 of
flexion and Ti concentrations in periprosthetic tissue

Figure B-23. Relationship between posterior displacement at (A) 0 and (B) 30 of
flexion and Ti concentrations in periprosthetic tissue
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Figure B-24. Relationship between posterior displacement at (A) 60 and (B) 90 of
flexion and Ti concentrations in periprosthetic tissue
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APPENDIX C. CORRELATIONS BETWEEN LAXITY AND INFLAMMATORY
CYTOKINES

Figure C-1. Relationship between IE rotational laxity at (A) 0 and (B) 30 of
flexion and TNF- concentrations in synovial fluid
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Figure C-2. Relationship between IE rotational laxity at (A) 60 and (B) 90 of
flexion and TNF- concentrations in synovial fluid

Figure C-3. Relationship between IE rotational laxity at (A) 0 and (B) 30 of
flexion and IL-1 concentrations in synovial fluid
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Figure C-4. Relationship between IE rotational laxity at (A) 60 and (B) 90 of
flexion and IL-1 concentrations in synovial fluid

Figure C-5. Relationship between IE rotational laxity at (A) 0 and (B) 30 of
flexion and IL-6 concentrations in synovial fluid
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Figure C-6. Relationship between IE rotational laxity at (A) 60 and (B) 90 of
flexion and IL-6 concentrations in synovial fluid

Figure C-7. Relationship between IE rotational laxity at (A) 0 and (B) 30 of
flexion and MCP-1 concentrations in synovial fluid
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Figure C-8. Relationship between IE rotational laxity at (A) 60 and (B) 90 of
flexion and MCP-1 concentrations in synovial fluid

Figure C-9. Relationship between IE rotational laxity at (A) 0 and (B) 30 of
flexion and MIP-3 concentrations in synovial fluid
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Figure C-10. Relationship between IE rotational laxity at (A) 60 and (B) 90 of
flexion and MIP-3 concentrations in synovial fluid

Figure C-11. Relationship between IE rotational laxity at (A) 0 and (B) 30 of
flexion and M-CSF concentrations in synovial fluid
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Figure C-12. Relationship between IE rotational laxity at (A) 60 and (B) 90 of
flexion and M-CSF concentrations in synovial fluid

Figure C-13. Relationship between VV laxity at (A) 0 and (B) 30 of flexion and
TNF- concentrations in synovial fluid
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Figure C-14. Relationship between VV laxity at (A) 60 and (B) 90 of flexion and
TNF- concentrations in synovial fluid

Figure C-15. Relationship between VV laxity at (A) 0 and (B) 30 of flexion and
IL-1 concentrations in synovial fluid
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Figure C-16. Relationship between VV laxity at (A) 60 and (B) 90 of flexion and
IL-1 concentrations in synovial fluid

Figure C-17. Relationship between VV laxity at (A) 0 and (B) 30 of flexion and
IL-6 concentrations in synovial fluid
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Figure C-18. Relationship between VV laxity at (A) 60 and (B) 90 of flexion and
IL-6 concentrations in synovial fluid

Figure C-19. Relationship between VV laxity at (A) 0 and (B) 30 of flexion and
MCP-1 concentrations in synovial fluid
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Figure C-20. Relationship between VV laxity at (A) 60 and (B) 90 of flexion and
MCP-1 concentrations in synovial fluid

Figure C-21. Relationship between VV laxity at (A) 0 and (B) 30 of flexion and
MIP-3 concentrations in synovial fluid
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Figure C-22. Relationship between VV laxity at (A) 60 and (B) 90 of flexion and
MIP-3 concentrations in synovial fluid

Figure C-23. Relationship between VV laxity at (A) 0 and (B) 30 of flexion and
M-CSF concentrations in synovial fluid
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Figure C-24. Relationship between VV laxity at (A) 60 and (B) 90 of flexion and
M-CSF concentrations in synovial fluid

Figure C-25. Relationship between anterior laxity at (A) 0 and (B) 30 of flexion
and TNF- concentrations in synovial fluid
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Figure C-26. Relationship between anterior laxity at (A) 60 and (B) 90 of flexion
and TNF- concentrations in synovial fluid

Figure C-27. Relationship between posterior laxity at (A) 0 and (B) 30 of flexion
and TNF- concentrations in synovial fluid
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Figure C-28. Relationship between posterior laxity at (A) 60 and (B) 90 of flexion
and TNF- concentrations in synovial fluid

Figure C-29. Relationship between anterior laxity at (A) 0 and (B) 30 of flexion
and IL-1 concentrations in synovial fluid
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Figure C-30. Relationship between anterior laxity at (A) 60 and (B) 90 of flexion
and IL-1 concentrations in synovial fluid

Figure C-31. Relationship between posterior laxity at (A) 0 and (B) 30 of flexion
and IL-1 concentrations in synovial fluid
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Figure C-32. Relationship between posterior laxity at (A) 60 and (B) 90 of flexion
and IL-1 concentrations in synovial fluid

Figure C-33. Relationship between anterior laxity at (A) 0 and (B) 30 of flexion
and IL-6 concentrations in synovial fluid
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Figure C-34. Relationship between anterior laxity at (A) 60 and (B) 90 of flexion
and IL-6 concentrations in synovial fluid

Figure C-35. Relationship between posterior laxity at (A) 0 and (B) 30 of flexion
and IL-6 concentrations in synovial fluid
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Figure C-36. Relationship between posterior laxity at (A) 60 and (B) 90 of flexion
and IL-6 concentrations in synovial fluid

Figure C-37. Relationship between anterior laxity at (A) 0 and (B) 30 of flexion
and MCP-1 concentrations in synovial fluid
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Figure C-38. Relationship between anterior laxity at (A) 60 and (B) 90 of flexion
and MCP-1 concentrations in synovial fluid

Figure C-39. Relationship between posterior laxity at (A) 0 and (B) 30 of flexion
and MCP-1 concentrations in synovial fluid
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Figure C-40. Relationship between posterior laxity at (A) 60 and (B) 90 of flexion
and MCP-1 concentrations in synovial fluid

Figure C-41. Relationship between anterior laxity at (A) 0 and (B) 30 of flexion
and MIP-3 concentrations in synovial fluid
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e
Figure C-42. Relationship between anterior laxity at (A) 60 and (B) 90 of flexion
and MIP-3 concentrations in synovial fluid

Figure C-43. Relationship between posterior laxity at (A) 0 and (B) 30 of flexion
and MIP-3 concentrations in synovial fluid
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Figure C-44. Relationship between posterior laxity at (A) 60 and (B) 90 of flexion
and MIP-3 concentrations in synovial fluid

Figure C-45. Relationship between anterior laxity at (A) 0 and (B) 30 of flexion
and M-CSF concentrations in synovial fluid
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Figure C-46. Relationship between anterior laxity at (A) 60 and (B) 90 of flexion
and M-CSF concentrations in synovial fluid

Figure C-47. Relationship between posterior laxity at (A) 0 and (B) 30 of flexion
and M-CSF concentrations in synovial fluid
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Figure C-48. Relationship between posterior laxity at (A) 60 and (B) 90 of flexion
and M-CSF concentrations in synovial fluid
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APPENDIX D. CORRELATIONS BETWEEN TISSUE METAL
CONCENTRATIONS AND INFLAMMATOR CYTOKINES

Figure D-1. Relationship between Co concentrations in periprosthetic tissue and
TNF- concentrations in synovial fluid

Figure D-2. Relationship between Co concentrations in periprosthetic tissue and
IL-1 concentrations in synovial fluid
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Figure D-3. Relationship between Co concentrations in periprosthetic tissue and
IL-6 concentrations in synovial fluid

Figure D-4. Relationship between Co concentrations in periprosthetic tissue and
MCP-1 concentrations in synovial fluid
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Figure D-5. Relationship between Co concentrations in periprosthetic tissue and
MIP-3 concentrations in synovial fluid

Figure D-6. Relationship between Co concentrations in periprosthetic tissue and
M-CSF concentrations in synovial fluid
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Figure D-7. Relationship between Cr concentrations in periprosthetic tissue and
TNF- concentrations in synovial fluid

Figure D-8. Relationship between Cr concentrations in periprosthetic tissue and
IL-1 concentrations in synovial fluid
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Figure D-9. Relationship between Cr concentrations in periprosthetic tissue and
IL-6 concentrations in synovial fluid

Figure D-10. Relationship between Cr concentrations in periprosthetic tissue and
MCP-1 concentrations in synovial fluid
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Figure D-11. Relationship between Cr concentrations in periprosthetic tissue and
MIP-3 concentrations in synovial fluid

Figure D-12. Relationship between Cr concentrations in periprosthetic tissue and
M-CSF concentrations in synovial fluid
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Figure D-13. Relationship between Ti concentrations in periprosthetic tissue and
TNF- concentrations in synovial fluid

Figure D-14. Relationship between Ti concentrations in periprosthetic tissue and
IL-1 concentrations in synovial fluid
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Figure D-15. Relationship between Ti concentrations in periprosthetic tissue and
IL-6 concentrations in synovial fluid

Figure D-16. Relationship between Ti concentrations in periprosthetic tissue and
MCP-1 concentrations in synovial fluid
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Figure D-17. Relationship between Cr concentrations in periprosthetic tissue and
MIP-3 concentrations in synovial fluid

Figure D-18. Relationship between Ti concentrations in periprosthetic tissue and
M-CSF concentrations in synovial fluid
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